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Introduction. Animal-adapted Staphylococcus aureus (S. aureus), including methicillin-
resistant S. aureus (MRSA) and multidrug-resistant S. aureus (MDRSA), have emerged 
as an infective agent among pigs raised on industrial hog operations (IHOs) and IHO 
workers, or those who live near IHOs. IHO workers are at an increased risk of livestock-
associated (LA-) S. aureus carriage and developing LA-S. aureus skin and soft tissue 
infections (SSTI). The population structure, transmission dynamics, relative 
pathogenicity, and immunological biomarkers of LA-S. aureus contracted by IHO 
workers and their family members remain poorly understood. Objectives. 1) Elucidate 
the population structure and transmission dynamics of LA-S. aureus clonal complex 9 
(CC9) between pigs raised on IHOs (IHO pigs) and humans in North Carolina (NC), 
USA. 2) Determine the degree to which LA-S. aureus strains contracted by IHO workers 
cause disease relative to a highly pathogenic epidemic community-associated (CA-) 
MRSA strain in a mouse model of SSTI. 3) Develop antigen-specific antibody-based oral 
fluid (OF) biomarkers and examine their associations with S. aureus nasal carriage and 
SSTI outcomes among a population of IHO workers and their household contacts. 
Methods. 1) 89 LA-S. aureus CC9 isolates were subject to bioinformatic and SNP-based 
phylogenetic analysis and genotyping analyses for antimicrobial resistance (AMR) and 
virulence factor genes. 2) Measures of pathogenicity – lesion size, innate immune host 
response, and colony forming units (CFUs) – were compared between mice infected with 
either LA-S. aureus CC9 or CC398 strains to mice infected with CA-MRSA clone 
SF8300. 3) Develop an OF multiplex S. aureus Luminex enzyme immunoassay (EIA) 
that can be employed in occupational and community settings. Associations between S. 
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aureus nasal carriage and SSTI outcomes and S. aureus antigen-specific antibody levels 
in OF were examined among IHO workers and their family. Results. 1) High-resolution 
phylogenetic and genotyping analysis of LA-S. aureus CC9 isolates revealed two distinct 
transmission clusters which contained IHO pig and human isolates with a high degree of 
phylogenetic relatedness. Transmission cluster isolates were enriched with multiple 
acquired AMR genes and a MDRSA phenotype. 2) Mice infected with CC398 LA-S. 
aureus strains developed larger lesion sizes with higher bacterial burden than mice 
infected with CA-MRSA (USA300 clone, SF8300). The LA-S. aureus infected mice had 
decreased IL-1β protein levels compared to CA-MRSA-infected mice, suggesting a 
suboptimal host response to LA-S. aureus SSTIs. 3) An OF multiplex S. aureus EIA was 
developed. OF IgG antibody levels against SCIN, ClfA, and AT were elevated among 
adults compared to children. OF IgG levels waned with aging, whereas IgA levels 
remained elevated independent of age. Anti-ClfA IgA and IgG antibody levels were 
elevated among IHO workers who carried S. aureus, multidrug-resistant S. aureus 
(MDRSA), and tetracycline-resistant S. aureus (tet[R]-S. aureus) intranasally. Anti-ClfA 
IgA levels were positively and anti-SCIN levels negatively associated with self-reported 
SSTI. Conclusions. 1) LA-S. aureus CC9 in the USA is distinct from lineages in Europe 
and Asia, and may be transmissible between IHO pigs and humans. Pig-human 
transmission isolates were associated with the MDRSA phenotype and a greater number 
of acquired AMR genes. 2) LA-S. aureus CC398 and CC9 display an equivalent or 
greater degree of pathogenicity compared to CA-MRSA USA300, SF8300, in a mouse 
model of SSTI. 3) OF antibodies against ClfA may serve as non-invasive biomarkers of 
S. aureus colonization and SSTI among IHO workers and their household contacts. 
iv 
 
Research Committee Members: 
Dr. Christopher D. Heaney,#* Associate Professor, Environmental Health and 
Engineering, Johns Hopkins Bloomberg School of Public Health  
Dr. Alan Scott,*$ Professor, Molecular Microbiology and Immunology, Johns Hopkins 
Bloomberg School of Public Health 
Dr. Lloyd Miller,* Associate Professor, Dermatology, Johns Hopkins School of Medicine 
Dr. Meghan Davis,* Assistant Professor, Environmental Health and Engineering, Johns 
Hopkins Bloomberg School of Public Health  
Dr. Fenna Sille,^ Assistant Professor, Environmental Health and Engineering, Johns 
Hopkins Bloomberg School of Public Health  
Dr. Aaron Milstone,^ Associate Professor, Infection Disease, Johns Hopkins School of 
Medicine 
Dr. Robert Gilman,^ Professor, International Health, Johns Hopkins Bloomberg School 
of Public Health 
# = PhD advisor 
$ = Final oral exam committee chair 
* = Served on final oral exam 










ABSTRACT ......................................................................................................................................... ii 
LIST OF TABLES ................................................................................................................................ vii 
LIST OF FIGURES ...............................................................................................................................ix 
INTRODUCTION ................................................................................................................................ 1 
CHAPTER 1 Livestock-associated (LA-) Staphylococcus aureus clonal complex (CC) 9: Population 
structure and evidence of transmission between pigs raised on industrial hog operations and 
humans in the United States ........................................................................................................... 7 
ABSTRACT ..................................................................................................................................... 8 
INTRODUCTION .......................................................................................................................... 10 
METHODS ................................................................................................................................... 12 
RESULTS...................................................................................................................................... 16 
DISCUSSION ................................................................................................................................ 22 
CONCLUSIONS ............................................................................................................................ 27 
SUPPLEMENTARY INFORMATION FOR CHAPTER 1 .................................................................... 35 
CHAPTER 2 Comparison of livestock-associated and community-associated Staphylococcus 
aureus pathogenicity in a mouse model of skin and soft tissue infection .................................... 45 
ABSTRACT ................................................................................................................................... 46 
INTRODUCTION .......................................................................................................................... 47 
METHODS ................................................................................................................................... 49 
RESULTS...................................................................................................................................... 55 
DISCUSSION ................................................................................................................................ 60 
CONCLUSIONS ............................................................................................................................ 63 
CHAPTER 3 Development and application of antibody-based biomarkers of Staphylococcus 
aureus exposure, colonization, and infection in oral fluid among industrial hog operation 
workers and their household contacts in North Carolina, United States ...................................... 70 
ABSTRACT ................................................................................................................................... 71 
INTRODUCTION .......................................................................................................................... 73 
METHODS ................................................................................................................................... 75 
RESULTS...................................................................................................................................... 82 
DISCUSSION ................................................................................................................................ 90 
CONCLUSIONS ............................................................................................................................ 98 
SUPPLEMENTARY INFORMATION FOR CHAPTER 3 .................................................................. 113 
CHAPTER 4 ................................................................................................................................... 122 
vi 
 
Conclusions and future directions ............................................................................................... 122 
CONCLUSIONS .......................................................................................................................... 123 
FUTURE RESEARCH ................................................................................................................... 127 
MISCELLANEOUS METHODS AND RESULTS ................................................................................. 129 
Miscellaneous Methods ........................................................................................................... 129 
Miscellaneous Results .............................................................................................................. 133 
REFERENCES ................................................................................................................................. 149 

























LIST OF TABLES 
Table 1.1. Comparison of the average number of acquired AMR genes between 
transmission cluster isolates and non-transmission cluster isolates. (29) 
Table 1.2. Antimicrobial resistance (AMR) genes and antibiotic susceptibility testing 
(AST) by putative transmission classification. (30)  
Table 1S.1. Isolate characteristics. (36) 
Table 1S.2. Epidemiological characteristics of isolates by major lineage of LA-S. aureus 
CC9. (40) 
Table 1S.3. Presence of Immune evasion cluster (IEC) and antimicrobial resistance 
(AMR) genes by major lineage of LA-S. aureus CC9. (41) 
Table 1S.4. Epidemiological characteristics of LA-S. aureus CC9 isolates by 
transmission cluster classification. (43)   
Table 3.1. Participant characteristics and S. aureus isolate characteristics. (100) 
Table 3.2. Nasal carriage of S. aureus subpopulations and OF anti-SCIN, anti-ClfA, and 
anti-AT IgA and IgG antibody levels. (101) 
Table 3.3. Modification of the association between S. aureus, MDRSA, tet[R]-S. aureus, 
and LA-S. aureus carriage and OF anti-SCIN, anti-ClfA, and anti-AT antibody levels by 
self-reported facemask use among IHO-workers. (105)  
Table 3.4. OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG antibody levels and self-
reported SSTI. (109) 
Table 3S.1. Minimum inhibitory concentration (MIC) cut-off values for antibiotic 
susceptibility testing. (114)  
Table 3S.2. Age and OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG antibody levels. 
(115)  
Table 3S.3. Nasal carriage of S. aureus and OF anti-SCIN, anti-ClfA, and anti-AT IgA 
and IgG antibody levels after exclusion of IHO-derived S. aureus subpopulations. (116) 
Table 1M.1. Quality metrics for whole genome sequencing datasets. (136)  
Table 1M.2. Table of average pairwise SNP-distances by cluster in high-resolution 
phylogeny. (140)  
Table 3M.1. Table of candidate S. aureus antigens with references. (141) 
viii 
 
Table 3M.2. Preliminary association between S. aureus nasal carriage status and oral 





























LIST OF FIGURES 
Figure 1.1. Population structure of LA-S. aureus CC9. (31)   
Figure 1.2. High-resolution phylogenetic analysis of Lineage III (LIII) LA-S. aureus 
CC9 isolates. (33)  
Figure 1S.1. Maximum likelihood phylogeny of 49 LA-S. aureus CC9 isolates from the 
NC collection and 32 LA-S. aureus CC9 isolates from the international collection with 
detailed genotyping and epidemiological data. (44)    
Figure 2.1. Hemolytic activity and antibiotic susceptibilities of LA-S. aureus and CA-
MRSA. (65)  
Figure 2.2. LA-S. aureus-infected mice develop larger lesion sizes compared to CA-
MRSA. (66)   
Figure 2.3. Ex vivo colony forming units (CFU) in LA-S. aureus and CA-MRSA infected 
skin. (67)  
Figure 2.4. Cytokine, chemokine and growth factor protein levels in LA-S. aureus and 
CA-MRSA infected skin. (68)  
Figure 2.5. Virulence factor and AMR genes in LA-S. aureus and CA-MRSA. (69) 
Figure 3.1. Age and OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG antibody levels. 
(110) 
Figure 3S.1. Scatter plot of age vs. OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG 
antibody levels with lowess curves. (120) 
Figure 2M.1. Growth curves for SF8300, NCHW8, IHW398-1, IHW398-2, and NCHW9 
S. aureus isolates. (143) 
Figure 3M.1. Coupling confirmation for S. aureus antigen xMap™ beads using pre- and 
post- infection mouse serum. (144) 
Figure 3M.2. Correlation between OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG 







Staphylococcus aureus is a leading cause of human bacterial infections in the 
United States (USAUSA), and can cause both superficial and invasive infections, 
including sepsis, bacteremia, abscesses, pneumonia, osteomyelitis, endocarditis, and 
meningitis.1 This pathogen is also a common human commensal organism carried 
asymptomatically in the nares of ~30% of the human population,2 which is noteworthy 
because nasal carriage of S. aureus is associated with S. aureus infection3. The 
emergence of methicillin-resistant S. aureus (MRSA) has made treatment of these 
infections difficult, and increasing resistance to multiple antibiotics, giving rise to 
multidrug-resistant S. aureus (MDRSA), has further complicated this situation.3,4 In the 
United States, invasive infection with MRSA is associated with an in-hospital case 
fatality rate of 13%.5 While the Center for Disease Control and Prevention (CDC) reports 
a decrease in hospital-associated (HA) MRSA infections in the USA since 2009, largely 
due to the successful uptake of hospital infection control measures,5 community-
associated MRSA (CA-MRSA) and methicillin-susceptible S. aureus (CA-MSSA) 
infections have only marginally decreased or remained steady since 2009.5,6 In contrast to 
HA-S. aureus infections that occur among individuals with predisposed hospitalization 
risk factors or co-morbidities, CA-S. aureus occurs independent of exposure to the 
hospital environment among otherwise healthy individuals.7 CA-S. aureus is now a 
health problem in nearly all industrialized countries, and is prevalent and widespread as 
both an asymptomatic human colonizer and symptomatic pathogen.8 In particular, skin 
and soft tissue infections (SSTI) represent a majority of CA-MRSA infection cases,3 and 
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it has been estimated that up to 50% of SSTI’s in the USA are attributable to CA-
MRSA.8 Thus, the reservoirs and drivers of antimicrobial resistant S. aureus outside of 
the hospital setting, and the dissemination of these pathogens into human communities, 
represent a major and urgent public health concern. 
In the past decade it has become evident that animal-adapted S. aureus, including 
MRSA and MDRSA, have emerged among pigs raised on industrial hog operations 
(IHOs) and among humans who have frequent contact with, or live in close proximity to 
IHOs both globally and in the USA.9–11 Price et al. provided a framework for the 
bidirectional transmission of livestock-associated (LA-) S. aureus between pigs and 
humans: antibiotic-susceptible LA-S. aureus of human origin may be contracted by IHO 
pigs, where the use of antibiotics created a selective pressure for methicillin-resistant and 
tetracycline-resistant LA-S. aureus that could then disseminate back into human 
populations.12 In certain regions of the world there is evidence that LA-S. aureus has 
successfully disseminated into the human community and become a major contributor to 
human morbidity—in areas of Europe, LA-S. aureus accounts for up to 25% of MRSA 
cases.13 Consistent with these observations, studies demonstrate that IHO workers in the 
USA are at an increased risk of carrying LA-S. aureus, including LA-MRSA and LA-
MDRSA,10,14 and developing LA-S. aureus skin and soft tissue infections (SSTI).15,16 
However, the state of knowledge in the USA is less developed than it is in Europe. In 
North Carolina (NC), evidence suggests that LA-S. aureus originating at IHO’s can be 
transmitted between IHO workers and their household contacts, and that the prevalence 
of MDRSA and MRSA carriage among children living in the same household as IHO 
workers was greater than that of children living in households with adults with no known 
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livestock exposure in the same communities.10 More recent studies have begun to 
uncover environmental routes of exposure,17 raising questions about the extent to which 
community residents might be exposed to airborne LA-S. aureus derived from IHOs.18  
The transmission dynamics and extent to which LA-S. aureus strains contribute 
to human disease represent critical knowledge gaps in the USA, which until filled, 
will hinder efforts to control and prevent the dissemination of LA-S. aureus into 
human populations. Furthermore, the development and application of S. aureus-
specific, non-invasive, immunological biomarkers to measure early biologic effects 
of S. aureus exposure, colonization, and infection among IHO worker populations 
remains entirely unexplored. The dissemination and pathogenic potential of LA-S. 
aureus in humans has been met with skepticism, with reports suggesting that these strains 
are transient nasal colonizers of IHO workers, display a decreased capacity for human-to-
human transmission, and are less pathogenic than typical CA- and HA-S. aureus 
strains.12,19–22 Nevertheless, LA-S. aureus strains of pig origin have indeed been reported 
to produce active and symptomatic SSTIs in humans in USA,16,23 Canada,24 and 
Europe.12,13,25,26 While epidemiological studies have concluded that IHO workers face 
occupational exposure to S. aureus,14,17 including MRSA and MDRSA, the development 
and application of immunological biomarkers of S. aureus colonization and infection has 
largely focused on high-risk populations in the clinical setting.27 As our efforts to 
understand and combat the community origins of antimicrobial-resistant S. aureus 
infections become a priority, it is critical that we examine the transmission dynamics and 
pathogenic potential of LA-S. aureus that have contributed to human morbidity in parts 
of the world and are now raising concern in parts of the USA Furthermore, there is a need 
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to develop non-invasive immunological biomarkers that can be employed in community 
and occupational settings, to target and intervene on human exposure, colonization, and 
infection with these emerging multidrug-resistant LA-S. aureus strains.  
This dissertations aims to fill the following three (3) critical knowledge gaps: 
1. While LA-S. aureus clonal complex (CC) 398 (CC398) appears to be the major 
circulating LA-S. aureus clone in Europe,12,25 LA-S. aureus CC9 has emerged as 
an important LA-S. aureus clone in Asia.28–30 Epidemiologic and whole genome 
sequence analysis (WGSA-) based studies have provided evidence of the 
population structure and transmission dynamics of LA-S. aureus CC398 between 
pigs and humans,25 and an increasing prevalence of LA-S. aureus CC398 SSTI’s 
and blood stream infections (BSIs) in parts of Europe.31 LA-S. aureus CC398 has 
also been reported to cause SSTI among IHO workers in the USAUSA.16,32 
Especially concerning is that LA-S. aureus CC398 is largely methicillin or 
multidrug-resistant, which has been attributed to the use of antibiotics in IHOs.12 
While multiple studies have identified IHO worker populations with a high 
prevalence of LA-S. aureus CC9 nasal carriage,14 and some cases of SSTI-
associated LA-S. aureus CC915 in the USA, no studies, to our knowledge, have 
employed WGSA to investigate the population structure and transmission 
dynamics of LA-S. aureus CC9 between IHO pigs and humans in the USAUSA 
Chapter 1 of this dissertation aims to elucidate the population structure of 
LA-S. aureus CC9, and provide evidence of transmission of LA-S. aureus 
CC9 between IHO pigs and human in NC, USA, a region with a particularly 
high density of IHOs.33   
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2. The majority of CA-S. aureus infections in the USA involve skin and soft 
tissue.3,34–36 USA300 is one of the most common CA-S. aureus clones recovered 
from individuals presenting to hospitals with SSTIs.36 USA300 is a CA-S. aureus 
clone of reputable pathogenicity with the capacity to cause unusually severe SSTI 
disease.37 These observations have been supported by and are consistent in mouse 
models, with reports concluding that CA-MRSA strains, including USA300 clone 
SF8300, are significantly more virulent than HA-MRSA in both a mouse model 
of bacteremia and SSTI.38 Apart from a single study suggesting that LA-S. aureus 
displays greater lethality than human-associated S. aureus in a murine sepsis 
model,39 there is a paucity of data regarding the phenotypic pathogenicity of 
predominant LA-S. aureus lineages contracted by IHO workers and implicated in 
human SSTI. No studies, to our knowledge, have attempted to compare the 
pathogenic potential of LA-S. aureus CC398 and CC9 of IHO origin to a CA-
MRSA infection strain of reputable pathogenicity – i.e. USA300 clone SF830037 
– in a mouse model of SSTI. Chapter 2 of this dissertation aims to understand 
the degree to which LA-S. aureus strains contracted by IHO workers cause 
disease relative to an epidemic CA-MRSA strain of high pathogenicity 
(USA300 clone SF8300) in a mouse model of SSTI.  
3. The S. aureus genome encodes for approximately 2700 proteins.40 The human 
adaptive immune response can serve as a sensor of S. aureus protein expression in 
vivo, which is recorded and maintained in the profile of human antigen-specific 
antibody levels directed against S. aureus-specific proteins. Previous studies have 
characterized important associations between serum IgA and IgG antibody levels 
6 
 
against various S. aureus proteins and outcomes of S. aureus colonization and 
infection in diverse healthy populations,27 hospitalized adults,27,41 adults with 
invasive S. aureus infections,27,42 dialysis patients,27 intravenous drug-users,42 and 
children colonized or presenting with S. aureus infections.43 All of these studies 
measured IgA and IgG antibody levels in serum. To our knowledge, no studies 
have developed non-invasive antibody-based biomarkers of S. aureus 
colonization and infection in oral fluid (OF) that could be employed in 
occupational and community populations, particularly in children, from whom 
blood collection may be challenging. Furthermore, no studies, to our knowledge, 
have aimed to measure S. aureus antigen-specific IgA and IgG antibody levels in 
OF among a population of IHO workers who experience unique occupational 
exposure to LA-S. aureus.14 Chapter 3 of this dissertation aims to develop 
antigen-specific antibody-based OF biomarkers and examine their 
association with S. aureus nasal carriage outcomes and SSTI among a 
population of IHO workers and their adult and child (7-17 years of age) 
household contacts.  
 It is anticipated that this dissertation will provide significant contributions to 
understanding of the transmission dynamics of LA-S. aureus between IHO pigs and 
humans and pathogenic potential of LA-S. aureus commonly contracted by IHO workers 
in NC, USA. Furthermore, this dissertation will advance the development and application 
of non-invasive immunological biomarkers of S. aureus colonization and infection that 
could be employed broadly in occupational and community population settings where 
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Introduction. Livestock-associated (LA-) S. aureus clonal complex (CC) 398 
predominates in Europe, whereas LA-S. aureus CC9 has emerged as an important lineage 
in Asia and the USA. While whole genome sequence analysis (WGSA) provided robust 
evidence of the population structure and transmission dynamics of LA-methicillin (LA-
MRSA) and LA-multidrug-resistant (LA-MDRSA) S. aureus CC398 between pigs and 
humans in Europe, other LA-S. aureus strains, particularly CC9, remain poorly 
characterized. 
Objectives. To evaluate the population structure and transmission dynamics of LA-S. 
aureus CC9 in industrial hog operation (IHO) pigs and individuals who work in or live 
near IHOs. 
Methods. Forty nine LA-S. aureus CC9 collected from IHO pigs, IHO workers, adult 
and child (7-17 years) household contacts of IHO workers, and community referent (CR) 
adults and their child household contacts (households with no known exposure to 
livestock) living in the top 10 hog-producing counties in North Carolina (NC), USA, 
between 2013-2017, were prepared for sequencing. Along with whole genome sequence 
data from 32 LA-S. aureus CC9 isolates representing an international collection, a total 
of 81 LA-S. aureus CC9 were subjected to bioinformatic analyses. Transmission clusters, 
defined as IHO pig and human LA-S. aureus CC9 isolates separated by 42 or fewer 
SNPs, were identified. 
Results. Phylogenetic analysis demonstrated three major lineages of geographically 
restricted LA-S. aureus CC9, of which a single lineage contained 100% of the NC LA-S. 
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aureus CC9 isolates (Lineage III). High-resolution phylogenetic and genotyping analysis 
of Lineage III isolates revealed multiple distinct sub-lineages of LA-S. aureus CC9, two 
of which contained transmission clusters with a high degree of phylogenetic relatedness 
between IHO pig and human isolates. Transmission cluster isolates carried a statistically 
significantly higher number of acquired antimicrobial resistance (AMR) genes and a 
higher proportion were MDRSA, compared to non-transmission cluster isolates. 
Conclusions. This study suggested that LA-S. aureus CC9 isolates from humans and 
IHO pigs in NC originate from a common pool, and provided evidence of transmission of 
LA-S. aureus CC9, including LA-MDRSA, between IHO pigs, IHO workers, and 
community referent adults with no known exposure to livestock in a region in the USA 





The intensive use of antimicrobials in food animal production may create a 
selective pressure that gives rise to antimicrobial resistant (AMR) pathogens. Thus, 
industrial hog operations (IHO) may be reservoirs of occupational and community 
exposure to antimicrobial resistant (AMR) pathogens.44 In particular, livestock-associated 
(LA-) Staphylococcus aureus (LA-S. aureus) has emerged among swine raised in IHOs 
(hereafter IHO pigs) and individuals who live near or have frequent contact with pigs 
raised in IHOs globally, including the United States (USA) .9–11 Consistent with these 
observations, IHO workers who are occupationally exposed to pigs are at increased risk 
of carrying S. aureus intranasally, including methicillin-resistant S. aureus (MRSA), 
multidrug-resistant S. aureus (MDRSA), and LA-S. aureus.14,16 Furthermore, individuals 
exposed to LA-S. aureus are at risk of developing mild-to-severe infections, including 
skin and soft tissue infections (SSTIs), pneumonia, endocarditis, osteomyelitis, and 
bactermia.15,16,25,32 S. aureus CC398 appears to be the predominant LA-S. aureus lineage 
circulating in Europe12,25 and some areas of the USA – e.g., Iowa.45 Since it was first 
reported in the early 2000’s,46 zoonotic LA-S. aureus CC398 is an increasing cause of 
human infection in the general population of several EU nations.25,32 More recently, it has 
become clear that diverse clones may be emerging in association with IHOs. For 
example, S. aureus CC9 has been reported as a dominant LA-S. aureus lineage in Asia 
and it has been described as an emerging clone in some areas of the US with intensive 
industrial livestock production.28,29 
While whole genome sequence analysis (WGSA) studies have provided robust 
support for the transmission of LA-MRSA and LA-MDRSA CC398 between swine and 
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humans in Europe,12,14,16,25,32 the population structure and transmission dynamics of 
emerging LA-S. aureus strains, particularly CC9, remain poorly understood in the USA. 
To our knowledge, no studies in the USA have employed WGSA to elucidate the global 
and regional transmission dynamics of LA-S. aureus CC9. Previous epidemiologic 
studies in North Carolina – the 2nd leading pork producing state in the USA (behind 
Iowa) – showed a high prevalence of LA-S. aureus CC9 among pigs raised on IHOs 
(IHO-pigs)17 and IHO-workers.14 Epidemiologic findings also provided support for 
transmission of LA-S. aureus CC9 between IHO-workers and their household contacts,14 
and identified some instances of LA-S. aureus CC9 occurrence among community 
residents with no known exposure to livestock in high density IHO areas of NC (hereafter 
community referent [CR] adults) .10 However, no studies of this emerging LA-S. aureus 
CC9 clone have employed WGSA to characterize the population structure and 
transmission dynamics in a region of intensive industrial hog production in the USA. The 
objectives of this study were to employ whole genome sequencing and phylogenetic 
analysis to: 1) elucidate the population structure of LA-S. aureus CC9 collected from 
various regions in North America, South America, Europe, and Asia; 2) characterize the 
transmission dynamics of LA-S. aureus CC9 collected from IHO pigs, IHO workers, 
children of IHO workers (IHO child), and CR adults in NC, USA.; and 3) examine 
whether the antimicrobial use (AMU) plays a role in driving the clonal expansion of LA-
S. aureus CC9 in the USA, represented by the frequency of AMR genes within 





S. aureus isolate selection from humans. 
S. aureus isolates were collected from participants who were previously enrolled 
into one of three separate epidemiologic studies and screened for nasal carriage of S. 
aureus. The first study (Study 1) was cross-sectional and surveyed 204 IHO workers for 
S. aureus nasal carriage at a single time point.9 The second study (Study 2) was 
longitudinal and followed 183 IHO workers and their adult and child (7-17 year) 
household contacts for 4 months, and assessed S. aureus nasal carriage at baseline and 8 
biweekly (once every two weeks) time points.14 The third study (Study 3) was cross-
sectional and assessed S. aureus nasal carriage among 800 participants living in the top 
10 hog producing counties of NC; approximately half were household comprised of one 
IHO worker and one child (<7 years) [IHO child]) and the remainder were households 
comprised of one CR adult and one CR child (<7 years) who had no known exposure to 
livestock.10 Questionnaires were used to collect demographic information, household-
level characteristics, and habitual activities (including occupational activities) that could 
be related to S. aureus exposure. For human LA-S. aureus CC9 isolates, one of each 
unique CC9-associated spa type (t337, t1415, t3446, t3270, t1419), per individual was 
selected for sequencing. For Study 2, the longitudinal study, an IHO worker must have 
carried a putative S. aureus CC9 isolate at two time points, or have had a household 
contact who carried a putative S. aureus isolate at one time point, to be included in the 
study. For Study 1, Study 2, and Study 3, a BD BBLTM CultureSwabTM was used to 
collected nasal swab samples from both nares of each participant. For Study 1, Swabs 
were inoculated into 10ml of Mueller-Hinton broth containing 6.5% NaCl (MHB+NaCl) 
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and incubated overnight at 37oC. A loop of the enriched media was then streaked onto 
CHROMagarTM Staph aureus (CA) plates (BD, Franklin Lakes, NJ) and incubated at 
37oC for 24 hours. Colonies with morphology characteristic of S. aureus were streaked to 
isolation. For Study 2 and Study 3, 100ul of participants self-collected nasal swab 
samples were first directly plated on CA and incubated at 37oC for 24 hours. Swabs 
resulting in no presumptive S. aureus growth following direct plating were processed 
using methods previously described.47 Up to two colonies with morphological 
characteristics of S. aureus were streaked to isolation on either CA or tryptic soy agar 
with 5% sheep erythrocytes (blood agar, Remel).   
S. aureus isolate selection from pigs. 
S. aureus isolates from IHO pigs were collected from a convenience sample of a 
single IHO in North Carolina (IHO-1), as described previously,17 or from IHO pig rope 
samples from 20 IHOs in North Carolina (IHO-2 through IHO-21); the latter have not 
been previously published. For IHO-1 pig isolates, Copan E-swabs were used for sample 
collection – each pig was swabbed in the right nares, right side of mouth, skin behind the 
right ear, right perineal mucosa, and any observed skin lesion as previously described.17 
Pig swabs were subjected to double-enrichment in broth culture using the methods 
previously described.17 For IHO-2 through IHO-21, rope sample elution’s were processed 
for S. aureus following the same procedure outlined for Study 2 and Study 3. Direct 
plating of rope sample elutions did not result in any S. aureus growth, thus all rope 
sample isolates included in this study were enriched prior to isolation. 
Molecular characterization of S. aureus isolates. 
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The spa-type or sequence type (ST) was previously characterized for all S. aureus 
isolates,9,10,14,17 and used to assign each isolate to a putative multi-locus sequence type 
(MLST).  
Genome sequencing. 
A representative sample of LA-S. aureus CC9 isolates from the parent studies 
were sequenced and assembled. For human LA-S. aureus CC9 isolates, one of each 
unique CC9-associated spa type (t337, t1415, t3446, t3270, t1419), per individual was 
selected for sequencing. For IHO-1 pig samples, one of each CC9-associated spa type per 
pig life stage per barn was selected for sequencing. For the IHO pig rope samples, one of 
each CC9-associated spa type per S. aureus positive rope was selected for sequencing 
(each rope corresponded to a single IHO). DNA was prepared for multiplexed, paired-end 
sequencing on an Illumina MiSeq (Illumina, Inc., San Diego, CA). Libraries for 25 
isolates were prepared using the Nextera XT DNA Library Preparation Kit (Illumina, 
Inc.) according to manufacturer instructions. Libraries for 48 isolates were prepared using 
the Kapa Hyper Prep Kit (Kapa Biosystems, Inc.), using the recommended adaptor 
concentrations for libraries constructed from 500 ng input DNA. For libraries prepared 
using the Kapa Hyper Prep Kit, uniquely barcoded adaptors were obtained from BioO 
Scientific® (BioO Scientific®, NED, NEXTflex-96™ DNA Barcodes for DNA), and 
libraries were quantified via quantitative PCR using the Kapa Library Quantification kit 
(Kapa Biosystems, Inc. Wilmington, MA,). Based on individual library concentrations, 
equimolar pools of S. aureus libraries were prepared at a concentration of 2nM. The 
pooled libraries were qc’d on an Agilent bioanalyzer and sequenced on an Illumina 
MiSeq at 2X 300 bp.  
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Core-genome-based phylogenetic analysis.  
To study the genetic relatedness of LA-S. aureus CC9 isolates to each other and 
to an international collection of S. aureus CC9, SNPs from the core genome of all NC 
CC9 isolates along with 32 publicly available S. aureus CC9 whole genome sequence 
datasets (National Center for Biotechnology Information: Reference Sequence Database 
[RefSeq]; https://www.ncbi.nlm.nih.gov/refseq/), were used to construct a maximum 
likelihood phylogeny. We closed the genome of the highest quality CC9 sequence from 
the NC collection, and used this as a reference for alignment. Using the NASP pipeline 
(v.1.0.0),48 Illumina short-read sequences were aligned to the reference S. aureus CC9 
genome by using BWA-MEM (v.0.7.12).49 SNPs were called using GATK (v.3.5) 50 with 
the following parameters: ≥10× mapping coverage; ≥90% unambiguously base calls; 
insertions and deletions were ignored. Recombinant regions were removed using Gubbins 
(v.2.1) ,51 and the resulting SNP matrix was used to construct phylogenetic trees in 
PhyML with Smart Model selection (v.3.0).52 Support values were calculated by 
bootstrap sampling (n=100). The methods were then repeated for a subset of clustered S. 
aureus CC9 isolates. Isolates that were collected from NC are referred to hereafter as the 
“NC collection”. Isolates collected from RefSeq are referred to hereafter as the 
“International collection”.  
Molecular characterization of virulence factor (VF) genes, and antimicrobial 
resistance (AMR) genes. 
Virulence factor (VF) and Antimicrobial resistance (AMR) genes were 
determined using the VirulenceFinder 1.553 and ResFinder 3.054 databases available on 
the Center for Genomic Epidemiology (CGE) server. Contigs were screened for VF and 
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AMR genes using ABRicate (https://github.com/tseemann/abricate), a modified BLASTn 
based tool for the screening of genes in assemblies.  
Statistical analysis. 
A data driven approach was used to identify epidemiological evidence of 
clustering, which was then used to define a SNP threshold for identifying putative LA-S. 
aureus CC9 transmission between IHO pigs and humans (hereafter referred to as 
“transmission clusters”).  To examine the relationship between transmission cluster 
isolates and acquired AMR, we compared the average number of AMR genes per isolate 
among transmission cluster isolates to non-transmission cluster isolates. Beta coefficients 
and 95% confidence intervals (CIs) were estimated using a generalized linear model. We 
compared the prevalence of AMR genes and phenotypic resistance between transmission 
cluster isolates and non-transmission cluster isolates using a Chi-square exact test.    
RESULTS 
We screened a total of 1,121 S. aureus isolates collected from the nares of 1,187 
people enrolled in one of three separate epidemiologic studies in NC, between 2012 and 
2016, for LA-S. aureus CC9. We assigned a putative CC9 MLST to 145 of these S. 
aureus isolates, based on spa-type or sequence type as previously described 14. Among 
the 145 putative CC9 isolates collected from humans, 53 representative isolates were 
selected for whole genome sequencing based on the selection criteria outlined in the 
methods. A total of 37 S. aureus CC9 isolates were collected from 20 pigs from IHO-1, 
all of which were assigned a putative CC9 MLST.17 11 of these isolates were selected for 
whole genome sequencing (at least one isolate per pig life stage, per barn). Among 20 
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IHO pig rope samples, representing 20 different IHOs, we recovered a total of 57 S. 
aureus isolates from 5 IHO pig rope samples. 54 of these isolates were assigned a 
putative CC9 MLST, of which 6 isolates were selected for sequencing (one of each 
unique CC9-associated spa type, per rope). Thus, a total of 70 putative S. aureus CC9 
isolates were prepared for whole genome sequencing. After removing 21 low-quality 
genomes, due to either contamination or poor coverage (<2,000,000 bases) at 25x of 
depth, 49 MLST confirmed LA-S. aureus CC9 genomes were sequenced at an average 
depth of 65.76x (SD = 27.66), using the 2,815,299 base IHOW6 chromosome as a 
reference. The IHOW6 reference genome had excellent coverage at 25x (2,771,213) and 
only 1.33% unclassified reads. Among these 49 LA-S. aureus CC9 genomes from the NC 
collection, 39 human isolates were collected from 30 humans, and 10 pig isolates were 
collected from 5 IHOs. Additional isolate characteristics for these 49 LA-S. aureus CC9 
isolates are provided in Table 1S.1. 
Population structure of LA-S. aureus CC9.  
A total of 81 LA-S. aureus CC9 genome sequences were included in a core 
genome SNP-based phylogenetic analysis aimed to elucidate the population structure of 
LA-S. aureus CC9 originating from different countries and hosts. This included 49 
MLST confirmed, high quality, LA-S. aureus CC9 isolates from the NC collection 
(including the reference), and 32 LA-S. aureus CC9 isolates from the International 
collection. The total LA-S. aureus CC9 population exhibited three major lineages (LI, 
LII, and LIII), that were geographically restricted (Figure 1.1). One of these lineages, 
LIII, included 100% (49/49) of the LA-S. aureus CC9 isolates from the NC collection, 
which made up 98% (49/50) of LIII isolates (Figure 1.1, Table 1S. 2). LI was composed 
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of primarily isolates from the Asian continent (92%, 12/13 isolates), 46% (6/13) from 
China, and 46% (6/13) from Taiwan (Figure 1.1, Table 1S.2). LII was composed 
primarily of isolates originating from the European continent (100%, 14/14 isolates), 
71% (10/14) from Germany, 21% (3/14) from the Netherlands, and 7% (1/14) from 
Denmark (Figure 1.1, Table 1S.2). LIII was composed primarily of isolates collected 
from the USA (98%, 49/50 isolates) (Figure 1.1, Table 1S.2). Only two isolates grouped 
into a lineage that did not correspond to continent of predominance within the ML. A 
single isolate from Colombia grouped into LIII with isolates from the USA, and a single 
isolate from the Netherlands grouped into LI with isolates from Asia (Figure 1.1, Table 
1S.2). The three (3) ML’s of LA-S. aureus CC9 appear to correspond to continent of 
origin, and display little evidence of inter-continental spread.  LA-S. aureus CC9 from 
humans and pigs in USA are distinct from the European and Asian lineages.  
Presence of Immune Evasion Cluster (IEC) genes. 
Absence of the scn gene is commonly used as a biomarker of LA-S. aureus 
contracted from pig.14 A total of five isolates were positive for the scn gene (Figure 1S.1). 
Three were from humans, and two were missing host data. Only a single NC collection 
isolate carrying the scn gene clustered in LI-LIII, and it was contained in LIII (Figure 1.1, 
Table 1S.3). This isolate was collected from an IHO-worker in NC. The remaining 4 
scn(+) isolates did not cluster into LI-LIII and were the most distantly related isolates 
from LI-LIII isolates. These isolates were from the International collection and were 
collected from the USA, UK, and Taiwan. The scn gene is a part of the immune evasion 
cluster (IEC) carried on the mobile Sa3-prophage.55 Additional genes that can be encoded 
on the Sa3-prophage include sak, encoding for staphylokinase, and sea and sek, encoding 
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for the superantigens staphylococcal enterotoxin A and K respectively.55 A total of three 
isolates were positive for the sak gene, and were not contained in LI-LIII (Figure 1.1, 
Table 1S.3). All of the sak-carrying isolates also carried scn. No isolates were positive for 
the sea or sek gene. An absence of IEC genes in LI-LIII isolates suggest that LI-LIII 
isolates may be members of a larger LA-S. aureus CC9 clade. 
 Presence of acquired AMR genes.  
The genetic foundation for the successful expansion of LA-S. aureus CC9 in the 
USA was investigated by comparing the prevalence of AMR genes in LIII (Americas) to 
LI (Asia) and LII (Europe) respectively. Compared to LIII isolates, LI and LII isolates 
were enriched for determinants conferring resistance to methicillin and trimethoprim 
antibiotics (Figure 1.1, Table 1S.3). The mecA gene conferring resistance to methicillin 
was only found in LI and LII. Trimethoprim resistance was encoded exclusively by dfrG 
in LI, and dfrK in LII. Determinants conferring resistance to macrolides were evenly 
distributed in LI-LIII (Table 1S.3). Compared to LIII, LI was enriched with determinants 
conferring resistance to lincosamides, whereas lincosamide resistance was absent from 
LII. lnu(B) was exclusive to LI, whereas lnu(A) was exclusive to LIII (Table 1S.3). 
Compared to LIII, LI isolates were enriched with determinants conferring resistance to 
tetracyclines (Table 1S.3). tet(L) was the most abundant tetracycline resistance gene in 
LI, while tet(K) and tet(L) were present equal proportions in LIII. Compared to LIII, LI 
isolates were enriched for determinants conferring resistance to aminoglycosides, 
whereas these genes were absent from LII. The spc gene was the most abundant 
aminoglycoside resistance gene in LIII, and was exclusive to LIII (Table 1S.3). The 
ant(6)-la and aac(6’)-aph(2”) genes were the most abundant aminoglycoside resistance 
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genes in LI, and ant(6)-la was exclusive to LI. The vga(A)LC gene encoding resistance to 
Streptogramin B was exclusive to LIII. Taken together, determinants of resistance to  
tetracycline, macrolide, lincosamide, and aminoglycoside antibiotics were associated 
with genetic lineage, and if strains carrying these determinants were enriched through 
selective pressure, then it is possible that AMU in humans or animals may have played a 
role in the clonal expansion of LA-S. aureus CC9 in the USA. 
High-resolution phylogenetic analysis of LIII LA-S. aureus CC9.  
Because 100% of the NC collection isolates grouped into LIII, we performed a 
high-resolution core-genome SNP-based phylogenetic analysis on all LIII isolates. A 
total of 50 isolates were included in the high-resolution phylogenetic analysis. 49 isolates 
were from IHO-pigs (n=10), IHO-workers (n=34), IHO-minors (n=3), or CR-adults (n=2) 
in NC, USA. A single (1) isolate was from the international collection, and originated 
from a pig in Columbia. High-resolution phylogenetic analysis of LIII revealed multiple 
distinct sublineages, one of which included exclusively IHO-pig isolates (IHO-pig 
cluster) (Figure 1.2). The maximum SNP-distance among these phylogenetically 
clustered IHO pig isolates from the same farm (n=6) was used to define putative 
transmission clusters. The maximum pairwise SNP distance of this IHO-pig cluster was 
42 SNP’s (range: 2-42 SNP’s), and was set as the threshold to classify putative pig-
human transmission clusters. Employing this standard, a total of 19 human and pig 
isolates were separated by 42 SNP’s or less, and were included in two distinct 
transmission clusters (Figure 1.2). The average pairwise SNP-distance between IHO-pig 
cluster isolates was 24 SNP’s (95% CI: 19.33, 28.67), and the average pairwise SNP-
distance between transmission cluster isolates was 24.6 SNP’s (95% CI: 23.2, 25.9) and 
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10.8 SNP’s (95% CI: 6.67, 14.93) for each distinct transmission cluster. Taken together, a 
high degree of phylogenetic relatedness between intermingled IHO pig and human 
transmission cluster isolates strongly suggest that IHO-pig and human LA-S. aureus CC9 
in NC, USA come from a common pool. 
Evidence of transmission of LA-S. aureus CC9 between IHO-pigs and IHO-workers in 
NC, USA. 
Seventy four percent (14/19) of the transmission cluster isolates were collected 
from IHO workers (Figure 1.2, Table 1S.4). Two IHO-worker isolates differed from an 
IHO-pig isolate by only twelve SNPs. These results strongly suggest transmission of LA-
S. aureus CC9 between IHO pigs and IHO workers in NC, USA Notably, an IHO-worker 
isolate that was associated with a recent skin and soft tissue infection (SSTI) differed 
from a IHO-pig isolate by only 20 SNPs.   
Evidence of transmission of LA-S. aureus CC9 between IHO-workers and IHO-worker 
household contacts in NC, USA 
Sixty six percent (2/3) of IHO child isolates were identical (0 SNP differences) to 
IHO worker isolates (Figure 1.2), suggesting transmission of LA-S. aureus CC9 between 
IHO-workers and children living in the household of IHO-workers in NC, USA. 
Evidence of transmission of LA-S. aureus CC9 to community members with no known 
exposure to livestock.  
One out of the 19 transmission cluster isolates (5%) were collected from a CR 
adult with no known exposure to livestock (Figure 1.2, Figure 1S.4). The minimum SNP-
distance between this isolate and an IHO-pig isolate was 25 SNPs, and between this 
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isolate and an IHO-worker isolate was 22 SNPs. These results strongly suggest that IHO-
derived LA-S. aureus CC9 can disseminate into human populations in NC, USA beyond 
the context of occupational exposure on IHOs.       
The role of AMR in transmission of LA-S. aureus CC9.  
To determine the role of acquired AMR in the transmission of LA-S. aureus CC9 
between IHO pigs and humans, we compared the average number of AMR genes per 
isolate between transmission cluster isolates and all other isolates. We detected a 
significant trend toward an increased number of AMR genes per isolate among 
transmission cluster isolates compared to all other isolates (beta coefficient = 2.13; 95% 
CI: 1.31, 2.95) (Table 1.1). On average, transmission cluster isolates carried 3.84 
acquired AMR genes per isolate (standard deviation = 1.71) whereas non-transmission 
cluster isolates carried 1.71 acquired AMR genes per isolate (standard deviation = 1.24) 
(Table 1.1). Compared to non-transmission cluster isolates, transmission cluster isolates 
were enriched for determinants conferring resistance to tetracyclines, macrolides, 
streptogramin B, and lincosamides (p < 0.05) (Table 1.2). In particular, transmission 
cluster isolates were enriched with the tet(L) gene conferring resistance to tetracyclines (p 
< .05), a tetracycline resistant phenotype (p < 0.05), and a MDRSA phenotype (p < 0.05) 
(Table 1.2).    
DISCUSSION 
 This study is the first, to our knowledge, to provide: 1) evidence for the 
population structure of LA-S. aureus CC9 and 2) a high-resolution phylogenetic analysis 
that revealed distinct LA-S. aureus CC9 sublineages that strongly suggests transmission 
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of LA-S. aureus CC9 between IHO pigs and humans in NC, USA We also found that 
isolates implicated in transmission between IHO pigs and humans were largely multidrug 
resistant, enriched with multiple acquired AMR genes. Taken together our results 
strongly suggests transmission of multidrug-resistant LA-S. aureus CC9 between IHO 
pigs, IHO workers, IHO worker household contacts, and community residents with no 
known exposure to livestock. Furthermore, our results suggest an important role for 
AMU in the clonal expansion of LA-S. aureus CC9 in NC, USA. An abundance of 
previous studies have employed WGSA to understand global and regional transmission 
dynamics of LA-S. aureus CC398 and have concluded that transmission of LA-S. aureus 
CC398 indeed does occur between swine and humans and can result in human SSTI and 
BSI.12,17,32 Apart from this study, only a single SNP-based analysis on a limited number 
isolates has suggested transmission of LA-S. aureus CC9 between humans, cattle, and 
swine in China56. 
 The increased number of acquired AMR genes among transmission cluster 
isolates was largely attributable to the presence of the tet(L) gene conferring resistance to 
tetracyclines and the vga(A)LC gene conferring resistance to streptogramin B. This was 
confirmed by an increased proportion of transmission cluster isolates phenotypically 
resistant to tetracycline, and displaying a MDRSA phenotype, compared to non-
transmission cluster isolates. While the tet(M) and tet(K) genes are commonly found in 
MSSA and MRSA isolates,57 including LA-S. aureus CC9 and CC398,30,58 the tet(L) 
gene is rarely detected in S. aureus.57,59 The tet(L) gene is plasmid mediated and encodes 
for an efflux pump conferring resistance to tetracycline.59 The vga(A)LC gene is also a 
plasmid mediated gene encoding for a putative efflux pump conferring resistance to 
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streptogramin compounds60 and reduced susceptibility to pleuromutilins.61 LA-MRSA 
CC398 carrying plasmid-borne vga(A) has been previously reported in IHO workers and 
pigs in the USA,62 but to our knowledge, has not been reported in LA-S. aureus CC9. In 
the current study, these plasmid mediated resistance genes were enriched among 
transmission cluster isolates. These findings are of concern, since they may have clinical 
implications regarding treatment regimens for LA-S. aureus CC9 infections. The single 
SSTI-associated isolate in our study that fell into a transmission cluster carried the 
vga(A)LC gene and displayed a MDRSA phenotype.  
Our study has several strengths. First, to our knowledge, our study is the first to 
employ core genome SNP-based analyses to examine the population structure and 
transmission dynamics of multidrug-resistant LA-S. aureus CC9 in the USA. In this 
study, isolates were collected from participants who lived in a region in NC with the 
highest density of industrial hog production in the USA,33 and where residents and IHO 
workers are expressing their concerns with IHO-related exposures63. This study addresses 
this critical knowledge gap by providing evidence of transmission of multidrug-resistant 
LA-S. aureus CC9 between IHO pigs and humans in NC. We also provide evidence that 
this transmission does not only lead to nasal carriage but may also result in human 
disease, as noted by the relatedness between an SSTI-associated human isolate and an 
IHO pig isolate (< 20 SNP difference). Moreover, our study reveals that community 
residents in NC with no known exposure to livestock are also exposed to, and can carry, 
LA-S. aureus CC9 that is highly related to those collected from IHO pigs. Considering 
that transmission cluster isolates are largely multidrug resistant, transmission of LA-S. 
aureus CC9 between IHO-pigs and humans in the USA constitutes a major public health 
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concern. Second, whereas previous groups have used spa-type, MLST, the scn gene, or 
phenotypic resistance to tetracycline to classify S. aureus isolates as “livestock-
associated,”10,14,17 our study used core genome SNP-based genetic distance to classify 
human isolates that were closely related to IHO pig isolates. This method of classification 
provides a greater discriminatory capacity for identification of human isolates that are 
highly related to pig isolates and the associated risks of transmission of LA-S. aureus 
CC9 between IHO pigs and humans. Third, our study does not use an arbitrary SNP 
threshold to define transmission, as is commonly done in previous literature.64 Rather, 
this analysis uses an empirical method to set a SNP threshold to define transmission 
clusters. 
This study had several limitations. First, the international collection could be a 
poor representation of global LA-S. aureus CC9 isolates. Several SNP-based analyses 
have concluded intercontinental spread of particular S. aureus clonal groups, including 
LA-S. aureus CC398.12,65,66 It may be the case that LA-S. aureus CC9 also displays 
intercontinental spread, but this international collection of isolates is not representative 
enough to capture this. However, the depth of publicly available LA-S. aureus CC9 
sequence data is limited. Different sample processing and sequencing methods between 
isolates from the international and NC collection may also contribute to the observed 
phylogenetic relationships between LA-S. aureus CC9 from different countries of origin. 
This is likely not the case, however, considering that variability in year of collection did 
not explain core-genome SNP-based clustering, and contig-based AMR gene hits 
grouped well with core-genome SNP-based clusters. Second, our study may not fully 
represent IHO pig isolates from NC, USA. To study transmission between pigs and 
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humans, we would ideally have an equal distribution of LA-S. aureus CC9 collected from 
humans and from IHO pigs, as has been done with LA-S. aureus CC39812,25. Third, we 
did not have data to match IHO worker participants to the IHO where they worked, thus 
we are unable to explore intra- and inter-farm level transmission dynamics. This metadata 
is not available to us based on the request of community partners to de-couple these data 
to protect worker participant anonymity. We hypothesize that we would see even closer 
genetic relatedness between IHO worker and IHO pig LA-S. aureus CC9 collected from 
the same farm. Despite this limitation, we still found a high degree of phylogenetic 
relatedness between IHO pig and IHO worker LA-S. aureus CC9 isolates collected in 
NC, USA. Lastly, we are not able to provide directionality of transmission in our 
conclusions. This study was not aimed to reconstruct the evolutionary history of LA-S. 
aureus CC9, as has been done with LA-S. aureus CC39812. We rooted our high-
resolution phylogenetic tree at the midpoint, and are, therefore, unsure if the most 
ancestral clade of LA-S. aureus CC9 is of human or animal origin. This is a research 
question of critical importance, and the pursuit of a current study.  
SNP-based analyses have shown promise, and are now commonly used, in 
clinical infectious disease outbreak settings, including those concerning MRSA 
infection67–69. Our study shows that these tools can also be applied in meaningful ways 
within community and occupational settings to understand transmission dynamics 
between animals and humans in regions of the USA with intensive spatial concentration 
of IHOs. Industrial food animal production facilities regularly emit S. aureus by venting 
animal barns and spraying animal waste on proximal fields.18,70 Staphylococcus aureus is 
resistant to desiccation and may persist on indoor surfaces for weeks to months. 
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Environmentally-disseminated LA-S. aureus CC9 from IHOs could contribute to 
contamination of household property and recreational parks,71 for example, leading to 
increased exposure to multidrug-resistant pathogens and S. aureus-related outcomes in 
the community. Of particular concern was our finding that adults who reside in the 
community, with no known exposure to livestock, can also carry LA-MDRSA CC9 
Future studies should employ WGSA to investigate environmental exposure routes 
implicated in transmission of LA-S. aureus CC9 between IHO pigs and community 
residents with no known exposure to livestock.  
CONCLUSIONS 
WGSA of LA-S. aureus CC9 resulted in five major findings. 1) Population 
structure analysis of LA-S. aureus CC9 revealed three distinct major lineages of LA-S. 
aureus CC9 that were associated with continent of origin. Clonal expansion of LA-S. 
aureus CC9 in NC, USA appears to be distinct from those in Europe and Asia, although 
similarly driven by the use of tetracycline, macrolide, and aminoglycoside antibiotics. 2) 
High-resolution phylogenetic analysis revealed several distinct sublineages of LA-S. 
aureus CC9, two of which included intermingled IHO pig and human isolates 
(transmission clusters). A high degree of phylogenetic relatedness among transmission 
cluster isolates strongly suggest that IHO pig and IHO human LA-S. aureus CC9 isolates 
come from a common pool. 3) Analysis of transmission cluster isolates provided 
evidence of transmission of LA-S. aureus CC9 between IHO pigs, IHO workers, IHO 
children, and CR adults with no known exposure to livestock, suggesting that exposure to 
multidrug-resistant LA-S. aureus CC9 is both an occupational health concern and a larger 
public health concern. Carriage of multidrug-resistant LA-S. aureus CC9 is not limited to 
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the occupational setting. 4) Analysis of transmission cluster isolates provided evidence 
that LA-S. aureus CC9 may result in human disease (SSTI). 5) Lastly, analysis of 
transmission cluster isolates suggested that LA-S. aureus CC9 implicated in transmission 
between IHO pigs and humans in NC., USA are enriched with determinants conferring 
resistance to multiple antibiotics that are critically important for human health.72 Taken 
together, our results strongly suggest that LA-S. aureus CC9 from IHO pigs and humans 
in NC., USA come from a common pool, and that transmission between pigs and humans 
is associated with a multidrug-resistant phenotype and genotype. We provide the first 
LA-S. aureus CC9 reference dataset, which future studies can use to expand our 
understanding of LA-S. aureus CC9 transmission, exposure, colonization, and infection. 
In particular, we believe this reference dataset can be used to help in worker and 
community health hazard concerns regarding dynamics of LA-S. aureus acquisition in 
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  n (%) mean (standard deviation) 
Non-transmission  
isolates 
31 (62) 1.71 (1.24) REF 
0.0001 
Putative transmission  
cluster isolates  
19 (38) 3.84 (1.71) 2.13 (1.31, 2.95) 
 
Table 1.1. Comparison of the average number of acquired AMR genes between 
transmission cluster isolates and non-transmission cluster isolates. Beta coefficients 
and 95% confidence intervals were estimated using a generalized linear model, 
comparing the average number of acquired AMR genes/isolate among the putative 


























n (%) n (%) 
Tetracycline resistance 
tet(K) 4 (21) 8 (25.8) 0.702 
tet(L) 11 (57.9) 1 (3.23) 0.0001 
tet(T) 0 2 (6.5) 0.258 
At least one gene 15 (79) 10 (32.3) 0.001 
Macrolide resistance 
erm(A) 14 (73.7) 11 (35.5) 0.009 
erm(C ) 4 (21) 1 (3.23) 0.041 
At least one gene 17 (89.5) 11 (35.5) 0.0001 
Streptogramin B resistance vga(A)LC 7 (36.8) 1 (3.23) 0.002 
Lincosamide resistance lnu(A) 12 (63.2) 9 (29) 0.018 
Aminoglycoside resistance 
aac(6')-aph(2'') 5 (26.3) 5 (16) 0.382 
spc 14 (73.7) 13 (42) 0.029 
aadD 2 (10.5) 2 (6.5) 0.606 
At least one gene 14 (73.7) 9 (52.9) 0.079 
Phenotypic resistance 
MDRSA 18 (94.7) 13 (42) 0.0001 
Tetracycline 17 (90) 9 (29) 0.0001 
 
Table 1.2 Antimicrobial resistance (AMR) genes and antibiotic susceptibility testing 
(AST) by putative transmission classification. p values were estimated by a Chi 
squared exact test. Bolded p values are statistically significant. Note. IHO = industrial 
hog operation; MDRSA = multidrug resistant S. aureus; TET = phenotypic resistance to 
tetracycline; transmission cluster isolates = IHO pig and human isolates separated by 42 









Figure 1.1. Population structure of LA-S. aureus CC9. A total of 81 LA-S. aureus 
CC9 isolates from human and livestock specimens were included in this unrooted 
maximum-likelihood phylogeny. 32 isolates were obtained from RefSeq, and represent 
the international collection of LA-S. aureus CC9. 49 isolates were collected from IHO 
pigs, IHO workers, IHO children, or CR adults in North Carolina, U.S, and represent the 
NC collection of LA-S. aureus CC9. The major lineages of LA-S. aureus CC9 appear to 
correspond to continent of origin. 100% of the NC collection isolates fell into Lineage III. 
Note. IHO = industrial hog operation; CR = community referent with no known exposure 




































Figure 1.2. High-resolution phylogenetic analysis of Lineage III (LIII) LA-S. aureus 
CC9 isolates. 49 LA-S. aureus CC9 isolates collected from IHO pigs, IHO workers, IHO 
children, and CR adults were included in this high-resolution phylogeny. A single 
sublineage, denoted as the IHO pig cluster, included only IHO pig isolates and was used 
to set a threshold of 42 SNP’s for identifying transmission clusters. Two sublineages 
included intermingled human and IHO pig isolates with a high degree of phylogenetic 
relatedness and were considered transmission clusters. Transmission cluster tended to 
carry a greater number of acquired antimicrobial resistance genes/isolate, and a included 
a greater proportion of MDRSA compared to non-transmission cluster isolates. Note. 
IHO = industrial hog operation; CR = community referent with no known exposure to 
livestock; MDRSA = multidrug resistant S. aureus; TET = phenotypic resistance to 
tetracycline; SSTI = skin and soft tissue infection transmission cluster isolates = IHO pig 
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Table 1S.1. Isolate characteristics. Isolate characteristics are provided for 81 LA-S. 




























































698045 2009 China China: Harbin Human Human nares 0 . 9 
698065 2009 China China: Harbin Human Human nares 0 . 9 
698085 2009 China China: Harbin Human Human nares 0 . 9 
1298325 2014 China China: Shannxi Cow cow milk 0 . 9 
M3 2018 China China Pig pig   0   9 
M6 2018 China China Pig pig   0   9 
2250135 2014 Colombia Colombia Pig pig nares 0 . 9 
638195 NA Denmark Denmark Pig pig Bodily fluid 0 . 9 
636155 NA Germany Germany Pig pig Bodily fluid 0 . 9 
636235 NA Germany Germany Human human Bodily fluid 0 . 9 
636795 NA Germany Germany Chicken chicken Bodily fluid 0 . 9 
636835 NA Germany Germany Chicken chicken Bodily fluid 0 . 9 
636935 NA Germany Germany Chicken chicken Bodily fluid 0 . 9 
637035 NA Germany Germany Cow cow Bodily fluid 0 . 9 
637075 NA Germany Germany NA . . 0 . 9 
684755 NA Germany Germany NA . . 0 . 9 
684775 NA Germany Germany NA . . 0 . 9 
684985 NA Germany Germany Pig pig Bodily fluid 0 . 9 
636515 2008 Netherlands Netherlands Human human Bodily fluid 0 . 9 
636575 2010 Netherlands Netherlands Human human Bodily fluid 0 . 9 
636595 2010 Netherlands Netherlands Human human Bodily fluid 0 . 9 
636615 2011 Netherlands Netherlands Human human Bodily fluid 0 . 9 
2247015 1998 Taiwan Taiwan Human human Inf (Wound) 1 . 9 
2247065 2012 Taiwan Taiwan Human human Inf (Wound) 1 . 9 
2247245 2002 Taiwan Taiwan Human human Inf (Wound) 1 . 9 
2247005 2002 Taiwan Taiwan Human human Pus 0 . 9 
2247045 2004 Taiwan Taiwan Human human throat 0 . 9 
2247105 2010 Taiwan Taiwan Human human 
Synovial 
fluid 
0 . 9 
2247125 2006 Taiwan Taiwan Human human blood 0 . 9 
2247315 2006 Taiwan Taiwan Human human urine 0 . 9 
900042135 2006 United  
United 
Kingdom: 




IHOW1 2013 USA NC Human 
IHO 
worker 
nares 1 0 9 
IHOW2 2013 USA NC Human 
IHO 
worker 
nares 1 1 9 
IHOW3 2013 USA NC Human 
IHO 
worker 
nares 0 1 9 
IHOC1 2013 USA NC Human IHO child nares 0 0 9 
IHOW4 2013 USA NC Human 
IHO 
worker 
nares 0 0 9 
IHOW5 2013 USA NC Human 
IHO 
worker 
nares 0 1 9 
IHOW6 2013 USA NC Human 
IHO 
worker 
nares 0 1 9 
IHOW7 2013 USA NC Human 
IHO 
worker 
nares 0 0 9 
IHOW8 2013 USA NC Human 
IHO 
worker 
nares 0 1 9 
IHOW9 2014 USA NC Human 
IHO 
worker 
nares 0 0 9 
IHOW10 2013 USA NC Human 
IHO 
worker 
nares 0 1 9 
IHOC2 2014 USA NC Human IHO child nares 0 0 9 
IHOW11 2014 USA NC Human 
IHO 
worker 
nares 0 1 9 
IHOW12 2014 USA NC Human 
IHO 
worker 
nares 0 0 9 
IHOW13 2014 USA NC Human 
IHO 
worker 
nares 0 0 9 
IHOW14 2014 USA NC Human 
IHO 
worker 
nares 0 0 9 
IHOC3 2014 USA NC Human IHO child nares 0 1 9 
IHOW15 2014 USA NC Human 
IHO 
worker 
nares 0 0 9 
IHOW16 2014 USA NC Human 
IHO 
worker 
nares 0 0 9 
IHOW17 2014 USA NC Human 
IHO 
worker 
nares 0 0 9 
IHOW18 2014 USA NC Human 
IHO 
worker 
nares 0 1 9 
IHOW19 2014 USA NC Human 
IHO 
worker 
nares 0 0 9 
IHOW20 2014 USA NC Human 
IHO 
worker 
nares 0 1 9 
IHOW21 2013 USA NC Human 
IHO 
worker 
nares 0 1 9 
IHOW22 2013 USA NC Human 
IHO 
worker 
nares 0 1 9 
IHOW23 2013 USA NC Human 
IHO 
worker 
nares 0 1 9 
IHOW24 2013 USA NC Human 
IHO 
worker 
nares 0 1 9 
IHOW25 2013 USA NC Human 
IHO 
worker 
nares 0 0 9 
IHOW26 2013 USA NC Human 
IHO 
worker 
nares 0 1 9 
IHOW27 2013 USA NC Human 
IHO 
worker 
nares 0 1 9 
IHOW28 2013 USA NC Human 
IHO 
worker 
nares 0 1 9 
IHOW29 2013 USA NC Human 
IHO 
worker 
nares 0 0 9 
IHOW30 2013 USA NC Human 
IHO 
worker 
nares 0 1 9 
IHOP1 2015 USA NC Pig IHO pig   0 1 9 
IHOP2 2015 USA NC Pig IHO pig   0 1 9 
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IHOP3 2015 USA NC Pig IHO pig   0 0 9 
IHOP4 2015 USA NC Pig IHO pig   0 1 9 
IHOP5 2015 USA NC Pig IHO pig   0 1 9 
IHOP6 2015 USA NC Pig IHO pig   0 1 9 
900082095 2009 USA USA NA . Inf (Wound) 1 . 9 
IHOW31 2012 USA NC Human 
IHO 
worker 
nares 0 1 9 
IHOW32 2012 USA NC Human 
IHO 
worker 
nares 0 0 9 
IHOW33 2012 USA NC Human 
IHO 
worker 
nares 0 . 9 
IHOW34 2014 USA NC Human 
Work 
IHO 
nares 0 1 9 
CRA1 2014 USA NC Human CR adult nares 0 1 9 
CRA2 2014 USA NC Human CR adult nares 0 1 9 
IHOP7 2015 USA NC Pig IHO pig Rope 0 1 9 
IHOP8 2015 USA NC Pig IHO pig Rope 0 1 9 
IHOP9 2015 USA NC Pig IHO pig Rope 0 1 9 

















  Lineage I Lineage II Lineage III All other isolates Total 
  N=13 N=14 N=50 N=4 N=81 
Host n (%) n (%) n (%) 0 n (%) 
Human 10 (77) 4 (29) 39 (78) 2 (50) 55 (68) 
Pig 2 (15) 3 (21) 11 (22) 0 16 (20) 
Chicken 0 3 (21) 0 0 3 (4) 
Cow 1 (8) 1 (7) 0 0 2 (2) 
NA 0 3 (21) 0 2 (50) 5 (6) 
  
     
Country of origin 
     
USA 0 0 49 (98) 1 (25) 50 (62) 
Colombia  0 0 1 (2) 0 1 (1) 
Germany 0 10 (71) 0 0 10 (12) 
Netherlands 1 (8) 3 (21) 0 0 4 (5) 
Denmark 0 1 (7) 0 0 1 (1) 
China 6 (46) 0 0 0 6 (7) 
Taiwan 6 (46) 0 0 2 (50) 8 (10) 
United Kingdom 0 0 0 1 (25) 1 (1) 
  
     
Collection 
     
NC 0 0 49 (98) 0 49 (60) 
International 13 (100) 14 (100) 1 (2) 4 (100) 32 (40) 
 
Table 1S.2. Epidemiological characteristics of isolates by major lineage of LA-S. 





Table 1S.3. Presence of Immune evasion cluster (IEC) and antimicrobial resistance 
(AMR) genes by major lineage of LA-S. aureus CC9.  p values were estimated by a 




    Lineage I Lineage II Lineage III 
 
   N=13 N=14 N=50 p value 
(LIII vs. LI) 
p value 
(LIII vs. LII)     n (%) n (%) n (%) 
Immune Evasion Cluster (IEC) genes 
scn 0 0 1 (2) NA NA 
sak 0 0 0 NA NA 
Methicillin resistance mecA 11 (84.6) 10 (71.4) 0 0 0 
Tetracycline resistance 
tet(K) 2 (15.4) 1 (7.1) 12 (24) 0.506 0.166 
tet(L) 11 (84.6) 9 (64.3) 12 (24) 0 0.005 
tet(T) 0 0 2 0.464 0.447 
At least one gene 11 (84.6) 10 (71.4) 25 (50) 0.025 0.155 
Macrolide resistance 
erm(A) 0 0 25 (50) 0.001 0.001 
erm(B) 0 7 (50) 0 NA 0.0001 
erm(C ) 6 (46.2) 0 5 (10) 0.002 0.218 
At least one gene 6 (46.2) 7 (50) 28 (56) 0.526 0.69 
Streptogramin B resistance vga(A)LC 0 0 8 (16) 0.123 0.11 
Lincosamide resistance 
lnu(A) 0 0 21 (42) 0.004 0.003 
lnu(B) 11 (84.6) 0 0 0 NA 
At least one gene 11 (84.6) 0 21 (42) 0.004 0.003 
Aminoglycoside resistance 
str 2 (15.4) 1 (7.1) 0 0.005 0.057 
ant(6)-la 12 (92.3) 0 0 0 NA 
aac(6')-aph(2'') 12 (92.3) 0 10 (20) 0 0.069 
spc 0 0 27 (54) 0 0 
aadD 11 (84.6) 0 4 (8) 0 0.274 
At least one gene 12 (92.3) 1 (7.14) 31 (62) 0.021 0.001 
Trimethoprim resistance 
dfrG 12 0 0 0 NA 
dfrK 0 9 0 NA 0 






Table 1S.4. Epidemiological characteristics of LA-S. aureus CC9 isolates by 
transmission cluster classification.  Note. IHO=industrial hog operation; transmission 














Transmission cluster  
isolates 





N=19 N=31 N=50 
 
n (%) n (%) n (%) 
Host 
   
IHO-pig 4 (21) 6 (19) 10 (20) 
IHO-worker 14 (73.7) 21 (68) 35 (70) 
IHO-minor 0 3 (10) 3 (6) 
CR-adult 1 (5.3) 1 (3) 2 (4) 
  
 






















Figure 1S.1. Maximum likelihood phylogeny of 49 LA-S. aureus CC9 isolates from 
the NC collection and 32 LA-S. aureus CC9 isolates from the international collection 
with detailed genotyping and epidemiological data.   Note. IEC = Immune evasion 
cluster; AMR = antimicrobial resistance; Chick = chicken. 
 
= AMR gene present 
= AMR gene absent 
= IEC gene present 




Comparison of livestock-associated and community-associated 
Staphylococcus aureus pathogenicity in a mouse model of skin and 

























Introduction. Industrial hog operation (IHO) workers are at increased risk of carrying 
Staphylococcus aureus in their nares, particularly strains that are livestock-associated 
(LA) and multidrug-resistant. The pathogenicity of LA-S. aureus strains remains unclear, 
with some prior studies suggesting reduced transmission and virulence in humans 
compared to community-associated methicillin-resistant (CA-MRSA) S. aureus. 
Objectives. The objective of this study was to determine the degree to which LA-S. 
aureus strains contracted by IHO workers cause disease relative to a representative CA-
MRSA strain in a mouse model of skin and soft tissue infection (SSTI). 
Results. Mice infected with CC398 LA-S. aureus strains (IHW398-1 and IHW398-2) 
developed larger lesion sizes with higher bacterial burden than mice infected with CA-
MRSA (SF8300) (p < 0.05). The greatest lesion size and bacterial burden was seen with a 
CC398 strain that produced a recurrent SSTI in an IHO worker. The LA-S. aureus 
infected mice had decreased IL-1β protein levels compared with CA-MRSA-infected 
mice (p < 0.05), suggesting a suboptimal host response to LA-S. aureus SSTIs. WGSA 
revealed heterogeneity in virulence factor and antimicrobial resistance genes carried by 
LA-S. aureus and CA-MRSA strains. 
Conclusions. The observed pathogenicity suggest LA-S. aureus are highly pathogenic in 
a mouse model of SSTI and that more attention should be placed on preventing the 








In the past decade it has become evident that animal-adapted multidrug resistant 
Staphylococcus aureus (MDRSA) has emerged among food animals raised in 
concentrated animal feeding operations (CAFOs) and individuals who have frequent 
contact with food animals raised in CAFOs globally,46,73 including the United 
States.14,17,23 A study conducted in Pennsylvania concluded that residential proximity to 
swine CAFO manure land application crop fields was associated with increased odds of 
methicillin-resistant S. aureus (MRSA) infection and skin and soft tissue infection 
(SSTI),11 suggesting an environmental exposure pathway wherein community members 
could become infected with antimicrobial-resistant S. aureus originating at swine 
CAFOs. This is consistent with evidence suggesting that industrial hog operation (IHO) 
workers are at an increased risk of carrying livestock-associated (LA) S. aureus, 
including LA-MDRSA, intranasally.9,14–16  LA-MDRSA originating at IHOs may also be 
carried and transmitted from IHO workers to family contacts, noted by an increased 
prevalence of MRSA and MDRSA nasal carriage among children living with IHO 
workers in North Carolina compared to children living with community resident adults 
with no livestock exposure.10 Less is known about the extent to which nasal carriage of 
such LA-S. aureus is associated with infection, particularly skin and soft tissue infections 
(SSTIs).  
While large-scale surveillance studies from Europe suggest that LA-MRSA 
strains are capable of causing the full suite of human infections,25 some reports suggest 
that these strains display a decreased capacity for human-to-human transmission and may 
be less pathogenic than typical community associated (CA)- and hospital associated 
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(HA)-S. aureus strains.12,19–22  USA300 is a hypervirulent clone of CA-S. aureus that 
emerged in the USA in the late 1990’s, and has become the dominant CA-MRSA strain 
circulating in North America.66  Consistent with its ability to cause severe and 
widespread disease, USA300 clone, SF8300, displayed considerably increased virulence 
in a mouse model of skin and soft tissue infection (SSTI) compared to other MRSA 
lineages.27  
At a genetic level, LA-S. aureus tend to lack genetic factors associated with 
human infection that are typically found in CA-MRSA lineages, including the human 
immune evasion cluster (IEC) genes (scn) and Panton-Valentine leukocidin (PVL)-
encoding genes (lukS-PV and lukF-PV) .12,74,75  Nevertheless, LA-S. aureus strains have 
been reported to produce skin and bloodstream infections in humans in Europe,13,25,26,76,77 
the USA,15,16,32,78,79 and Canada.24  A recent study concluded that a LA-MDRSA isolate 
collected from poultry displayed greater lethality in a murine sepsis model compared to a 
clinical methicillin-susceptible S. aureus (MSSA) isolate and provided information on 
differential gene expression.39 To our knowledge, no studies have assessed the relative 
pathogenesis of LA-S. aureus acquired from swine on an IHO compared to a well-
characterized and highly pathogenic CA-MRSA strain isolated from a human SSTI 
outbreak in the community. Considering that LA-S. aureus has surfaced in community 
members, including children, who experience environmental exposure to CAFOs, it is 
critical to improve our understanding of the pathogenic potential of LA-S. aureus strains 
emerging from CAFO environments and resulting in human SSTI.  This study aims to 
understand the degree to which LA-S. aureus strains contracted by IHO workers cause 
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disease relative to a representative hypervirulent CA-MRSA strain -- i.e., USA300 clone, 
SF8300,37,38 in a mouse model of SSTI.  
METHODS 
 
Selection of S. aureus isolates.  
 One CC9 and one CC8 LA-MDRSA strain were selected that were collected from 
the anterior nares of two IHO workers who reported a SSTI within the past 3 months 
between October 2013 and February 2014 in a prospective cohort study of IHO workers 
in North Carolina (NCHW9 and NCHW8).15 Two CC398 LA-MDRSA isolates were 
selected that were collected directly from two IHO workers’ active skin infections 
between May 2011 and February 2013 in a prospective cohort study of IHO workers in 
Iowa,16 and were provided by Dr. Tara C. Smith from Kent State University (IHW398-1 
and IHW398-2). IHW398-1 was responsible for a physician-diagnosed recurrent SSTI in 
a male hog worker.32 The representative CA-MRSA strain SF8300 was isolated from a 
SSTI in a patient treated at the San Francisco General Hospital and was provided by Dr. 
Henry Chambers of University of California San Francisco. SF8300 is pulsed-field type 
USA300, which is the type responsible for the vast majority of CA-MRSA SSTI in the 
USA, Canada, and Europe,37 and displays a high degree of pathogenicity in a mouse 
model of SSTI.38 Hemolytic activity was treated as a binary variable and was confirmed 
for each isolate by observation of a zone of hemolysis after 24-hours of growth on blood 
sheep agar plates.   
Indicators of livestock association.  
50 
 
  There is currently no established molecular marker for LA-S. aureus. LA-
MDRSA has been consistently classified as: (i) MDRSA carriage or infection in humans 
arising from exposure to livestock, (ii) belonging to the clonal complex 398 (CC398) or 
CC9, and (iii) lacking the staphylococcal complement inhibitor gene scn (scn-).14,15 Here 
we used CC9 or CC398 within the IIa livestock clade of the CC398 phylogeny, and the 
absence of the scn gene (scn-) as indicators of LA-S. aureus.  Putative clonal complex 
(CC) was assigned to each isolate based on spa type, using the Ridom StaphType 
software and the Ridom SpaServer (http://spa.ridom.de/index.shtml).  
Antimicrobial susceptibility testing. 
 Each selected S. aureus strain was subjected to a panel of antibiotics for antibiotic 
susceptibility testing (AST) using the Phoenix Automated Microbiology System (BD 
Diagnostic Systems, Sparks, MD) by the the Clinical Microbiology Laboratory at the 
Johns Hopkins Hospital, according to guidelines for clinical isolates.  MRSA was defined 
as resistant to cefoxitin or oxacillin and positive for the mecA or mecC gene.  MDRSA 
was defined as resistant to greater than or equal to three classes of antibiotics. MIC cut 
off’s used to establish resistant, intermediate, or susceptible phenotypes, and antibiotic 
abbreviations, are provided in Chapter 3: Supplementary Information (Table 3S.1).  
S. aureus growth curves. 
 S. aureus strains were streaked onto tryptic soy agar plates and grown overnight.  
Single colonies were selected and grown in tryptic soy broth (TSB) at 37°C in a shaking 
incubator overnight, shaking at 240 rpm and then sub-cultured at a 1:50 dilution in TSB.  
At 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, and 4.5 hours, 100 µL of the sub-cultures were pipetted 
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onto a 96-well plate and absorbance (600 nm) was read with a Synergy H1 Hybrid 
Microplate Reader (BioTek Instruments, Inc., Winooski, VT).  
Mice. 
Mice with a C57BL/6 genetic background were used in all experiments. Mice 
were obtained from The Jackson Laboratory (Bar Harbor, ME). Mice were bred and 
maintained under specific-pathogen-free conditions at an American Association for the 
Accreditation of Laboratory Animal Care (AAALAC)-accredited animal facility at Johns 
Hopkins and housed according to procedures described in the Guide for the Care and Use 
of Laboratory Animals published by the US National Institutes of Health (8th edition, 
2011). 
Mouse model of S. aureus skin and soft tissue infection. 
 Animal care and all experiments were approved and performed in accordance 
with the guidelines and regulations approved by the Johns Hopkins University Animal 
Care and Use Committee, which conform to the Guide for the Care and Use of 
Laboratory Animals published by the US National Institute of Health (8th edition, 2011). 
As a first step toward identifying the relative pathogenicity of LA-S. aureus compared to 
that of CA-MRSA, we evaluated the skin lesions that developed in response to 
intradermal (i.d.) infection of four LA-MDRSA isolates collected from IHO workers and 
a representative CA-MRSA strain (SF8300) in a mouse model of SSTI (Figure 2.2A). 
The SF8300 strain was chosen as a representative CA-MRSA strain for this study 
because it is the same pulsed-field USA300 type responsible for the epidemic of CA-
MRSA SSTI in humans in the USA37 and has been previously used to compare 
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pathogenicity of S. aureus cutaneous infections in mice.38 The upper backs of C57BL/6 
mice were shaved and inoculated intradermally with 3 × 107 colony-forming units (CFU) 
in 100 µl PBS of midlogarithmic growth phase SF8300 (CC8) (n=20 mice) or the 
following LA-S. aureus strains (n=10 mice/strain) BP772 (CC8), CA746 (CC9), 15606P 
(CC398), or 172784P (CC398). Digital photographs of mice taken on days 0, 1, 3, 7, 10, 
and 14 post-challenge were analyzed for measurements of total lesion size (area, cm2) 
using ImageJ software. Data reported as mean total lesion size (cm2) ± the standard error 
of the mean (SEM).  
Measuring bacterial burden. 
 Mice (n=5/group) were euthanized on day 3 post-infection and 10-mm skin punch 
biopsies of lesions, taken from the middle of the lesion, were homogenized (Pro200 
Series homogenizer; Pro Scientific, Oxford, CT) in PBS on ice. Samples were serially-
diluted and cultured on TSA plates overnight at 37°C and CFU were enumerated.   
Cytokine, chemokine, and growth factor evaluation in infected skin. 
 Infected skin biopsies from day 3 were analyzed for protein levels of cytokines, 
chemokines and growth factors to provide insights into the host response to CA-MRSA 
or LA- S. aureus i.d. inoculation.  Mice (n=5/group) were euthanized on day 3 post-
infection and 10-mm skin punch biopsies of lesions were weighed and snap-frozen in 
liquid nitrogen.  On ice, each specimen was homogenized with a hand-held homogenizer 
(Pro200 Series homogenizer; Pro Scientific) in Protein Lysis Buffer (Promega) 
containing protease inhibitor cocktail (Roche). All samples were stored at 80°C. Samples 
were then centrifuged at 4°C and supernatants were assayed for total protein, and protein 
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levels of cytokines, chemokines and growth factors using a 9-plex and 11-plex mouse 
protein array, according to the manufacturer’s recommendations (Bio-Plex Pro™, Biorad; 
Hercules, CA). Total protein concentration was determined using NanoDrop. For the 9-
plex and 11-plex arrays, samples were normalized to 0.75 mg/mL and 2 mg/mL total 
protein, respectively. Samples were also assayed for myeloperoxidase (MPO) levels 
using a commercially available ELISA kit (R&D Systems, Minneapolis, MN).  
Genome sequencing. 
 We sequenced and assembled the genomes of the LA-MDRSA isolates, and used 
the publicly available genomic sequence of SF830037 for WGSA. DNA was prepared for 
multiplexed, paired-end sequencing on an Illumina MiSeq (Illumina, Inc., San Diego, 
CA). For each isolate, 500 ng of DNA was sheared to an average fragment size of 300 bp 
in 50 µL using a Covaris E220 Focused-Ultrasonicator (Covaris, Woburn, MA).  End 
repair, A-tailing, and adaptor ligation of the total volume of sheared DNA was performed 
using the Kapa Hyper Prep Kit (Kapa Biosystems, Inc., Wilmington, MA) with 
recommended adaptor concentrations for libraries constructed from 500 ng input DNA. 
Uniquely barcoded adaptors used in adaptor ligation were obtained from BioO 
Scientific® (BioO Scientific®, Austin, TX, NEB, NEXTflex-96™ DNA Barcodes for 
DNA).  Following ligation of adaptors, KAPA Pure Beads (Kapa Biosystems, Inc., 
Wilmington, MA) were used to perform a 0.8X bead-based cleanup for each DNA 
library. Individual libraries were quantified in triplicate at two concentrations (1:100 and 
1:1000) via quantitative PCR using the Kapa Library Quantification kit (Kapa 
Biosystems, Inc. Wilmington, MA,). Based on individual library concentrations, 
equimolar pools of S. aureus libraries were prepared at a concentration of at least 1 nM. 
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The pooled libraries were quality controlled on an Agilent bioanalyzer and sequenced on 
an Illumina MiSeq at 2 × 300 bp.  
De novo assembly and molecular characterization of S. aureus genomes. 
 To gain information on the genetic basis for the pathogenic potential of LA-
MDRSA as compared to SF8300, we assessed the presence of core and mobile genetic 
element (MGE) encoded virulence factors (VF’s) and acquired antimicrobial resistance 
(AMR) genes important for pathogenesis in humans. Illumina short-read sequences were 
trimmed using trimmomatic80, and assembled into contigs using the SPADES assembler 
(v.3.5).81 Assembly quality was assessed using QUAST (v.2.3),82 and reference MLST 
housekeeping genes were identified using BLAST (Version 2.2.25+)83 at 100% query 
coverage and nucleotide identity (ID).  An in-house script was used to match genes and 
MLST profile data84 to determine the final MLST type.  These analyses were performed 
on the GWU Colonial High Performance Computing Cluster. Virulence factor (VF) and 
Antimicrobial resistance (AMR) genes were determined by uploading each assembled S. 
aureus genome onto the S. aureus VirulenceFinder 1.553 and ResFinder 3.0,54 available 
on the Center for Genomic Epidemiology (CGE) server. ABRicate 
(https://github.com/tseemann/abricate), a modified BLASTn based tool for the screening 
of genes in assemblies, was used with a custom database containing microbial surface 
components recognizing adhesive matrix molecules (MSCRAMMs), and several 
additional hemolysins and leucocidins, to detect the following genes on the assembled S. 
aureus genomes: clfA (GenBank accession no. Z18852) and clfB (GenBank accession no. 
AJ224764) encoding clumping factor A and B (ClfA and ClfB), sdrC (GenBank 
accession no. AJ005645), sdrD (GenBank accession no. AJ005646), and sdrE (GenBank 
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accession no. AJ005647) encoding serine-aspartate repeat protein C, D, and E (SdrC, 
SdrD, and SdrE), bbp (GenBank accession no. BX571856) encoding bone sialoprotein-
binding protein (Bbp), fnbpA (GenBank accession no. J04151) and fnbpB (GenBank 
accession no. X62992) encoding Fibrinogen-binding protein A and B (FnBPA and 
FnBPB), and cna (GenBank accession no. M81736) encoding collagen adhesin (Cna), hla 
(GenBank accession no. CP000255 , BX571856, BX571857, BA000017, BA000033, 
BA000018, CP000046) encoding for alpha hemolysin, hlb (GenBank accession no. 
BX571856, BX571857, BA000017, BA000033, BA000018, CP000046) encoding for 
beta hemolysin, lukA and lukB (GenBank accession no. AP009351) encoding for the 
LukAB leucocidin, and nor (GenBank accession no. BX571856) encoding for nitric 
oxide reductase.  For all genome hits, the threshold of ID was set to 85% and percentage 
of minimum gene length was set to 60%. All genome hits were manually inspected for 
confirmation. 
Statistical analysis. 
 Data were compared using Student’s t test (two-tailed), comparing each LA-S. 
aureus strain to the representative SF8300 CA-MRSA referent strain. p-values < 0.05 
were considered statistically significantly.  
RESULTS 
 
LA-S. aureus and antibiotic susceptibility testing. 
 
Of the 17 antibiotics tested, complete or intermediate resistance was observed to 
all antibiotics except for vancomycin, linezolid, daptomycin, rifampicin, and 
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nitrofurantoin (Figure 2.1). All S. aureus clones were resistant to ampicillin and 
penicillin, and displayed a multidrug resistant phenotype, while only the CA-MRSA 
clone SF8300 displayed a methicillin-resistant phenotype. The SF8300 isolate also 
displayed complete resistance to erythromycin and cefotaxime, and intermediate 
resistance to quinupristin/dalfopristin. The NCHW8 isolate, collected from an IHO 
worker’s nares, additionally displayed resistance to erythromycin, clindamycin, and 
gentamycin. Both CC398 isolates displayed resistance to tetracycline and intermediate 
resistance to quinupristin/dalfopristin and minocycline, while the IHW398-1 isolate, 
responsible for a recurrent SSTI in an IHO worker, also displayed resistance to 
moxifloxacin and sulfamethoxazole/trimethoprim. The SSTI-associated CC9 isolate 
displayed resistance to erythromycin, clindamycin, and moxifloxacin.        
 
LA-S. aureus-infected mice and skin lesion size.  
 
Growth curves showed a mid-logarithmic phase at 3 hours for all isolates, and 
there were no statistically significant differences in growth curves between isolates 
(Figure 2M.1). Mice were inoculated i.d. with 3x107 CFU’s of mid-logarithmic growth 
phase S. aureus and skin lesion sizes were evaluated over time (Figure 2.2B). All of the 
S. aureus strains resulted in visible skin lesions that healed by day 14. SF8300 and 
NCHW9 infected mice developed maximum lesion size on day 7 of 0.9 ± 0.1 cm2 and 0.8 
± 0.1 cm2, respectively. IHW398-1, IHW398-2, and NCHW8 infected mice developed 
maximum lesion sizes on day 3 of 1.3 ± 0.1 cm2, 1.0 ± 0.1 cm2, and 0.9 ± 0.2 cm2, 
respectively. Both CC398 LA-MDRSA strains collected directly from IHO workers with 
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active SSTI developed significantly larger lesion sizes on day 3 compared with SF8300 
(P < 0.05) (Figure 2.2B). The skin lesions sizes of all other LA-MDRSA isolates (CC9 or 
CC8) were not statistically different from those of SF8300 at any time point. Of note, 
mice infected with the IHW398-1 clone which was responsible for a recurrent SSTI in an 
IHO worker, developed the largest lesion sizes, peaking on day 3 and were 2-fold greater 
than those of SF8300-infected mice (Figure 2.2C). 
 
LA-S. aureus-infected mice and bacterial burden.  
Given that the CC398 lesion sizes peaked on day 3, we evaluated the bacterial 
burden by determining ex vivo CFU isolated from skin punch biopsy specimens of the 
entire skin lesions obtained on day 3. Ex vivo CFU from CC398 (IHW398-1 and 
IHW398-2) and CC9 LA-MDRSA-infected mice were significantly greater compared 
with SF8300-infected mice (Figure 2.3), suggesting increased bacterial proliferation 
and/or persistence of these particular LA-MDRSA strains in vivo.  
LA-S. aureus-infected mice and local cytokine, chemokine, and growth factor levels. 
At day 3 post-infection, SF8300-infected mice had significantly greater protein 
levels of IL-1β compared with all LA-MDRSA-infected mice (P < 0.05) (Figure 2.4A). 
IHW398-1-, IHW398-2-, and NCHW9-infected mice had significantly greater protein 
levels of IL-6 compared with the CC8 strains SF8300 and BP772 (P < 0.05). IHW398-1-, 
IHW398-2-, and NCHW9-infected mice also had significantly increased protein levels 
IL-12(p70) compared with SF8300-infected mice (P < 0.05). Proteins that showed no 
difference between LA- and CA- S. aureus infected mice were IL-10 (Figure 2.4A), TNF, 
IL-12(p40), LIF, MIG, M-CSF, VEGF, and MPO and several cytokines were below the 
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limit of detection (IFN-γ, IL-4, IL-5, and IL-17A) (Figure 2.4A and B). With respect to 
chemokines, the neutrophil-attracting chemokine MIP-2 were significantly greater in day 
3 lesions of SF8300 infected mice compared to lesions of NCHW8, IHW398-1, and 
NCHW9 infected mice (P < 0.05) (Figure 2.4A). Taken together, LA-S. aureus strains 
had lower IL-1β and MIP-2 but higher levels of IL-6 and IL-12(p70) compared with 
SF8300.  
 
Whole-genome sequencing analysis (WGSA) of CA- and LA-S. aureus.  
 
Figure 2.5 displays genomes hits for VFs and acquired AMR genes present in at 
least one of the five S. aureus genomes used in this study. WGSA of VF genes led to the 
following key findings (Figure 2.5A). First, MSCRAMM genes clfA, clfB, fnbA, and 
fnbB, known to play a role host cell adhesion,85 are present among CA- and LA- S. 
aureus strains. Second, human IEC genes scn and sak were present among CC8 isolates 
and were absent from LA-MDRSA CC398 and CC9 isolates. Third, the splA, splB, and 
splC genes encoding serine proteases, and reported to increase virulence in-vivo, present 
only among the CC8 strains.86 The nor gene encoding for a nitric oxide reductase enzyme 
has also been reported to increase S. aureus virulence but was only present among the 
LA-S. aureus CC398 strains.87 Fourth, hemolysin genes hla, known to play a critical role 
in dermo-necrosis,88–91 and the hlgA, hlgB, and hlgC genes were conserved across CA-
MRSA and LA-S. aureus isolates. hlb appeared to be truncated in the CA-MRSA strain 
and intact in the LA-S. aureus strains. Fifth, the leukotoxin encoding genes lukD and 
lukE, known to induce inflammation and dermonecrosis,92,93 were present among CC8 S. 
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aureus isolates, but only the SF8300 CC8 isolate carried the Panton-Valentine 
Leukocidin encoding genes lukF-PV and lukS-PV.  lukA and lukB genes encoding for the 
bicomponent LukAB leucocidin were present among CA- and  LA- S. aureus genomes. 
Lastly, neither CC398 LA-MDRSA isolates contained any known enterotoxin genes 
typically encoded on prophages and pathogenicity islands. The genes encoding 
enterotoxin K (sek) and enterotoxin Q (seq) were conserved across CC8 isolates, while 
the SSTI-associated NCHW8 CC8 isolate additionally carried the enterotoxin A (sea) and 
enterotoxin C (sec) encoding genes. Unique to the CC9 LA-MDRSA isolate was the egc 
cluster, encoding for enterotoxin G, I, M, N, and O (seg, sei, sem sen, seo)..  
WGSA of AMR genes led to the following key findings (Figure 2.5B). First, the 
mecA gene, encoding for methicillin resistance, was absent from LA-MDRSA, but these 
isolates carried the beta-lactamase encoding gene blaZ. Second, both CC398 and the CC9 
LA-MDRSA genomes encoded for tetracycline resistance. The CC398 isolates carried a 
tet(M) gene, while the CC9 isolate carried a tet(L) gene. Third, macrolide resistance 
encoding genes were found only in LA-MDRSA isolates. The NCHW8 and NCHW9 
isolate carried the erythromycin resistance encoding gene erm(A), and the IHW398-2 and 
NCHW9 isolates carried the ATP-binding protein encoding gene vga(A) conferring 
resistance to streptogramin A antibiotics. Fourth, unique to the IHW398-1 isolate, 
responsible for a recurrent SSTI in an IHO worker, was the dfrG gene encoding 
resistance to trimethoprim antibiotics. Fifth, the spc gene, conferring resistance to 
spectinomycin, was found only in the LA-MDRSA isolates collected from IHO workers 
in North Carolina (NCHW8 and NCHW9). Finally, unique to the NCHW8 isolate was 





The results of this study demonstrate an increased degree of pathogenicity 
associated with LA-S. aureus, marked by increased lesion size and bacterial burden, 
compared to CA-MRSA in a mouse model of SSTI. The IHW398-1 isolate in particular, 
which belongs to the LA-CC398-IIa lineage,32 displayed the greatest degree of 
pathogenicity and was a LA-MDRSA isolate. It is notable that the lesion size of the 
NCHW9 LA-CC9 isolate was equivalent to the CA-MRSA strain (SF8300). Additionally, 
the S. aureus CFU counts recovered from the NCHW9 LA-CC9 infected lesions were 
significantly greater than the CA-MRSA strain (SF8300) and comparable to those of the 
highly pathogenic IHW398-1 LA-CC398-IIa strain. The CC9 LA-MDRSA strain appears 
to display increased bacterial proliferation and/or persistence in vivo. This is important 
because the CC9 lineage of S. aureus is emerging as a predominant clone among IHO 
workers and community residents in North Carolina10,15 It is critical to continue to 
monitor the spread of LA-S. aureus CC9 into human populations, and further elucidate 
mechanisms of virulence and persistence. In certain regions of the world , LA-S. aureus 
has successfully disseminated into the human community and is a major contributor to 
human morbidity, accounting for 25% of MRSA isolated in parts of Europe.13 IHO 
workers are at an increased risk of carrying LA-MDRSA,9,15,45 and developing LA-S. 
aureus SSTI.11,15,16 As our efforts to understand and combat the environmental and 
community origins of antimicrobial resistant S. aureus infections become a priority in the 
USA, it is critical to examine the pathogenic potential of LA-S. aureus that have 
contributed to human morbidity.  
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We also observed that the host cytokine and chemokine response to LA-MDRSA 
strains differed from that of CA-MRSA. Neutrophil derived IL-1β plays a critical role in 
amplifying and maintaining a neutrophilic response for abscess formation and bacterial 
clearance,94 and previous studies have reported that S. aureus-infected IL-1β-deficient 
mice develop larger skin lesions with higher bacterial counts than wildtype mice.95 An 
optimal response to S. aureus SSTI is associated with elevated local IL-1β protein 
levels89,94–97.  Furthermore, engulfment of S. aureus by polymorphonuclear cells (PMNs) 
is known to alter macrophage production of IL-6, which subsequently lowers secretion of 
IL-1β.96  Our cytokine results indicated that the host response to LA-S. aureus infections 
might be suboptimal, as LA-S. aureus-infected mice had larger lesions, higher bacterial 
burden and decreased IL-1β and MIP2 and increased IL-6 levels compared with SF8300-
infected mice. A possible explanation for these findings is that LA-S. aureus have a 
distinct VF repertoire that might have suppressed the optimal IL-1β neutrophilic response 
required for bacterial clearance of CA-MRSA from the site of the SSTI. S. aureus alpha-
toxin, for example, has been shown to suppress local IL-1β production in a mouse model 
of SSTI.89  
Although all of the isolates displayed phenotypic hemolysis, our WGSA revealed 
that only LA-S. aureus CC398 and CC9 carried an intact beta-hemolysin gene. An 
insertion of the Sa3 prophage into the beta-hemolysin gene55 results in a truncated beta-
hemolysin gene in both of the CC8 genomes (SF8300 and NCHW8). A previous study 
has reported that mutant strains lacking the Sa3 prophage, thereby carrying an intact beta-
hemolysin gene, display a greater degree of hemolysis compared to its wild type.98 An 
intact hlb gene has been previously shown to increase S. aureus fitness for colonization 
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and persistence in mice.98 However, a critical role for hlb in the pathogenesis of SSTI is 
not entirely clear.88  The gain of an intact beta-hemolysin gene is dependent on the loss of 
human immune evasion cluster (IEC) genes – the Sa3 prophage can carry several human 
IEC genes including scn and sak,55 which were absent from the genomes of the LA-S. 
aureus CC9 and CC398 isolates (NCHW9, IHW398-1, and IHW398-2). The 
staphylococcal complement inhibitor protein has been reported to be highly 
immunogenic99 and functional only against components of the human immune system.55 
For these reasons, it may be the loss of the Sa3 prophage and its associated proteins that 
provides improved virulence for LA-S. aureus CC398 in a mouse model of SSTI. 
Furthermore, the nor gene, commonly associated with pathogenic bacteria and 
hypothesized to provide improved virulence and fitness for S. aureus infections in vivo,87 
was also only found among the LA-S. aureus CC398 isolates that produced the largest 
lesions (IHW398-1 and IHW398-2). Taken together, there are many genetic differences 
between S. aureus CC8 and CC398 that could be responsible for the observed lesion 
sizes, including the gain or loss of genes encoding for important hemolytic toxins or 
immune evasion proteins. 
Our study had several strengths. First, to our knowledge, this was the first 
experimental design involving LA-S. aureus strains isolated from nasal carriage and SSTI 
events of IHO workers in the United States. Second, this study was the first, to our 
knowledge, to characterize the relative pathogenicity of a LA-S. aureus CC9 strain, 
which appears to be an emerging clone among IHO workers in North Carolina and 
Asia.10,15,30 Finally, we compared all LA-S. aureus strains to a well-characterized 
USA300 CC8 strain that has consistently demonstrated substantial pathogenicity in 
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C57BL/6 mouse models of SSTI and capacity to cause human infections in community 
settings.37,38  
Our study also has several limitations.  First, certain S. aureus virulence factors 
(VFs) expected to increase pathogenicity may have low, or no activity in a mouse model 
of SSTI, such as PVL, HlgAB, and HlgBC.92 Furthermore, LA-S. aureus largely do not 
carry human immune evasion cluster (IEC) genes, scn and sak55, suggesting a host 
adaptation to animals.12 Thus, these results should be interpreted within the limitations of 
using a mouse model to compare the virulence of the included S. aureus strains. Second, 
this study was done with a single large dose inoculum. Future studies should conduct 
multiple dose inoculums to determine a dose response relationship and whether dose 
plays a role in the observed differences in pathogenicity. Finally, our study characterizes 
the pathogenicity of a single LA-S. aureus nasal carriage isolate, whereas isolates within 
the LA-S. aureus CC398 and CC9 lineages display considerable diversity. Thanh-Thao et 
al. reports a conservation of core-genome elements, such as spa type, between nasal 
carriage isolates within individual, but more heterogeneity between isolates for mobile 
genetic element (MGE) encoded genes, such as scn and AMR genes.100 Differences in 
pathogenicity between closely related isolates of S. aureus is well established, and future 
studies should compare multiple isolates of each lineage to make confident lineage 
related conclusions.   
CONCLUSIONS 
 
The results of this study provide new insights into the pathogenicity of emerging 
LA-S. aureus strains that are commonly contracted by IHO workers and may have 
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potential for dissemination into the community.10  The increased disease and bacterial 
burden observed in the mice in response to the LA-S. aureus skin infection compared to a 
highly virulent CA-MRSA skin infection indicate an importance for occupational and 
public health. The WGSA suggests that a subset of VF genes involved in the 
pathogenesis of S. aureus SSTIs was conserved across CA-MRSA and LA-S. aureus 
isolates, while LA-S. aureus isolates carried a greater frequency and diversity of AMR 
genes encoding for resistance to antibiotics that are critically important for human 
health.72 Therefore, future research efforts to study, monitor and determine virulence 
mechanisms, host immune responses and response to treatment in humans that suffer 













Figure 2.1. Hemolytic activity and antibiotic susceptibilities of LA-S. aureus and 
CA-MRSA. Hemolysis and antibiotic susceptibility testing results are shown for each S. 
aureus isolate Hemolytic activity was measured as a binary variable, and defined as the 
formation of a zone of hemolysis after 24 hours of growth on blood sheep agar. MRSA 
was defined as cefoxitin or oxacillin resistant or positive for the mecA or mecC gene. 
MDRSA was defined as resistant or intermediate to at least three classes of antibiotics. 
For the hemolytic, MRSA, and MDRSA categories, black = positive and white = 
negative. For antibiotic susceptibility categories, black = resistant, grey = intermediate, 










Figure 2.2. LA-S. aureus-infected mice develop larger lesion sizes compared to CA-
MRSA.  (A) Schematic of mouse model of SSTI. (B) Mean total lesion size (cm2) ± 
SEM. (C). Representative photographs of the lesions at day 3 for two mice. 1*, p < 0.05 
= each LA-S. aureus strain (n=10/group) versus CA-MRSA SF8300 (n=20), as calculated 
by a two-tailed Student’s t-test. Note. LA = livestock-associated. CA = community-








Figure 2.3. Ex vivo colony forming units (CFU) in LA-S. aureus and CA-MRSA 
infected skin. On day 3, homogenates of infected skin were assayed for ex vivo CFU 
levels. Ex vivo CFU ± SEM. *, p < 0.05, between LA-S. aureus strains versus SF8300 












Figure 2.4. Cytokine, chemokine and growth factor protein levels in LA-S. aureus 
and CA-MRSA infected skin. On day 3, homogenates of infected skin were assayed for 
ex vivo protein levels of host response proteins. (A) Mean protein levels (pg/mL 
homogenate) ± SEM. *, p < 0.04, between LA-S. aureus strains versus SF8300, as 
calculated by a two-tailed Student’s t-test. (B) Summary of LA-S. aureus protein levels 
compared to CA-MRSA (SF8300) protein levels for all 21 proteins. *, p < 0.04; **, p < 
0.002 = statistically significant difference via two-tailed students t-test compared to 




Figure 2.5. Virulence factor and AMR genes in LA-S. aureus and CA-MRSA. The 
presence of a genome hit (indicated by red shading) was defined >85% gene 
identification similarity and >60% gene length similarity and confirmed by manual 
inspection. (A) Microbial surface components recognizing adhesive matrix molecules 
(MSCRAMM), human immune evasion, metabolic enzyme, hemolysin, leucocidin/toxin, 
and Staphylococcal enterotoxin gene genome hits generated via VirulenceFinder 1.5 or 
ABRicate tool. (B) Acquired antimicrobial resistance gene genome hits generated via 
ResFinder 3.0. Note. LA = livestock-associated. CA = community-associated. MRSA = 





Development and application of antibody-based biomarkers of 
Staphylococcus aureus exposure, colonization, and infection in oral 
fluid among industrial hog operation workers and their household 























Introduction. Recent advances in our understanding of the adaptive immune response to 
S. aureus have lead to the investigation of antibody-based biomarkers associated with S. 
aureus colonization and infection. While epidemiological studies provide strong support 
for occupational exposure to S. aureus among industrial hog operation (IHO) workers, to 
our knowledge, no studies have aimed to measure IgA and IgG antibodies against 
candidate S. aureus antigens in a population of IHO workers and their household 
contacts. Furthermore, no studies, to our knowledge, have evaluated S. aureus antigen-
specific IgA and IgG antibody levels in oral fluids. 
Objectives: The objectives of this study were to measure IgA and IgG antibody levels 
against staphylococcal complement inhibitor (SCIN), clumping factor A (ClfA), and 
alpha toxin (AT) in OF collected from IHO workers and their household contacts and 
examine these biomarkers’ association with S. aureus nasal carriage outcomes,self-
reported skin and soft tissue infection (SSTI), and personal protective equipment (PPE) 
use. 
Methods. An OF multiplex S. aureus Luminex enzyme immunoassay (EIA) was 
developed. Magnetic microsphere bead coupling was confirmed for SCIN, ClfA, and AT 
antigens. The multiplex Luminex EIA for IgA and IgG specific to SCIN, ClfA, and AT 
antigens was applied to OF samples collected from a cohort of IHO workers and their 
household contacts in North Carolina (NC), United States (USA). Associations were 
assessed between median fluorescence intensity (MFI) for IgA and IgG in OF specific to 
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SCIN, ClfA, and AT and S. aureus nasal carriage outcomes, and self-reported SSTI and 
facemask use. 
Results. OF IgA and IgG antibody levels against SCIN, ClfA, and AT among children 
(7-17 years) were significantly lower than those among adults. OF IgA antibody levels 
remained elevated among elderly adult age groups (≥50 years of age), whereas OF IgG 
antibody levels waned at elderly ages. Anti-ClfA IgA and IgG antibody levels were 
significantly elevated among IHO workers who carried S. aureus, multidrug-resistant S. 
aureus (MDRSA), and tetracycline-resistant S. aureus (tet[R]-S. aureus) intranasally. 
These associations were attenuated among IHO workers who reported they always or 
sometimes wore a facemask. Anti-ClfA IgA levels were positively and anti-SCIN levels 
were negatively associated with self-reported SSTI. 
Conclusions. An OF-based S. aureus multiplex immunoassay was developed that can be 
employed in occupational and community settings to measure early biologic antibody-
based response to S. aureus exposure. IHO workers who are occupationally exposed to 
IHO-derived S. aureus subpopulations, including MDRSA and tet[R]-S. aureus, 
displayed elevated antigen-specific IgA and IgG antibodies against S. aureus in OF. OF 
antibodies against ClfA may serve as a promising biomarker of occupational exposure 
and progression to early biologic effects related to S. aureus acquisition among IHO 







Recent advances in our understanding of the adaptive immune response to S. 
aureus have lead to the investigation of antibody-based biomarkers associated with S. 
aureus colonization and infection.27,99 While a number of antigen-specific antibodies 
against S. aureus antigens may serve as candidate biomarkers of S. aureus exposure,99,101 
multiple groups have shown elevated serum IgA and IgG antibody levels against 
clumping factor A (ClfA) and alpha toxin (AT) in response to S. aureus 
colonization.27,99,101 Furthermore, anti-AT IgG antibody levels are consistently elevated 
among clinical populations experiencing S. aureus SSTI,27 bacteremia,102 and exposure 
through injection drug use.42 A robust serum IgA and IgG signal against Staphylococcal 
Complement Inhibitor (SCIN) has also been demonstrated among populations nasally 
colonized with S. aureus99 and experiencing S. aureus bacteremia,101 indicating that 
SCIN is a highly immunogenic S. aureus protein. Thus, IgA and IgG antibodies directed 
against S. aureus antigens that play a role in adhesion, immune evasion, and 
pathogenicity, may serve as antibody-based biomarkers of early biological effect in 
response to S. aureus exposure.  
A growing body of evidence suggests that having frequent contact with, or living 
near, swine raised on industrial hog operations (IHO) is associated with increased S. 
aureus exposure, including carriage of methicillin- (MRSA) and multidrug- (MDRSA) 
resistant S. aureus.10,11,14–16,103 Furthermore, individuals exposed to livestock-associated 
(LA-) S. aureus are at risk of developing mild-to-severe infections, including skin and 
soft tissue infections (SSTIs) and blood stream infections.16,25 In particular, IHO-workers 
in North Carolina (NC), United States (USA) who are occupationally exposed to swine 
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are at an increased risk of carrying S. aureus intranasally,10,14,15 including MDRSA,14,15 
tetracycline resistant S. aureus (tet[R]-S. aureus) ,14,15 and LA-S. aureus.14,15 While 
epidemiologic studies provide strong support for an occupational exposure to S. aureus in 
the IHO environment, to our knowledge, no studies have aimed to measure IgA and IgG 
antibodies against candidate S. aureus antigens in a population of IHO-workers and their 
household contacts in the USA     
While most studies aimed to understand the anti-S. aureus humoral response are 
focused on serum, oral fluids (OF) represent a noninvasive biological fluid with scientific 
and clinical potential in the context S. aureus colonization and infection. The potential for 
utilizing OF in longitudinal epidemiologic studies, particularly those focused on 
understanding the temporal kinetics of transient exposure-response dynamics, has 
prompted the development and application of OF-based immunoassays to measure the 
burden of human exposure to environmental and clinical pathogens.104,105 The two 
dominant antibody classes that operate in OF are secretory IgA (SIgA), produced by local 
plasma cells in OF glands, and IgG, derived primarily from passive leakage of blood via 
the gingival crevicular epithelium.106 A growing body of evidence now supports that OF 
IgA and IgG can dependably reflect mucosal and systemic immune activity,107 and it has 
been previously reported that anti-S. aureus antibody levels (IgA and IgG) in secretions 
from the nasal mucosa correlate with levels in serum.102 To our knowledge, IgA and IgG 
antibodies against S. aureus antigens in OFs remains entirely unexplored. Considering 
the consistent observation of elevated serum anti-ClfA, anti-AT, and anti-SCIN antibody 
levels among S. aureus exposed populations,27,42,101,102 we parsimoniously chose to probe 
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OF samples collected from IHO workers and their household contacts in NC, USA for 
IgA and IgG antibodies against ClfA, AT, and SCIN. 
The objectives of this study were to: 1) Develop an OF multiplex S. aureus EIA, 
2) study the relationship between age and OF anti-ClfA, anti-AT, and anti-SCIN IgA and 
IgG levels among IHO workers and their household contacts, and determine if this 
relationship is consistent with previously published research, 3) determine the 
relationship between S. aureus nasal carriage outcomes (MDRSA, tet[R]-S. aureus, and 
LA-S. aureus) and OF IgA and IgG levels against SCIN, ClfA, and AT among IHO-
workers and their household contacts, 4) understand how the relationship between OF 
IgA and IgG levels against ClfA, AT, and SCIN are modified by protective facemask 
use14 among IHO-workers; and 5) evaluate associations between OF IgA and IgG levels 
against SCIN, ClfA, and AT and self-reported SSTI among IHO workers and their 
household contacts.   
METHODS 
 
Population and sample collection.  
For this study, data and samples were collected from IHO-workers and their adult 
and minor household contacts who participated in a prospective cohort study in North 
Carolina (NC), USA between October 2013 and February 2014.14,15 IHO-workers were 
recruited who fit the following inclusion criteria: resided in NC, currently worked at an 
IHO, could speak English or Spanish, and was at least 18 years of age. Participants were 
considered IHO-workers only if they were employed in the production of live pigs. 
Individuals employed in other types of food animal production, such as meat processing, 
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were not included in the study. Up to three (3) IHO-worker household contacts were 
allowed to participate, and they were eligible to participate if they were at least seven 
years of age and spoke English or Spanish.       
At enrollment, participants completed a baseline questionnaire. Participants were 
followed for 4 months after baseline, and completed up to eight questionnaires every 2 
weeks (biweekly) throughout the study. The baseline questionnaire captured demographic 
information, household-level characteristics, and time-invariant activities that could be 
related to S. aureus exposure. At baseline and at each biweekly visit, participants 
provided a self-collected BD BBL CultureSwab (BD Diagnostics) from both of their 
nares and an oral fluid sample (Oracol S10 saliva swab, Malvern Medical Development, 
Worcester, UK). To collect OF samples, participants were first instructed to rinse their 
mouth with cold water and then brush the Oracol along their gum line for one minute.  
Following collection, OF samples were stored at 4oC until reaching the lab. Once at the 
lab, the Orocol sponge of each OF collection devise was turned upside down (sponge 
down) using sterile forceps, and was centrifuged for 10 mins at 1,500 g to spin the OF out 
of the sponge. The sponge was then removed, OF was transferred into cryovials, and 
were then stored at -80oC.      
Detection of S. aureus.  
Each self-collected BD BBL CultureSwab was clipped into 1mL of phosphate-
buffered saline (PBS) and vortexed for 60 seconds. 100ul of this eluate was plated onto 
CHROMagar™ Staph aureus (BD, Franklin Lakes, ND) and incubated at 37oC for 24 
hours. After 24 hours of incubation, at least two colonies with morphological 
characteristics indicative of S. aureus were re-streaked to isolation on a new CSA plate. If 
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direct plating did not result in any colony formation with S. aureus morphology, swabs 
and the remaining PBS were enriched in 10mL of Mueller-Hinton broth with 6.5% NaCl 
overnight. 10ul of the enriched broth was streaked onto both CSA and Baird Parker plates 
to increase sensitivity of detection.47 Up to two colonies with morphology indicative of S. 
aureus were re-streaked to isolation on a new CSA plate. Presumptive colonies were 
archived in brain heart infusion broth with 15% (w/v) glycerol at -80C.           
Assessment of antibiotic susceptibility. 
Antibiotic susceptibility testing (AST) was completed by the Clinical 
Microbiology Laboratory at the Johns Hopkins Hospital. One isolate from each S. aureus 
positive nasal swab was assessed for susceptibility to a panel of antibiotics 
(Supplementary information: Table 3S.1) using the Phoenix Automated Microbiology 
System (BD Diagnostic Systems, Sparks, MD).  
Molecular characterization of S. aureus isolates.  
A crude DNA extraction was performed on each isolate using a previously 
described protocol.14 S. aureus spa, scn, mecA, and mecC genes were amplified using 
multiplex PCR as previously described.14 PCR products were visualized on 2% agarose 
gels stained with ethidium bromide. Colonies positive for the spa gene were classified as 
S. aureus. All S. aureus confirmed isolates were characterized by spa typing using the 
Ridom StaphType software and the Ridom SpaServer 
(http://spa.ridom.de/index.shtml).108 We did not perform multi-locus sequence typing 
(MLST). Putative MLST for each isolate was assigned based on previously reported spa 
types associated with S. aureus CC398 and CC9.14    
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Definition of S. aureus subpopulations.   
In the current study we consider a S. aureus positive nasal swab as a S. aureus 
positive nasal carriage event. If no S. aureus could be isolated by direct plating or after 
enrichment, we consider this a S. aureus negative carriage event. Because previous 
studies have reported an increased risk of MDRSA, tet[R]-S. aureus, and LA-S. aureus 
nasal carriage among IHO-workers in NC, USA,9,14,15 in the current study we consider 
MDRSA, tet[R]-S. aureus, and LA-S. aureus as IHO-derived S. aureus subpopulations. 
MDRSA was defined as S. aureus isolates resistant to three or more classes of antibiotics, 
based on clinical MIC threshold values (Supplementary information: Table 3S.1). Tet[R]-
S. aureus was defined as S. aureus isolates resistant to tetracycline, based on clinical MIC 
threshold values (Supplementary information: Table 3S.1). There is currently no 
established marker for LA-S. aureus. Strain type CC398, strain type CC9, an absence of 
the scn gene, and phenotypic resistant to tetracycline have been used previously as 
markers of LA-S. aureus.14 In the current study, we consider isolates that are strain type 
CC398, strain type CC9, scn(-), or phenotypically resistant to tetracycline as LA-S. 
aureus.     
Multiplex immunoassay for S. aureus antigen-specific IgA and IgG in oral fluids 
(OF). 
Recombinant S. aureus proteins for Staphylococcal Complement Inhibitor 
(SCIN), and Clumping Factor A (ClfA) were developed and purchased from 
MyBioSource (MyBioSource Inc., San Diego, CA). Both recombinant SCIN and ClfA 
contained an N-terminal 6xHis tag. Natural S. aureus Alpha-toxin protein (AT) protein 
was sourced from LifeSpan Biosciences (LifeSpan BioSciences Inc., Seattle, WA).  
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Each protein was covalently coupled to unique magnetic microparticle sets, 
hereafter referred to as “bead sets” (MagPlex microspheres, Luminex) as described 
previously. 109Successful coupling of each bead set was confirmed using a serial dilution 
of monoclonal mouse antibodies against each S. aureus protein (SCIN, ClfA, AT), 
followed by R-phycoerythrin (PE)-labelled anti-mouse antibody. Coupling of each bead 
set was also confirmed using convalescent sera from mice intradermally inoculated with 
S. aureus. Coupling of S. aureus proteins to bead sets was considered confirmed if bead 
sets revealed a fluorescent signal of >18,000 mean fluorescence intensity (MFI).   
We selected baseline (visit 0), biweekly visit 1 (visit 1), and biweekly visit 8 (visit 
8) oral fluid (OF) samples from all participants to probe with ClfA, AT, and SCIN 
coupled bead sets. OF samples were centrifuged for 5 minutes at 10,000g and 20oC, 
resulting in a cell pellet and varying volumes of OF samples returning less than 100ul of 
volume after centrifugation were excluded from the sample set. 10ul of the oral fluid 
supernatant was added to 40ul of assay buffer (PBS with 0.05% Tween20 and 1% bovine 
serum albumin) containing 1500 beads of each bead set (SCIN, ClfA, AT) per microplate 
well. The plate was covered and incubated at room temperature for 1 hour on a plate 
shaker at 500 rpm. Beads were washed 3 times and then incubated with 50ul of PE-
labelled anti-human IgA diluted 1:100 in assay buffer for 1 hour on a plate shaker at 500 
rpm. Beads were washed again and then suspended in 100ul assay buffer. The 
fluorescence signal was measured on a Bio-Plex 200 instrument (Bio-Rad). The same 
process was repeated, but using PE-labelled anti-human IgG diluted 1:100 for the 
secondary incubation. Two (2) blanks were included on each plate to subtract 
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background, and ~10% of OF samples were tested in duplicate to determine intra-assay 
variability.    
Statistical analysis. 
We first characterized the association between age and antigen-specific IgA and 
IgG antibody levels in OF samples of participants. A total of 42 observations were 
missing data on participant age (8.5%) and were excluded from all subsequent analysis. 
The age variable was grouped into five categories as follows: 1). Children 7-17 years of 
age; 2). Adults 18-29 years; 3). Adults 30-39 years; 4). Adults 40-49 years; and 5). 
Elderly 50-82 years. MFI values for OF IgA and IgG antibody levels were log10 
transformed prior to analysis. To examine the relationship between age and change in 
antigen-specific OF IgA and IgG levels, we compared each adult age category to the 
reference group of children 7-17 years of age. Beta coefficients and 95% confidence 
intervals were estimated using generalized linear models, clustering at the individual 
level to account for a lack of independence of repeated measures. Two-way scatter plots 
and LOWESS curves were used to examine potential non-linearity of the relationship 
between continuous age and antigen-specific IgA and IgG levels in OF (Figure 3S.1). 
Because prior studies demonstrated an age-dependent variability in antigen-specific IgA 
and IgG in serum, all regression models were adjusted for continuous age. 
Similar to prior studies of S. aureus-specific IgA and IgG27, children (7-17 years 
of age) were excluded from regression models aimed at evaluating the association 
between S. aureus nasal carriage outcomes (S. aureus, MDRSA, tet[R]-S. aureus, or LA-
S. aureus) as the independent variable and continuous log10 transformed OF IgA and IgG 
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MFI values (of SCIN, ClfA, AT) as the dependent variable. Log10 transformed average 
OF IgA and IgG MFI values were compared between S. aureus carriage positive events 
and non-carriage events. Age-adjusted beta coefficients and 95% confidence intervals 
(CIs) of OF IgA or IgG MFI were estimated using generalized linear models, clustering 
to account for a lack of independence of repeated measures within participant, comparing 
S. aureus positive carriage events to non-carriage events. We analyzed pooled effect 
estimates among IHO-workers and household member adults combined and also 
stratified effect estimates among IHO-workers and adults separately.  
To examine variability in the association between S. aureus carriage outcomes (S. 
aureus, MDRSA, tet[R]-S. aureus, or LA-S. aureus) and log10-transformed OF IgA and 
IgG MFI values by facemask use we evaluated regression models among IHO worker 
only stratified by self-reported frequency of facemask use at baseline defined as: always, 
sometimes, never.  Binary S. aureus nasal carriage outcomes were modeled as the 
independent variable and log10 transformed OF IgA and IgG MFI values for each S. 
aureus antigen target (SCIN, ClfA, AT) were included as continuous dependent 
variables, within each stratum of facemask use. 
To evaluate the robustness of the relationship between IHO-derived S. aureus 
(MDRSA, tet[R]-S. aureus, or LA-S. aureus) exposure and the magnitude of OF IgA and 
IgG antibody levels, we conducted three sensitivity analyses. In regression models of the 
association between S. aureus nasal carriage and log10 transformed OF IgA and IgG MFI 
values for each S. aureus antigen target (SCIN, ClfA, AT) we first excluded all MDRSA 
nasal carriage events, second, excluded all tet[R]-S. aureus carriage events, and finally, 
we excluded all LA-S. aureus nasal carriage events. These sensitivity analyses were 
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designed to determine whether excluding specific S. aureus subpopulations (some of 
which are putatively livestock-associated) would lead to an attenuation of effect 
estimates. 
To determine whether OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG 
antibody levels might serve as improved biomarkers of SSTI risk relative to S. aureus 
nasal carriage outcomes, we estimated prevalence ratios (PRs) and 95% confidence 
intervals (CIs) of self-reported SSTI via log-binomial regression models that included 
covariates for log10 transformed anti-SCIN, anti-ClfA, and anti-AT antibody levels (IgA 
and IgG each evaluated separately) as well as S. aureus nasal carriage outcomes 
(included one at a time along with all three anti-S. aureus antibody levels). Because 50% 
(6/12) of self-reported SSTIs were observed in children, all participants were included in 
this analysis.  Log-binomial regression models were estimated, clustering at the 
individual level to account for a lack of independence of repeated measures within 
participant. We analyzed pooled effect estimates among IHO-workers, adults, and 
children. All statistical analyses were completed using Stata version 14.2 (StataCorp, 




We probed a total of 496 OF samples, collected at 3 different time points 
(baseline visit 0, biweekly visit 1, and biweekly visit 8), from 179 participants for anti-
SCIN, anti-ClfA, and anti-AT IgA and IgG antibody levels. Ninety five  IHO-workers 
contributed 255 OF samples, 27 adults contributed 67 OF samples, and 52 minors 
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contributed 149 OF samples. A total of 25 observations (5%) were missing host data, and 
a total of 42 observations (8.5%) were missing age data. Out of the 179 participants, 83% 
(n=148) contributed an OF sample at all three time points, 13% (n=22) contributed an OF 
sample at two time points, and 4% (n=8) contributed a single OF sample. Anti-SCIN IgA 
and IgG fluorescent signals were undetectable in 3 OF samples each. Anti-ClfA IgA and 
IgG fluorescent signal were undetectable in 3 and 4 OF samples respectively. Anti-AT 
IgA and IgG fluorescent signal were undetectable in 3 and 4 OF samples, respectively.     
Relation of age with OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG antibody 
levels. 
We probed 451 saliva samples from 166 participants ranging in ages between 7 
and 82 for anti-SCIN, anti-ClfA, and anti-AT IgA and IgG antibody levels. Overall, OF 
anti-SCIN, anti-ClfA, and anti-AT IgA and IgG signals increased until about age 40 
followed by a decrease at older ages (Figure 3S.1), which is consistent with previous 
studies that measured antibodies in serum.27  
Because previous literature had reported significantly reduced serum anti-AT IgG 
antibody levels among infants and children,27 we compared the OF IgA and IgG signal in 
children to those of IHO workers and adults. All beta coefficient, confidence interval, and 
p values for age relationships are provided in Table 3S.2. OF anti-SCIN IgA and IgG 
antibody levels  significantly trended towards elevated among IHO-workers and adults 
ages 19-49 compared with children 7-17 years of age (Figure 3.1A, Table 3S.2). While 
anti-SCIN IgA levels were significantly elevated in the oldest age group of IHO workers 
and adults compared to children, this was not the case for anti-SCIN IgG levels (Figure 
3.1A, Table 3S.2). OF anti-ClfA IgA levels were significantly elevated among IHO 
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workers and adults 30 years of age or older compared to children 7-17 years of age 
(Figure 3.1B, Table 3S.2). OF anti-ClfA IgG levels were significantly elevated among 
IHO-workers and adults between the ages of 19-39 compared to children 7-17 years of 
age (Figure 3.1B, Table 3S.2). OF anti-ClfA IgG levels among IHO workers and adults 
of 40 years of age or older were not significantly elevated compared with children 7-17 
years of age (Figure 3.1B, Table 3S.2). OF anti-AT IgA and IgG antibody levels were 
significantly elevated among IHO-workers and adults ages 19-49 compared with those of 
children 7-17 years of age (Figure 3.1C, Table 3S.2). While OF anti-AT IgA levels were 
significantly elevated in the oldest age group of IHO-workers and adults compared to 
children, this was not the case for anti-AT IgG levels (Figure 3.1C, Table 3S.2).            
S. aureus nasal carriage and OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG 
antibody levels. 
 Previous studies have reported a modest population level increase in serum anti-
ClfA IgA antibody levels99, and serum anti-AT IgG antibody levels among S. aureus 
colonized adults compared to non-colonized adults.27 To determine if S. aureus nasal 
carriage is associated with increased OF IgA and IgG antibody levels, we compared OF 
anti-SCIN, anti-ClfA, and anti-AT IgA and IgG levels between S. aureus carriage 
(n=178) and non-carriage (n=142) events. Because previous studies limited analysis to 
adult aged participants,27,99 children were excluded from this and all subsequent analyses. 
When IHO-workers and adults were grouped together (n=320), we detected a trend for 
elevated OF anti-ClfA IgG (beta coefficient=0.131, 95% CI: -0.0004, 0.262) and anti-AT 
IgG (beta-coefficient=0.105, 95% CI: -0.007, 0.217) antibody levels when IHO-workers 
and adults were positive for nasal carriage with S. aureus, although these differences did 
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not reach statistical significance (Table 3.2). OF anti-SCIN IgG and all OF IgA antibody 
levels did not appear to show any association with S. aureus nasal colonization (Table 
3.2). We then analyzed IHO-workers and adults as separate groups, to account for 
different frequency and magnitude of occupational exposure to S. aureus and the IHO 
environment. Among IHO-workers only (n=250), we detected a significant trend for 
elevated OF anti-ClfA IgG antibody levels when IHO-workers were positive for S. 
aureus nasal carriage (beta coefficient=0.156, p < 0.031) (Table 3.2). We also detected a 
trend for elevated OF anti-ClfA IgA antibody levels when IHO-workers were positive for 
S. aureus nasal carriage (Table 3.2), albeit not reaching statistical significance (beta 
coefficient = 0.131, 95% CI: -0.016, 0.279). We did not detect any association between 
OF anti-SCIN and anti-AT IgG or IgA antibody levels and S. aureus nasal carriage 
among IHO-workers (Table 3.2). Among adults only, we did not detect any association 
between any of the OF IgA and IgG signals and S. aureus nasal carriage (Table 3.2). 
Taken together, nasal carriage of S. aureus is associated with a trend toward elevated OF 
anti-ClfA IgA and IgG antibody levels among IHO-workers but not among adults who 
are household contacts of IHO-workers, consistent with the elevated degree of acute S. 
aureus exposure experienced by IHO-workers.15,17  
Nasal carriage of IHO-derived S. aureus subpopulations (LA-S. aureus, tet[R]-S. 
aureus, and MDRSA) and OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG 
antibody levels.  
In our previous work we showed that IHO workers were specifically at an 
increased risk of carrying MDRSA, tet[R]-S. aureus, and LA-S. aureus compared to 
adults without any exposure to livestock, suggesting an occupational exposure to IHO-
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derived S. aureus.9,10,15 We thus sought to determine if exposure to IHO-derived 
subpopulations of S. aureus, defined as MDRSA, tet[R]-S. aureus, and LA-S. aureus, 
were associated with elevated OF IgA and IgG antibody levels. To determine if nasal 
carriage of IHO-derived S. aureus subpopulations was associated with increased OF IgA 
and IgG antibody levels, we compared OF anti-SCIN, anti-ClfA, and anti-AT IgA and 
IgG levels between IHO-derived S. aureus carriage and non-carriage events.  
When IHO-workers and adults were analyzed together (n=308), IHO-workers and 
adults who carried MDRSA intranasally displayed a significant trend towards elevated 
OF anti-SCIN and anti-ClfA IgA antibody levels (anti-SCIN IgA: beta coefficient = 0.18, 
95% CI: 0.042, 0.318; anti-ClfA IgA: beta coefficient = 0.281, 95% CI: 0.099, 0.463) 
compared to when IHO-workers and adults did not carry any S. aureus (Table 3.2). We 
detected a trend towards elevated OF anti-SCIN, anti-ClfA, and anti-AT IgG when IHO-
workers and adults carried MDRSA intranasally, but this did not reach statistical 
significance (Table 3.2). When IHO-workers and adults carried tet[R]-S. aureus, we 
detected a significant trend towards elevated OF anti-ClfA IgG antibodies compared to 
when IHO workers and adults did not carry any S. aureus (beta coefficient=.198, 95% CI: 
.020, .376). OF anti-ClfA IgA trended towards elevated levels among tet[R]-S. aureus 
carriage events, but did not reach statistical significance (beta coefficient=.192, 95% CI: -
0.011, 0.396). We did not detect any antibody trend associated with carriage of LA-S. 
aureus compared to non-carriage when IHO-workers and adults were analyzed together 
(Table 3.2).  
When analyzed among IHO-workers only (n=250), we detected a significant trend 
towards elevated OF anti-ClfA IgA (beta coefficient=.278,95% CI: 0.077, .479) and anti-
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ClfA IgG (beta coefficient=.191,95% CI: 0.003, 0.378) antibody levels when IHO-
workers carried MDRSA intranasally compared to when IHO-workers did not carry any 
S. aureus (Table 3.2). Although OF anti-SCIN IgA antibody signal displayed a trend 
toward elevated levels when IHO-workers carried MDRSA intranasally, this association 
was not statistically significant (beta coefficient=.143,95% CI: -0.017, 0.302). We also 
detected a trend towards elevated OF anti-ClfA IgA (beta coefficient=.203, 95% CI: -
0.016, .424) and IgG antibodies (beta coefficient=.185, 95% CI: -0.016, .0.386) when 
IHO-workers carried tet[R]-S. aureus compared to when they did not carry any S. aureus, 
which also did not reach statistical significance (Table 3.2).   
When analyzed among adults only (n=59), we detected a significant trend towards 
elevated OF anti-SCIN IgA antibody levels when adults carried MDRSA intranasally 
compared to when adults did not carry any S. aureus (beta coefficient=.349,95% CI: 
0.157, 0.541) (Table 3.2). We also detected a significant trend towards elevated OF anti-
SCIN IgA (beta coefficient=.269,95% CI: 0.028, 0.510)) and IgG (beta 
coefficient=.291,95% CI: 0.026, 0.556) antibody levels when adults carried tet[R]-S. 
aureus compared to when adults did not carry any S. aureus. 
Modification of the association between S. aureus, LA-S. aureus, tet[R]-S. aureus, and 
MDRSA colonization and OF anti-SCIN, anti-ClfA, and anti-AT antibody levels by 
self-reported facemask use among IHO-workers. 
 In our previous work, we show that consistent facemask use among IHO-workers 
is associated with decreased exposure to MDRSA and tet[R]-S. aureus.14 To determine 
how facemask use modified the association between IHO-derived S. aureus carriage 
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(MDRSA, tet[R]-S. aureus, and LA-S. aureus) and OF IgA and IgG antibody levels, we 
compared OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG levels between positive 
and negative IHO-derived S. aureus subpopulation carriage events, stratified by self-
reported facemask use at baseline (never, sometimes, or always). Among IHO-workers 
who reported sometimes (n=108) or always (n=83) wearing a facemask, we did not detect 
any trend in OF IgA or IgG antibody levels associated with carriage of any type of IHO-
derived S. aureus subpopulation (Table 3.3). IHO-workers who reported never wearing a 
facemask (n=53) displayed a significant trend towards elevated OF anti-SCIN IgA and 
IgG antibody levels when carrying MDRSA (anti-SCIN IgA: beta coefficient=.221, 95% 
CI: 0.014, 0.428); anti-SCIN IgG: beta-coefficient=.376,95% CI: 0.098, 0.653)) or tet[R]-
S. aureus (anti-SCIN IgA: beta coefficient=.176,95% CI: 0.005, 0.347; anti-SCIN IgG: 
beta coefficient=.368,95% CI: 0.070, 0.665) compared to when not carrying any S. 
aureus (Table 3.3). IHO-workers who reported never wearing a facemask also displayed 
a significant trend towards elevated anti-ClfA IgG antibody levels when carrying any S. 
aureus (anti-ClfA IgG: beta coefficient=.281,95% CI: 0.068, 0.493), and elevated anti-
ClfA IgA and IgG antibodies when carrying MDRSA (anti-ClfA IgA: beta 
coefficient=.473,95% CI: 0.218, 0.728); anti-ClfA IgG: beta coefficient=.437, 95% CI: 
0.090, 0.785), tet[R]-S. aureus (anti-ClfA IgA: beta coefficient=.418, 95% CI: 0.156, 
0.681); anti-ClfA IgG: beta coefficient=.513,95% CI: 0.180, 0.845), or LA-S. aureus 
(anti-ClfA IgA: beta coefficient=.356, 95% CI: 0.114, 0.599; anti-ClfA IgG: beta 
coefficient=.317,95% CI: 0.046, 0.589) compared to when not carrying any S. aureus. 
We also detected a significant trend towards elevated OF anti-AT IgG antibody levels 
when IHO-workers carried tet[R]-S. aureus compared to when they did not, among IHO-
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workers who reported never using a facemask (beta coefficient=.290,95% CI: 0.045, 
0.536) (Table 3.3). 
Taken together, facemask use by IHO-workers modified the effect of exposure to 
IHO-derived S. aureus subpopulations on OF anti-SCIN, anti-ClfA, and anti-AT IgA and 
IgG antibody levels. This is noted by a robust association of elevated OF IgA and IgG 
antibody levels among IHO-workers who reported never using a facemask and carried 
IHO-derived S. aureus compared to when they did not carry S. aureus. This is also 
supported by attenuated associations among IHO-workers who reported sometimes or 
always using a facemask.  
OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG antibody levels and self-reported 
skin and soft tissue infection (SSTI). 
In regression models that included both antibody-based and S. aureus nasal 
carriage outcome biomarkers we observed an attenuation of the association between each 
of the S. aureus nasal carriage outcomes and self-reported SSTI. For example, the S. 
aureus nasal carriage outcome SSTI PR was 1.75 (95% CI: 0.69, 4.45) (Table 3.4). For 
the MDRSA, tet[R]-S. aureus, and LA-S. aureus nasal carriage outcomes, the association 
between nasal carriage outcome and SSTI was also consistently attenuated. In these 
regression models, we observed consistently stronger associations between OF anti-ClfA 
and anti-SCIN IgA antibody levels and self-reported SSTI than for S. aureus nasal 
carriage outcomes. For example, every log10 increase in OF anti-ClfA IgA antibody level 
was associated with 4.17 (95% CI:1.44, 12.1) times increased prevalence of self-reported 
SSTI in the model that also included S. aureus nasal carriage as a covariate. In the same 
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regression model, each log10 increase in OF anti-SCIN IgA antibody level was associated 
with 0.19 (95% CI: 0.05, .666) times the prevalence of self-reported SSTI. There was no 
indication of an association between OF anti-AT (neither IgA nor IgG) and self-reported 
SSTI. These strong associations (positive for anti-ClfA and negative for anti-SCIN) were 
consistent for each of the other S. aureus nasal carriage outcomes evaluated (S. aureus, 
MDRSA, tet[R]-S. aureus, LA- S. aureus).  
DISCUSSION 
 
We developed a multiplex immunoassay to measure IgA and IgG antibody 
responses to three S. aureus antigens (SCIN, ClfA, and AT) in OF collected from IHO 
workers and their household contacts in NC, USA. Previous studies have characterized 
important associations between serum IgA and IgG antibody responses against various S. 
aureus antigens and outcomes of S. aureus colonization and infection in diverse healthy 
populations,27,102 hospitalized adults,27,41 adults with invasive S. aureus infections,27,110 
dialysis patients,27 intravenous drug-users,42 and children colonized with S. aureus or 
presenting with S. aureus infection.43 All of these studies have measured IgA and IgG 
antibody levels in serum. To our knowledge, no studies have attempted to measure or 
validate anti-S. aureus IgA and IgG antibody levels in OF in response to S. aureus 
exposure. While serum collection is a routine procedure in the healthcare setting, it is 
invasive, usually requires clinically trained personnel, and has practical constraints for 
studies involving repeated measures and susceptible populations, including young 
children. OF collection is minimally invasive, does not require clinical personnel, and can 
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be easily implemented in community and remote settings, such as the rural eastern NC 
project site of this IHO worker cohort.105,109   
Our findings in OF are remarkably consistent with previous research aimed at 
understanding age- and S. aureus exposure-dependent IgG responses in diverse human 
populations.27 Wu et al. reported lower serum anti-AT IgG antibody levels among 
children and significantly elevated anti-AT IgG antibody levels among adolescents and 
adults that was maintained throughout adulthood.27 In the current study, the lowest OF 
IgA and IgG antibody levels for ClfA, SCIN, and AT were observed among children 7-17 
years of age. This is consistent with an absence of frequent or accumulating exposure to 
S. aureus at younger ages. As age groups increased in our study population there was 
evidence of maturation of immunity to S. aureus.27 We observed that OF IgA and IgG 
antibodies against SCIN, ClfA, and AT were significantly elevated, and remained stable, 
throughout adult ages (ages 19-49). Previous serum-based studies suggest that serum 
anti-AT IgG antibody levels wane at elderly ages,27 but secretion of IgA into OF is not 
weakened with aging.111 Our findings were consistent with these studies in that OF IgG 
antibodies against all S. aureus antigens diminished at elderly ages (ages 50-82) while OF 
IgA antibodies remained significantly elevated compared to children 7-17 years of age. 
Taken together, we observed that the development of OF IgA and IgG antibodies against 
SCIN, ClfA, and AT was an age- and S. aureus exposure-dependent process, and that OF 
IgA antibody levels against S. aureus SCIN, ClfA, and AT did not diminish significantly 
at elderly ages.  
 While multiple epidemiological studies suggest that IHO-workers experience a 
strong exposure to S. aureus through occupational exposure to swine,10,15,17 this study 
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was the first to our knowledge to characterize associations between S. aureus nasal 
carriage outcomes and OF IgA and IgG antibody levels in a population of IHO-workers 
and their household contacts. Our results strongly suggest that IHO workers are 
occupationally exposed to, colonized by, and demonstrate early biologic effects of 
exposure to IHO-derived multidrug-resistant S. aureus. These antibody responses suggest 
an early biological effect indicative of S. aureus colonization rather than transient nasal 
contamination with or carriage of S. aureus.   
Verkaik et al. showed a significant association between S. aureus nasal 
colonization and serum anti-ClfA IgA levels, and a strong correlation between antibody 
levels in serum and secretions from the nasal mucosa.102 Considering the interconnected 
nature of the human mucosal immune system,112 we hypothesized that anti-ClfA IgA and 
IgG antibody levels in OF would also be elevated among IHO-workers carrying S. aureus 
intranasally. We found a significant association of elevated anti-ClfA IgG antibody levels 
in OF when IHO-workers carried S. aureus in their nares compared to when they did not. 
When we classified S. aureus into subpopulations commonly contracted by IHO-workers 
(MDRSA, tet[R]-S. aureus, and LA-S. aureus), IgA antibody levels against ClfA were 
elevated among IHO-workers carrying those strains vs. those who were not. Anti-ClfA 
IgA and IgG antibody levels in OF were not elevated among adult household-contacts of 
IHO-workers. These results are consistent with an elevated chronic exposure to S. aureus, 
and acute exposure to IHO-derived MDRSA, tet[R]-S. aureus, and LA-S. aureus, among 
IHO-workers regularly exposed to swine and the IHO environment.    
 In our work, and the work of Wu et al. ,27 IgG antibody levels of anti-AT were 
somewhat elevated among S. aureus nasal carriage compared to non-carriage, but the 
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association was not statistically significant. Previous studies have demonstrated a low 
level of hla gene expression in healthy individuals intranasally colonized with S. aureus, 
whereas increased hla gene expression and increased hemolytic activity have been 
correlated with S. aureus infection in both humans and animals.113–115 Elevated clfA 
transcript levels have been reported in S. aureus implicated in nasal colonization of 
healthy human participants, suggesting a role for ClfA in nasal colonization.115 It may be 
the case that anti-ClfA IgA and IgG antibodies and anti-AT IgA and IgG antibodies in 
OF serve as biomarkers for different stages of the infectious process, such as colonization 
and early biological effect vs. progression from colonization to infection. 
While the presence and sequence of ClfA and AT are highly conserved in diverse 
S. aureus clinical isolates including LA-S. aureus,116,117 the predominating LA-S. aureus 
lineages commonly contracted by IHO-workers14,15,103 tend to lack the scn gene encoding 
for SCIN, which is known to play a role in human immune evasion.55 We thus probed OF 
samples for anti-SCIN IgA and IgG antibody levels, hypothesizing that anti-SCIN IgA 
and IgG antibody levels would not be elevated among IHO-worker OF samples in 
response to S. aureus exposure. When analyzing IHO-workers and adults separately, we 
found a strong association of elevated OF anti-SCIN IgA and IgG antibody levels among 
S. aureus nasal carriage events compared to non-carriage events for adults household 
members only. This observation is consistent with a lack of the scn gene in S. aureus 
from swine and the IHO-environment,9,14,15,17 but an almost ubiquitous presence of the 
scn gene in S. aureus contracted from other non-livestock-settings – e.g., the communit 
and hospitals.118–120  
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To determine the contribution of each S. aureus subpopulation to the overall OF 
IgA and IgG signals against S. aureus, we conducted three sensitivity analyses (Table 
3S.3). In the first, we excluded all MDRSA observations, in the second we excluded all 
tet[R]-S. aureus observations, and in the third we excluded all LA-S. aureus observations. 
The significant association of elevated OF anti-ClfA IgG antibody levels among IHO-
workers positive vs. negative for S. aureus nasal carriage was attenuated when either 
MDRSA or tet[R]-S. aureus observations were excluded (Table 3S.3). Thus, we believe 
that persistent exposure to MDRSA and tet[R]-S. aureus may be driving, or largely 
contributing to, the observed elevated OF anti-ClfA IgG antibody levels among IHO-
workers in response to S. aureus exposure. This is consistent with previously reported 
occupational exposure to IHO-derived MDRSA and tet[R]-S. aureus experienced by 
IHO-workers,14 and indicative of a heightened exposure pressure for these strains within 
the IHO environment.  
In our previous work, we demonstrated that frequency of PPE use in IHOs was 
associated with S. aureus exposure, and that facemask use protects IHO-workers and 
their household contacts from IHO-derived S. aureus nasal carriage outcomes.14 Thus, 
facemasks appear to be a protective physical barrier between S. aureus nasal carriage and 
IHO-derived S. aureus exposures. Congruent with these previous observations, we found 
that OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG antibody levels were elevated 
among S. aureus carriage vs. non-carriage events only among IHO-workers who reported 
never wearing a facemask. This suggests that facemasks can protect IHO-workers from 
exposure to IHO-derived S. aureus, but also might mitigate early biological effects in 
response to IHO-derived S. aureus exposure. Because of the limited number of 
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observations in each facemask use stratum this finding should be interpreted with 
caution. One puzzling association with respect to facemask use was that of elevated anti-
SCIN IgA and IgG antibodies among IHO workers who never used a facemask and 
carried S. aureus intranasally, particularly because the prevailing notion is that IHO 
workers are largely exposed to S. aureus lacking the scn gene. SCIN is a highly 
immunogenic S. aureus protein that is only known to function against the human immune 
system.55,99 The scn and other IEC genes are encoded on a mobile genetic element called 
the Sa3 prophage,55 and many factors, including exposure to commercial biocides, may 
induce the transfer and integration of this prophage.121 Due to biweekly sampling, we do 
not know how long a particular strain of S. aureus inhabited IHO workers’ nares and it 
may be the case that IHO-derived S. aureus rapidly integrates and expresses IEC genes 
when encountering a host jump from pig to the human nasal mucosa.   
Previous studies of the same cohort established that IHO workers who carried S. 
aureus, MDRSA of LA-S. aureus were significantly more likely to report a recent SSTI 
compared to non-carriers.15 Prior work has shown that S. aureus nasal carriage was the 
strongest outcome associated with self-reported SSTI (PR = 4.5; 95% CI: 1.4, 14.9).15 
When the S. aureus nasal carriage variable was included in a regression model that also 
included anti-SCIN, anti-ClfA, and anti-AT IgA antibody levels, the association between 
S. aureus nasal carriage and self-reported SSTI was attenuated (PR = 1.8; 95% CI: 0.69, 
4.4), whereas anti-ClfA and anti-SCIN IgA antibody levels were strongly associated with 
self-reported SSTI (anti-ClfA PR = 4.2, 95% CI: 1.4, 12.1; anti-SCIN PR = 0.19, 95% 
CI: 0.05, 0.67). This observation was consistent when any S. aureus nasal carriage 
outcome that had been previously established as a biomarker of SSTI risk in this cohort 
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(i.e., MDRSA, tet[R]-S. aureus, or LA-S. aureus nasal carriage) was included in a 
regression model along with anti-SCIN, anti-ClfA, and anti-AT IgA antibody levels. 
These findings suggest that anti-ClfA and anti-SCIN IgA antibody levels are more 
strongly associated with self-reported SSTI among IHO workers than S. aureus nasal 
carriage outcomes are. Thus, OF anti-SCIN and anti-ClfA IgA antibody levels may serve 
as non-invasive and rapid biomarkers of progression from S. aureus colonization to SSTI 
among IHO workers. While increasing OF anti-ClfA IgA antibody levels were associated 
with an increased prevalence of reporting a recent SSTI, increasing OF anti-SCIN IgA 
antibody levels were associated with a decreased prevalence of reporting a recent SSTI. 
This is consistent with a predominance of scn-negative S. aureus being contracted by 
IHO workers and suggests that S. aureus lacking the scn genes may indeed have the 
capacity to increase SSTI risk. It was unexpected that IgA antibody levels were so 
strongly and consistently associated with self-reported SSTI, considering that previous 
literature has consistently supported a relationship between serum IgG antibody levels 
and risk of SSTI.27 However, given the lack of any prior knowledge on antigen-specific 
antibody-based OF biomarkers of S. aureus SSTI among IHO workers and their 
household contacts, the results provided in this study warrant further evaluation in terms 
of their consistency and repeatability.   
This study has several limitations. First, we do not have matched OF and serum 
samples from each participant at sampling each time point. Typically, matched OF and 
serum samples are used to validate and optimize OF based immunological biomarkers 
and immunoassays.122 No blood samples were collected from the cohort of IHO-workers 
and their household contacts, which is why we chose to compare age- and exposure-
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related patterns in OF IgA and IgG levels from our study to previously published 
literature on age- and S. aureus exposure-dependent serum IgA and IgG levels. Future 
studies should collect matched OF and serum samples in a prospective manner and 
evaluate assay performance characteristics of OF using serum IgA and IgG antibody 
levels as the gold standard reference method. Second, we probed OF samples for antigen-
specific IgA and IgG antibodies against only three S. aureus antigens. Although we based 
our antigen selection on prior research aimed at understanding S. aureus serology and 
vaccine development, this study only scratched the surface of candidate OF-based 
antibody biomarkers of S. aureus exposure, colonization, and infection. The S. aureus 
genome encodes for over 2700 proteins,40 and it is likely that additional antigen-specific 
antibodies may serve as unique biomarkers of S. aureus exposure in this population. 
Future studies aimed at developing OF-based antibody biomarkers of S. aureus exposure, 
colonization, and infection should multiplex using an expanded list of antigen-specific 
IgA and IgG antibodies against representative S. aureus proteins, similar to the work of 
Verkaik et al. in serum.99 Third, at baseline, a total of only 12 individuals reported 
experiencing an SSTI in the past 3 months. Six of these individuals were IHO workers, 
and the remaining six were children. Due to the limited number of self-reported SSTIs in 
this cohort, we were unable to fully interrogate OF-based antibody biomarkers of S. 
aureus SSTI. Lastly, because of the limited number of times points per participant 
included in this study, we were only able to provide a population-average level effect-
estimate on the repeated measures association between S. aureus exposure and IgA and 
IgG antibody levels against SCIN, ClfA, and AT in OF. Including additional time points 
would enable the use of statistical methods for longitudinal data analysis, and the 
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estimation of transient / time-varying within-person S. aureus exposure and OF-based 
antibody responses. While a population level effect is informative, a within-person effect 
may be more relevant for translating these findings into clinical or community based 
diagnostic tools. 
CONCLUSIONS 
 Our exploration of OF IgA and IgG against the S. aureus antigens SCIN, ClfA, 
and AT among IHO-workers and their household contacts resulted in three major 
findings. First, the maturation OF anti-ClfA and anti-AT IgA and IgG antibody responses 
was an age-dependent process which is consistent with previously published age-
dependent maturation of serum anti-ClfA and anti-AT IgA and IgG antibodies. While 
future studies should validate anti-S. aureus antibody levels in OF compared to those in 
matched serum samples, we believe these results show promise for the future 
development and application of OF based antibody-based biomarkers in studying S. 
aureus exposures and outcomes among IHO workers. Second, consistent with 
epidemiological studies, patterns of elevated OF anti-ClfA antibodies among IHO-
workers suggested that IHO-workers experience unique occupational exposure pressure 
to S. aureus, including IHO-derived subpopulations of S. aureus. Third, also consistent 
with epidemiological studies, facemask use appears to provide protection against S. 
aureus exposure as noted by the attenuation of the association between S. aureus nasal 
carriage outcomes and OF anti-SCIN, anti-ClfA, and anti-AT antibody levels. Taken 
together, this study developed an OF-based S. aureus multiplex immunoassay that can be 
employed in repeated-measures studies in occupational and community settings, and 
determined that OF from IHO-workers who are occupationally exposed to IHO-derived 
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S. aureus, particularly MDRSA, tet[R]-S. aureus, and LA-S. aureus, displayed elevated 
IgA and IgG antibodies against S. aureus-specific antigens. OF antibodies against ClfA 
may serve as a promising biomarker of occupational exposure to and infection with S. 





Visit 0 Visit 1 Visit 8 Total 
  N=170 N=171 N=155 N=496 
 
n (%) n (%) n (%) n (%) 




Worker 85 (50) 87 (50.9) 83 (53.6) 255 (51.4) 
Adult 20 (11.8) 26 (152) 21 (13.6) 67 (13.5) 
Child 50 (29.4) 49 (28.7) 50 (32.3) 149 (30) 










Ages 7-18 49 (28.8) 49 (28.7) 50 (32.3) 148 (29.8) 
Ages 19-29 25 (14.7) 27 (15.8) 24 (15.5) 76 (15.3) 
Ages 30-39 42 (24.7) 43 (25.2) 42 (27.1) 127 (25.6) 
Ages 40-49 18 (10.6) 20 (11.7) 18 (11.6) 56 (11.3) 
Ages 50-82 15 (8.82) 17 (9.94) 15 (9.68) 47 (9.48) 










Non-carrier 87 (51.2) 83 (48.5) 84 (54.2) 254 (51.2) 
Any S. aureus  68 (40) 78 (45.6) 70 (45.2) 216 (43.6) 
MDRSA 25 (14.7) 25 (14.6) 21 (13.6) 71 (14.3) 
tet[R]-S. aureus 21 (12.4) 23 (13.5) 19 (12.3) 63 (12.7) 
LA-S. aureus 28 (16.5) 36 (21) 30 (19.4) 94 (19) 










Never  18 (21.2) 17 (19.5) 18 (21.7) 53 (20.8) 
Sometimes 37 (43.5) 35 (40.2) 37 (44.6) 109 (42.8) 
Always 29 (34.1) 32 (36.8) 27 (32.5) 88 (34.5) 
Missing 1 (1.18) 3 (3.45) 1 (1.20) 36 (7.26) 
Table 3.1. Participant and S. aureus isolate characteristics
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Table 3.2. Nasal carriage of S. aureus subpopulations and OF anti-SCIN, anti-ClfA, 
and anti-AT IgA and IgG antibody levels. Log transformed MFI values for nasal 
carriage of S. aureus subpopulation were compared to the non-carriage reference group 
for OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG antibodies. Beta coefficients and 
95% confidence intervals were estimated using generalized linear models adjusted for 
age and within participant clustering. Bolded* values represent a significant trend toward 
elevated antibody levels in the S. aureus subpopulation group compared to the referent 
non-carriage group, using a generalized linear model, adjusted for age and within 
participant level clustering. Note. MDRSA = multidrug-resistant S. aureus ; tet[R]-S. 



























Salivary IgA  Salivary IgG 
OF 
Antibody Carriage type N 
Beta coefficient  (95% 
CI) 
N 




Non-carriage 170 REF 171 REF 
Any S. aureus carriage 139 0.049 (-.075, .172) 137 0.058 (-.063, .178) 
MDRSA carriage 61 0.180 (.042, .318)* 60  0.136 (-.015, .288) 
tet[R]-S. aureus carriage 59 0.098 (-.064, .261) 58 0.136 (-.035, .306) 
LA-S. aureus carriage 81   0.072 (-.073, .218) 79 0.077 (-.068, .222) 
anti-ClfA 
Non-carriage 170 REF 171 REF 
Any S. aureus carriage 139 0.109 (-0.028, 0.246) 137 0.131 (-0.0004, 0.262) 
MDRSA carriage 61 0.281 (0.099, 0.463)* 60 0.158 (-0.005, 0.323) 
tet[R]-S. aureus carriage 59 0.192 (-0.011, 0.396) 58 0.198 (0.020, 0.376)* 
LA-S. aureus carriage 81 0.154 (-0.023, 0.332) 79 0.140 (-0.014, 0.293) 
anti-AT 
Non-carriage 170 REF 171 REF 
Any S. aureus carriage 139 0.063 (-0.030, 0.155) 137 0.105 (-0.007, 0.217) 
MDRSA carriage 61 0.043 (-0.058, 0.144) 60 0.134 (-0.019, 0.287) 
tet[R]-S. aureus carriage 59 0.106 (-0.000, 0.212) 58 0.151 (-0.011, 0.312) 






  Workers only 
 
    Salivary IgA  Salivary IgG 
OF 
Antibody Carriage type 
N 
Beta coefficient  (95% 
CI) 
N 




Non-carriage 133 REF 134 REF 
Any S. aureus carriage 117 0.031 (-.111, .172) 114 0.044 (-.089, .177) 
MDRSA carriage 52 0.143 (-.017, .302) 50  0.118 (-.056, .292) 
tet[R]-S. aureus carriage 49 0.059 (-.131, .248) 47 0.099 (-.095, .293) 
LA-S. aureus carriage 69 0.041 (-.126, .208) 66  0.037 (-.123, .196) 
anti-ClfA 
Non-carriage 133 REF 134 REF 
Any S. aureus carriage 117 0.131 (-0.016, 0.279) 114 0.156 (.014, .297)* 
MDRSA carriage 52 0.278 (0.077, 0.479)* 50  0.191 (.003, .378)* 
tet[R]-S. aureus carriage 49 0.203 (-0.016, 0.424) 47 0.185 (-.016, .000) 
LA-S. aureus carriage 69 0.169 (-0.023, 0.361) 66  0.126 (-.041, .294) 
anti-AT 
Non-carriage 133 REF 134 REF 
Any S. aureus carriage 117 0.040 (-0.063, 0.142) 114 0.101 (-0.022, 0.225) 
MDRSA carriage 52  0.017 (-0.093, 0.127) 50 0.133 (-0.037, 0.303) 
tet[R]-S. aureus carriage 49 0.066 (-0.040, 0.172) 47 0.149 (-0.034, 0.332) 





  Adults only 
 
    Salivary IgA  Salivary IgG 
OF 
Antibody Carriage type 
N 
Beta coefficient  (95% 
CI) 
N 




Non-carriage 37 REF 37 REF 
Any S. aureus carriage 22 0.116 (-.130, .363) 23 0.130 (-.136, .396) 
MDRSA carriage 9 0.349 (.157, .541)* 10 0.211 (-.027, .449) 
tet[R]-S. aureus carriage 10 0.269 (.028, .510)* 11 0.291 (.026, .556)* 
LA-S. aureus carriage 12 0.206 (-.025, .438) 13 0.271 (.009, .532)* 
anti-ClfA 
Non-carriage 37 REF 37 REF 
Any S. aureus carriage 22  -0.013 (-0.384, 0.358) 23 0.046 (-0.287, 0.379) 
MDRSA carriage 9  0.274 (-0.146, 0.694) 10  0.036 (-0.274, 0.345) 
tet[R]-S. aureus carriage 10 0.126 (-0.378, 0.630) 11 0.274 (-0.041, 0.589) 
LA-S. aureus carriage 12 0.048 (-0.408, 0.504) 13 0.251 (-0.060, 0.563) 
anti-AT 
Non-carriage 37 REF 37 REF 
Any S. aureus carriage 22 0.137 (-0.085, 0.360) 23 0.134 (-0.130, 0.397) 
MDRSA carriage 9 0.124 (-0.134, 0.383) 10 0.147 (-0.214, 0.507) 
tet[R]-S. aureus carriage 10 0.264 (-0.090, 0.618) 11 0.163 (-0.174, 0.500) 





Table 3.3. Modification of the association between S. aureus, MDRSA, tet[R]-S. 
aureus, and LA-S. aureus carriage and OF anti-SCIN, anti-ClfA, and anti-AT 
antibody levels by self-reported facemask use among IHO-workers. Log transformed 
MFI values for nasal carriage of S. aureus subpopulation were compared to the non-
carriage referent group for OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG antibodies 
among IHO-workers, stratified by self-reported facemask use (never, sometimes, or 
always). Beta coefficients and 95% confidence intervals were estimated using 
generalized linear models adjusted for age and within participant clustering.. Bolded* 
values represent a significant trend toward elevated antibody levels in the S. aureus 
subpopulation group compared to the referent non-carriage group, using a generalized 
lineage model adjusted for age and within participant clustering. Note. MDRSA = 
multidrug-resistant S. aureus ; tet[R]-S. aureus = tetracycline-resistant S. aureus; LA-S. 
































    N 
Beta coefficient 
(95% CI) N 
Beta coefficient 
(95% CI) 
S. aureus carriage           
Never 
Non-colonized 28 REF 28 REF 
S. aureus colonized 25  -0.005 (-0.220, 0.210)  25 0.211 (-0.018, 0.439) 
Sometimes 
Non-carrier 59 REF 59 REF 
S. aureus colonized 50  -0.058 (-0.274, 0.160) 49 0.016 (-0.221, 0.254) 
Always 
Non-carrier 44 REF 45 REF 
S. aureus colonized 39 0.149 (-0.096, 0.395) 38  -0.017 (-0.209, 0.174) 
MDRSA carriage           
Never 
Non-carrier 28 REF 28 REF 
MDRSA colonized 16 0.221 (0.014, 0.428)* 16 0.376 (0.098, 0.653)* 
Somtimes 
Non-carrier 59 REF 59 REF 
MDRSA colonized 26 0.053 (-0.183, 0.289) 25 0.002 (-0.291, 0.295) 
Always 
Non-carrier 44 REF 45 REF 
MDRSA colonized 8 0.053 (-0.232, 0.338) 8  -0.005 (-0.176, 0.167) 
Tet[R]-S. aureus carriage           
Never 
Non-carrier 28 REF 28 REF 
tet[R]-S. aureus colonized 13 0.176 (0.005, 0.347)* 13  0.368 (0.070, 0.665)* 
Sometimes 
Non-carrier 59 REF 59 REF 
tet[R]-S. aureus colonized 24 0.056 (-0.199, 0.311) 23  -0.008 (-0.022, 0.006) 
Always 
Non-carrier 44 REF 45 REF 
tet[R]-S. aureus colonized 10  -0.224 (-0.536, 0.087) 10  -0.001 (-0.009, 0.006) 
LA-S. aureus carriage           
Never 
Non-carrier 28 REF 28 REF 
LA-S. aureus colonized 18 0.139 (-0.042, 0.319) 18 0.256 (-0.004, 0.516) 
Sometimes 
Non-carrier 59 REF 59 REF 
LA-S. aureus colonized 34  -0.010 (-0.246, 0.227) 33  -0.005 (-0.260, 0.250) 
Always 
Non-carrier 44 REF 45 REF 



















    N 
Beta coefficient 
(95% CI) N 
Beta coefficient 
(95% CI) 
S. aureus carriage           
Never 
Non-colonized 28 REF 28 REF 
S. aureus colonized 25 0.094 (-0.204, 0.392) 25 0.281 (0.068, 0.493)* 
Sometimes 
Non-carrier 59 REF 59 REF 
S. aureus colonized 50 0.055 (-0.168, 0.278) 49 0.146 (-0.081, 0.372) 
Always 
Non-carrier 44 REF 45 REF 
S. aureus colonized 39 0.233 (-0.031, 0.496) 38 0.050 (-0.191, 0.291) 
MDRSA carriage           
Never 
Non-carrier 28 REF 28 REF 
MDRSA colonized 16 0.473 (0.218, 0.728)* 16 0.437 (0.090, 0.785)* 
Somtimes 
Non-carrier 59 REF 59 REF 
MDRSA colonized 26 0.124 (-0.177, 0.425) 25 0.078 (-0.165, 0.319) 
Always 
Non-carrier 44 REF 45 REF 
MDRSA colonized 8 0.139 (-0.141, 0.419) 8  -0.036 (-0.306, 0.235) 
Tet[R]-S. aureus carriage           
Never 
Non-carrier 28 REF 28 REF 
tet[R]-S. aureus colonized 13 0.418 (0.156, 0.681)* 13 0.513 (0.180, 0.845)* 
Sometimes 
Non-carrier 59 REF 59 REF 
tet[R]-S. aureus colonized 24 0.115 (-0.192, 0.422) 23 0.104 (-0.167, 0.376) 
Always 
Non-carrier 44 REF 45 REF 
tet[R]-S. aureus colonized 10  -0.026 (-0.402, 0.351) 10  -0.124 (-0.351, 0.102) 
LA-S. aureus carriage           
Never 
Non-carrier 28 REF 28 REF 
LA-S. aureus colonized 18 0.356 (0.114, 0.599)* 18 0.317 (0.046, 0.589)* 
Sometimes 
Non-carrier 59 REF 59 REF 
LA-S. aureus colonized 34 0.063 (-0.214, 0.340) 33 0.120 (-0.107, 0.347) 
Always 
Non-carrier 44 REF 45 REF 


















    N 
Beta coefficient 
(95% CI) N 
Beta coefficient 
(95% CI) 
S. aureus carriage           
Never 
Non-colonized 28 REF 28 REF 
S. aureus colonized 25  -0.071 (-0.224, 0.082) 25 0.128 (-0.062, 0.319) 
Sometimes 
Non-carrier 59 REF 59 REF 
S. aureus colonized 50  0.003 (-0.128, 0.133) 49 0.091 (-0.115, 0.297) 
Always 
Non-carrier 44 REF 45 REF 
S. aureus colonized 39 0.138 (-0.118, 0.393) 38 0.049(-0.153, 0.250) 
MDRSA carriage           
Never 
Non-carrier 28 REF 28 REF 
MDRSA colonized 16 0.064 (-0.107, 0.235) 16 0.181 (-0.048, 0.411) 
Somtimes 
Non-carrier 59 REF 59 REF 
MDRSA colonized 26  -0.053 (-0.182, 0.075) 25 0.069 (-0.195, 0.333) 
Always 
Non-carrier 44 REF 45 REF 
MDRSA colonized 8 0.042 (-0.374, 0.458) 8 0.054 (-0.280, 0.389) 
Tet[R]-S. aureus carriage           
Never 
Non-carrier 28 REF 28 REF 
tet[R]-S. aureus colonized 13 0.060 (-0.098, 0.218) 13 0.290 (0.045, 0.536)* 
Sometimes 
Non-carrier 59 REF 59 REF 
tet[R]-S. aureus colonized 24  -0.019 (-0.149, 0.111) 23 0.088 (-0.195, 0.370) 
Always 
Non-carrier 44 REF 45 REF 
tet[R]-S. aureus colonized 10 0.210 (-0.093, 0.513) 10  -0.024 (-0.385, 0.338) 
LA-S. aureus carriage           
Never 
Non-carrier 28 REF 28 REF 
LA-S. aureus colonized 18 0.037 (-0.103, 0.178) 18 0.158 (-0.041, 0.358) 
Sometimes 
Non-carrier 59 REF 59 REF 
LA-S. aureus colonized 34  -0.015 (-0.128, 0.098) 33 0.042 (-0.175, 0.258) 
Always 
Non-carrier 44 REF 45 REF 




Table 3.4. OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG antibody levels and self-reported SSTI. The relationship between 
prevalence of self-reported SSTI and log10 transformed OF IgA and IgG anti-SCIN, anti-ClfA, and anti-AT antibody levels was 
examined. Prevalence ratios and 95% confidence intervals were estimated using generalized linear models adjusted for age and within 
participant clustering. For both IgA and IgG antibody targets, model 1 included the S. aureus nasal carriage variable as a covariate, 
model 2 included the MDRSA nasal carriage variable as a covariate, model 3 included the tet[R]-S. aureus nasal carriage variable as a 
covariate, and model 4 included the LA-S. aureus nasal carriage variable as a covariate. Bolded* values represent a prevalence ratio 
that is significantly different from 1. Note. MDRSA = multidrug-resistant S. aureus ; tet[R]-S. aureus = tetracycline-resistant S. 
aureus; LA-S. aureus = livestock-associated S. aureus; SCIN = staphylococcal complement inhibitor; ClfA = clumping factor A; AT 
= alpha toxin.
 Skin and soft tissue infection outcome 
  PR (95% CI) 
  IgA IgG 
Covariate Model 1 Model 2 Model 3 Model 4 Model 1 Model 2 Model 3 Model 4 
anti-SCIN 0.19 , (0.05, .666)* 0.17 (0.04, 0.75)* 0.18 (0.04, 0.69)* 0.17 (0.04, 0.81)* 1.02 (0.29, 3.61) 0.90 (0.25, 3.28) 0.94 (0.26, 3.44) 1.10 (.338, 3.61) 
anti-ClfA 4.16 (1.44, 12.1)* 4.57 (1.39, 15.05)* 4.48 (1.52, 13.25)* 4.57 (1.33, 15.68)* 1.04 (0.25, 4025) 1.02 (0.21, 4.98) 1.15 (0.26, 5.19) .933 (0.21, 4.14) 
anti-AT 0.79 (0.15, 4.24) 0.84 (0.13, 5.38) 0.81 (0.13, 5.02) 0.78 (0.13, 4.61) 0.69 (0.23, 2.07) 0.73 (0.24, 2.22) 0.68 (0.21, 2.14) 0.67 (0.21, 2.09) 
S. aureus 1.75 (0.69, 4.45) - - - 1.88 (0.71, 4.95) - - - 
MDRSA - 2.15 (0.78, 5.91) - - - 2.31 (0.77, 6.88) - - 
Tet[R]-S. aureus - - 1.13 (0.39, 3.28) - - - 1.14 (0.39, 3.34) - 
LA-S. aureus - - - 2.35 (0.89, 6.20) - - - 2.63 (1.03, 6.69)* 
110 
 
Figure 3.1. Age and OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG antibody 
levels. Salivary IgA and IgG antibody levels in IHO-workers and their household 
contacts by different age groups. Geometric mean values and 95% confidence intervals 
are shown for A). Salivary anti-SCIN IgA, B). Salivary anti-ClfA IgA, C). Salivary anti-
































































































































































































































































Penicillin </=0.2 N/A >/=.25 
Erythromycin </=0.5 1.0-4.0 >/= 8 
Clindamycin 0.5 1.0-2.0 >/= 4.0 
Moxifloxacin </=0.5 1 >/= 2.0 
Tetracycline </=4 8 >/=16.0 
Trimethoprim/sulfamethoxazole </=2/38 N/A >/=4/76 
Gentamycin </=4 8 >/=16 
Cefoxitin </=4 N/A >/=4 
Oxacillin </= 0.25 N/A >/=0.5 
Quinupristin/dalfopristin </=1 2 >/=4 
Minocycline </=4 8 >/=16.0 
Nitrofurantoin </=32 64 >/=16 
Rifampin </=1 2 >/=4 
Linezolid </=4 N/A >/=8 
Daptomycin </=1 N/A N/A 
Vancomycin </=2 4.0-8.0 >/= 16 
Table 3S.1. Minimum inhibitory concentration (MIC) cut-off values for antibiotic 









anti-SCIN IgA       anti-SCIN IgG 
   









Ages 7-18 (N=147) 2.64 2.54 2.74 Ages 7-18 (N=148) 2.90 2.81 2.99 
Ages 19-29 (N=76) 2.95 2.85 3.06 Ages 19-29 (N=76) 3.35 3.27 3.44 
Ages 30-39 (N=126) 3.09 3.02 3.17 Ages 30-39 (N=126) 3.20 3.12 3.28 
Ages 40-49  (N=55) 2.98 2.86 3.11 Ages 40-49  (N=56) 3.34 3.23 3.44 
Ages 50-82 (N=47) 3.05 2.93 3.18 Ages 50-82 (N=45) 3.07 2.94 3.20 
anti-ClfA IgA 
   
anti-ClfA IgG 
   









Ages 7-18 (N=147) 2.38 2.27 2.49 Ages 7-18 (N=147) 2.58 2.49 2.69 
Ages 19-29 (N=76) 2.64 2.53 2.76 Ages 19-29 (N=76) 2.95 2.85 3.04 
Ages 30-39 (N=126) 2.81 2.72 2.90 Ages 30-39 (N=126) 2.89 2.80 2.98 
Ages 40-49  (N=55) 2.68 2.54 2.83 Ages 40-49  (N=56) 2.83 2.69 2.97 
Ages 50-82 (N=47) 2.79 2.66 2.93 Ages 50-82 (N=45) 2.66 2.48 2.84 
anti-AT IgA 
   
anti-AT IgG 
   









Ages 7-18 (N=147) 2.48 2.42 2.54 Ages 7-18 (N=147) 3.30 3.23 3.37 
Ages 19-29 (N=76) 2.74 2.67 2.81 Ages 19-29 (N=76) 3.56 3.47 3.65 
Ages 30-39 (N=126) 2.79 2.73 2.85 Ages 30-39 (N=126) 3.59 3.52 3.66 
Ages 40-49  (N=55) 2.68 2.59 2.76 Ages 40-49  (N=56) 3.55 3.43 3.68 
Ages 50-82 (N=47) 2.68 2.58 2.78 Ages 50-82 (N=45) 3.49 3.37 3.62 
Table 3S.2. Age and OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG antibody 
levels. The geometric mean of log transformed MFI values and 95% confidence within 
each age bin are shown for oral fluid anti-SCIN, anti-ClfA, and anti-AT IgA and IgG 
antibodies. For each IgA and IgG target, each age bin was compared to the Ages 7-18 
(minor) age bin using a generalized linear model, adjusted for within participant 
clustering. Bolded values display a significant trend towards elevated MFI values 






Table 3S.3. Nasal carriage of S. aureus and OF anti-SCIN, anti-ClfA, and anti-AT 
IgA and IgG antibody levels after exclusion of IHO-derived S. aureus 
subpopulations. Beta coefficients and 95% confidence intervals were estimated using 
generalized linear models adjusted for age and within participant clustering. MDRSA = 
multidrug-resistant S. aureus; Tet[R]-S. aureus = tetracycline-resistant S. aureus; LA-S. 























Workers and Adults 
  








MDRSA carriage events excluded         
SCIN 
Non-carrier 170 REF 171 REF 
S. aureus carriage 78  -.056 (-.210, .099) 77  -.004 (.148, .139) 
ClfA 
Non-carrier 170 REF 171 REF 
S. aureus colonized 78  -0.026 (-.184, .131) 77 0.109 (-.054, .272) 
AT 
Non-carrier 170 REF 171 REF 
S. aureus colonized 78 0.078 (-.044, .201) 77 .082 (-.040, .203) 
Tet[R]-S. aureus carriage events excluded         
SCIN 
Non-carrier 170 REF 171 REF 
S. aureus colonized 80 .012 (-.135, .158) 79 .000 (-.123, .124) 
ClfA 
Non-carrier 170 REF 171 REF 
S. aureus colonized 80 .048 (-.102, .198) 79 .081 (-.061, .224) 
AT 
Non-carrier 170 REF 171 REF 
S. aureus colonized 80 0.031 (-.091, .153) 79 .071 (-.040, .183) 
LA-S. aureus carriage events excluded         
SCIN 
Non-carrier 170 REF 171 REF 
S. aureus colonized 58 0.015 (-.159, .189) 58  .031 (-.114, .176) 
ClfA 
Non-carrier 170 REF 171 REF 
S. aureus colonized 58 .045 (-.131, .222) 58 .118 (-.046, .283) 
AT 
Non-carrier 170 REF 171 REF 







  Salivary IgA  Salivary IgG 
  
N 





MDRSA carriage events excluded         
SCIN 
Non-carrier 133 REF 134 REF 
S. aureus carriage 65  -0.06 (-.238, .118) 64  -.015 (-.172, .142) 
ClfA 
Non-carrier 133 REF 134 REF 
S. aureus colonized 65 0.013 (-.158, .183) 64 0.128 (-.045, .300) 
AT 
Non-carrier 133 REF 134 REF 
S. aureus colonized 65 0.058 (-.077, .192) 64 0.076 (-.057, .209) 
Tet[R]-S. aureus carriage events excluded         
SCIN 
Non-carrier 133 REF 134 REF 
S. aureus colonized 68 .011 (-.154, .175) 67 .005 (-.133, .143) 
ClfA 
Non-carrier 133 REF 134 REF 
S. aureus colonized 68 .079 (-.081, .239) 67 .135 (-.016, .286) 
AT 
Non-carrier 133 REF 134 REF 
S. aureus colonized 68 .021 (-.118, .159) 67 .068 (-.050, .186) 
LA-S. aureus carriage events excluded         
SCIN 
Non-carrier 133 REF 134 REF 
S. aureus colonized 48 .015 (-.179, .210) 48 .054 (-.113, .222) 
ClfA 
Non-carrier 133 REF 134 REF 
S. aureus colonized 48 .077 (-.111, .265) 48 0.196 (.016, .377)* 
AT 
Non-carrier 133 REF 134 REF 















MDRSA carriage events excluded         
SCIN 
Non-carrier 37 REF 37 REF 
S. aureus carriage 13  -0.045 (-.343, .252) 13  .067 (-.280, .415) 
ClfA 
Non-carrier 37 REF 37 REF 
S. aureus colonized 13  -.212 (-.567, .143) 13  .054 (-.386, .494) 
AT 
Non-carrier 37 REF 37 REF 
S. aureus colonized 13 0.146 ( -.153, .446) 13 0.124 (-.180, .428) 
Tet[R]-S. aureus carriage events excluded         
SCIN 
Non-carrier 37 REF 37 REF 
S. aureus colonized 12  -.011 (-.344, .322) 12  -.018 (-.308, .272) 
ClfA 
Non-carrier 37 REF 37 REF 
S. aureus colonized 12  -.128 (-.493, .236) 12  -.164 (-.506, .178) 
AT 
Non-carrier 37 REF 37 REF 
S. aureus colonized 12 .032 (-.167, .230) 12 .107 (-.217, .430) 
LA-S. aureus carriage events excluded         
SCIN 
Non-carrier 37 REF 37 REF 
S. aureus colonized 10 .010 (-.368, .387) 10  -.052 (-.350, .246) 
ClfA 
Non-carrier 37 REF 37 REF 
S. aureus colonized 10  -.085 (-.500, .331) 10  -0.220 (-.558, .119) 
AT 
Non-carrier 37 REF 37 REF 
S. aureus colonized 10 .011 (-.209, .232) 10 .101 (-.245, .446) 
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Figure 3S.1. Scatter plot of age vs. OF anti-SCIN, anti-ClfA, and anti-AT IgA and 
IgG antibody levels with lowess curves. A). Salivary anti-SCIN IgA, B). Salivary anti-
ClfA IgA, C). Salivary anti-AT IgA, D). Salivary anti-SCIN IgG, E). Salivary anti-ClfA 
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 The dissemination of LA-S. aureus from IHOs into human populations, and 
human infection with multidrug-resistant LA-S. aureus, pose urgent public health 
concerns. The intensive use of antimicrobials in food animal production strongly suggests 
that pigs raised on IHOs are the source of occupational and community exposure to 
multidrug-resistant LA-S. aureus.44  The objectives of this dissertation were to conduct 
research aimed at filling knowledge gaps in our understanding of the global and regional 
transmission dynamics of LA-S. aureus, the relative pathogenicity of LA-S. aureus 
compared to epidemic SSTI CA-MRSA strains, and novel non-invasive immunological 
biomarkers of S. aureus colonization and infection among IHO workers.    
 The research outlined in this dissertation addressed these critical knowledge gaps. 
In Chapter 1, a WGS and phylogenetic-analysis was conducted on a representative subset 
of LA-S. aureus CC9 isolates collected from IHO pigs, IHO workers, IHO worker 
household contacts, and community residents with no known exposure to livestock, 
aimed to elucidate the population structure of LA-S. aureus CC9, and to provide evidence 
of transmission of LA-S. aureus CC9 between IHO pigs and humans in NC, USA. 
Chapter 1 also examined the role of acquired antimicrobial resistance in pig-human 
transmission of LA-S. aureus CC9. In Chapter 2, in vivo animal studies were conducted 
to compare the relative pathogenicity of LA-S. aureus strains commonly contracted by 
IHO workers in the USA to highly pathogenic epidemic CA-MRSA SSTI strains in a 
mouse model of SSTI, and the innate-immune response in LA-S. aureus vs. CA-MRSA 
infected mice. Finally, Chapter 3 of dissertation demonstrated successful development 
and application of an OF multiplex S. aureus-specific antibody-based immunoassay to 
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investigate biomarkers of S. aureus colonization and infection among IHO workers and 
their household contacts in NC, USA.        
Research conducted in this dissertation contributed significantly to our 
understanding of transmission dynamics of LA-S. aureus between IHO pigs and humans, 
the relative pathogenicity of LA-S. aureus commonly contracted by IHO workers 
compared to highly pathogenic epidemic CA-MRSA SSTI strains, and biomarkers of 
early biological effect in response to S. aureus exposure among IHO workers. Taken 
together, the research provided in this dissertation suggested that: 
1. Clonal expansion of LA-S. aureus CC9 in the USA is distinct from those of 
European and Asian LA-S. aureus CC9 lineages.  
2. LA-S. aureus CC9 can be transmitted between IHO pigs and humans, and two 
factors—a  multidrug-resistant phenotype and a significantly-increased number of 
acquired AMR genes—are associated with pig-human transmission clusters. 
3. LA-S. aureus CC398 and CC9 commonly contracted by IHO workers display an 
equivalent or greater degree of pathogenicity compared to CA-MRSA USA300 
clone, SF8300, in a mouse model of SSTI.  
4. Oral fluid (OF) IgA and IgG antibodies directed against ClfA, in particular, may 
serve as non-invasive biomarkers of S. aureus colonization, and oral fluid IgA 
antibodies directed against ClfA and SCIN may serve as non-invasive biomarkers 
of S. aureus SSTI among IHO workers.  
Prior to this dissertation, LA-S. aureus in the USA had largely been studied in the 
context of occupational exposure,9,14,15,17 with some stakeholders asserting that 
community exposures are benign. This dissertation strongly suggests that LA-S. aureus 
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should be considered more than a benign exposure, and rather as a potential health hazard 
of broader public health concern. This dissertation is the first research study, to our 
knowledge, to show that multidrug-resistant LA-S. aureus can be transmitted between 
IHO pigs, IHO workers, and community residents who reported no exposure to livestock, 
suggesting this health hazard is not limited to the occupational setting. This is especially 
concerning, considering that isolates implicated in pig-human transmission were enriched 
with multiple determinants conferring resistance to antibiotics that are critically important 
for human health.72 Contrary to previous claims that LA-S. aureus are less pathogenic 
than typical HA- and CA- S. aureus strains,12,19–22 this dissertation provided in vivo 
evidence that LA-S. aureus are not only pathogenic, but display increased pathogenicity 
and fitness-for-survival compared to highly pathogenic epidemic CA-MRSA SSTI strains 
(i.e. USA300 clone, SF8300).37 Finally, in contrast to previous claims suggesting that 
LA-S. aureus display a reduced capacity for human colonization,21,22 this dissertation 
showed elevated IgA and IgG antibody levels against ClfA in OF collected from IHO 
workers positive for S. aureus nasal carriage outcomes, especially MDRSA and tet-[R]-S. 
aureus nasal carriers compared to non-carriers. Elevated antibody levels against ClfA is 
an early biological effect indicative of colonization of the nasal mucosa with S. aureus,99 
suggesting that nasal carriage of S. aureus among IHO workers is not merely transient 
contamination but true colonization of the nasal mucosa.    
To protect the U.S. public from exposure, colonization, and infection with IHO-
derived multidrug-resistant LA-S. aureus, this dissertation highlights the importance for 
future research of effective interventions that can prevent the expansion and transmission 
of multidrug-resistant LA-S. aureus in human populations. Preventative interventions 
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should be designed to mitigate IHO production practices that promote the expansion of 
multidrug-resistant LA-S. aureus, namely the intensive use of antibiotics. The results of 
this dissertation are immediately applicable to on-going community and worker health 
hazard concerns63 regarding harmful IHO-related exposures, such as the acquisition of 
multidrug-resistant LA-S. aureus in NC and other regions of the USA that have a high 
density of IHOs. Furthermore, this dissertation provides non-invasive immunological 
biomarkers of S. aureus colonization and infection that may improve longitudinal 
surveillance of S. aureus outcomes in IHO worker populations and susceptible subgroups 













This dissertation is foundational to several important areas of future research. In 
this dissertation we rooted our high-resolution phylogenetic tree at the midpoint, and are 
therefore unsure if the most ancestral clade of LA-S. aureus CC9 is of human or animal 
origin. By testing multiple outgroups in the analysis provided in Chapter 1, an inference 
on the most ancestral clade and directionality of transmission of LA-S. aureus CC9 
between IHO pigs and humans in could be provided. Regarding the evolutionary history 
of LA-S. aureus CC9, this is a research question of critical importance, and an important 
pursuit for future research. Furthermore, our collection of S. aureus from IHO pigs from 
NC, USA was limited, and a more comprehensive WGS dataset may reveal 
intercontinental spread and additional pig-human transmission clusters of LA-S. aureus 
CC9. Future studies aimed to understand transmission dynamics of LA-S. aureus 
between IHO pigs and humans may consider to include a well-represented collection of 
IHO pig LA-S. aureus isolates. In Chapter 2 of this dissertation, the pathogenicity of only 
three LA-S. aureus isolates was compared to the referent CA-MRSA SF8300 isolate. 
Previous research has established a diversity of mobile genetic elements (MGEs) carried 
by different LA-S. aureus strains.100 Considering that MGEs of S. aureus can encode for 
important virulence factors in S. aureus pathogenesis, and that closely related isolates of 
S. aureus may display differences in pathogenicity, future studies should compare 
multiple isolates of each LA-S. aureus lineage to make confident lineage related 
conclusions about the relative pathogenicity of LA-S. aureus. In Chapter 3 of this 
dissertation, the cohort of IHO workers and their household contacts included only 12 
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individuals with a self-reported recent SSTI. Although this chapter began to examine 
relationships between OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG antibody levels 
and self-reported SSTI, the analysis suffered due to the small number of self-reported 
SSTI’s. To develop biomarkers of S. aureus SSTI, which has applicability in 
occupational as well as community and hospital settings, future studies should be 
designed to collect matched serum and OF samples at acute and convalescent time points 
following culture-confirmed S. aureus SSTI. In future S. aureus antibody biomarker 
development studies, the list of S. aureus antigens should be expanded for discovery of 
additional antigen-specific antibody-based OF biomarkers. Furthermore, antigen-specific 
antibody-based OF biomarkers for S. aureus should be developed into point-of-use assays 
that could facilitate minimally invasive, rapid, and user friendly testing outputs that could 
be integrated into occupational health and safety and community health surveillance 











MISCELLANEOUS METHODS AND RESULTS 
Miscellaneous Methods 
Illumina Sequencing datasets.  
 Quality of sequence data was determined based on two criteria: 1). Genome size 
at 25x of depth (i.e. coverage) and 2). percent of reads unclassified or classified as non-S. 
aureus (i.e. contamination). Only isolates with at least 2,000,000 bp’s of length at 25x of 
depth, and no greater than 10% of reads classified as contaminated or unclassified, were 
included in the dataset for phylogenetic analysis.  
Average pairwise SNP-distances.  
 Average pairwise SNP-distances and 95% CI were estimated for each 
transmission cluster and the IHO pig cluster in the high-resolution phylogeny. Average 
pairwise SNP-distances were calculated using the bestsnp.tsv SNP matrix output of the 
NASP pipeline,48 following removal of recombinant tracks of DNA.51   
Growth curves for SF8300, NCHW8, IHW398-1, IHW398-2, and NCHW9 isolates. 
S. aureus strains were streaked onto tryptic soy agar plates and grown overnight.  
Single colonies were selected and grown in tryptic soy broth (TSB) at 37°C in a shaking 
incubator overnight, shaking at 240 rpm and then sub-cultured at a 1:50 dilution in TSB.  
At 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, and 4.5 hours, 100 µL of the sub-cultures were pipetted 
onto a 96-well plate and absorbance (600 nm) was read with a Synergy H1 Hybrid 
Microplate Reader (BioTek Instruments, Inc., Winooski, VT).  
Candidate S. aureus antigens with references. 
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 An extensive literature review was conducted to determine candidate S. aureus 
antigens that show potential as biomarkers of S. aureus colonization and infection. The 
literature review focused on antigen-specific antibody-based biomarkers of S. aureus 
colonization and infection. Antigens were considered candidate biomarkers if they were 
being used in a vaccine currently undergoing clinical trials, if previous studies have 
suggested considerable immunogenicity of the antigen in humans, or if previous studies 
have established that the antigen can serve as a biomarker of S. aureus colonization or 
infection.   
Coupling confirmation for S. aureus antigen xMap™ beads using pre- and post- 
infection mouse serum. 
Five (5) unique S. aureus antigen-coupled bead sets were prepared initially. 
Briefly, Staphylococcal Complement Inhibitor (SCIN), Clumping Factor A (ClfA), 
Clumping Factor B (ClfB), Alpha toxin (AT), and Beta toxin (BT) proteins were each 
covalently coupled to a unique magnetic microparticle bead set according to . Successful 
coupling of each bead set was confirmed using pre-infection (day 0), acute-phase (day 
14) and convalescent-phase (day 28) serum from mice intradermally inoculated with S. 
aureus. 1500 beads per bead set (SCIN, ClfA, ClfB, AT, BT) were incubated with 50ul of 
pre-infection, acute-phase, or convalescent-phase mouse sera, diluted 1:1000 in assay 
buffer (PBS with 0.05% Tween20 and 1% bovine serum albumin), for 1 hour on a plate 
shaker at 500 rpm. Beads were washed 3 times and then incubated with 50ul of PE-
labelled anti-mouse IgG diluted 1:100 in assay buffer for 1 hour on a plate shaker at 500 
rpm. Beads were washed again and then suspended in 100ul assay buffer. The 
fluorescence signal was measured on a Bio-Plex 200 instrument (Bio-Rad). Two (2) 
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blanks were included on each plate to subtract background, and ~10% of OF samples 
were tested in duplicate to determine intra-assay variability.    
Preliminary examination of 22 oral fluid samples using a 5-plex S. aureus 
immunoassay.  
 22 OF samples were initially selected to probe for IgA and IgG antibodies 
directed against SCIN, ClfA, ClfB, AT, and BT. All OF samples were selected from 
biweekly visit 8. 11 were selected from persistent S. aureus carriers (S. aureus positive 
nasal carriage at all 8 biweekly visits), and 11 were selected from S. aureus non-carriers 
(negative for S. aureus nasal carriage at all 8 biweekly visits). 10ul of the oral fluid 
supernatant was added to 40ul of assay buffer (PBS with 0.05% Tween20 and 1% bovine 
serum albumin) containing 1500 beads of each bead set (SCIN, ClfA, ClfB, AT, BT) per 
microplate well. The plate was covered and incubated at room temperature for 1 hour on 
a plate shaker at 500 rpm. Beads were washed 3 times and then incubated with 50ul of 
PE-labelled anti-human IgA diluted 1:100 in assay buffer for 1 hour on a plate shaker at 
500 rpm. Beads were washed again and then suspended in 100ul assay buffer. The 
fluorescence signal was measured on a Bio-Plex 200 instrument (Bio-Rad). The same 
process was repeated, but using PE-labelled anti-human IgG diluted 1:100 for the 
secondary incubation. Two (2) blanks were included on each plate to subtract 
background, and ~10% of OF samples were tested in duplicate to determine intra-assay 
variability. Average MFI, and 95% confidence intervals, were calculated for each 
antigen-specific antibody target stratified by S. aureus carrier status (persistent vs. non-
carrier). The average MFI for each antigen-specific antibody target among persistent 
carriers was compared to that of non-carriers using a students t test.  
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Correlation between OF IgA and IgG antibody levels against SCIN, ClfA, and AT.  
Spearman correlation coefficients were generated to assess the relationship 







Miscellaneous Results  
High quality whole genome sequencing datasets were included in phylogenetic 
analyses. 
 Isolates were included in the dataset for phylogenetic analysis if they had a 
coverage of greater than 2,000,000 bp at 25x of depth, and minimal percentage of 
contamination or unclassified reads. 49 MLST confirmed LA-S. aureus CC9 genomes 
were sequenced at an average depth of 65.76x (SD = 27.66), using the 2,815,299 base 
IHOW6 chromosome as a reference (Table 1M.1). Less than 10% of reads were 
unclassified for all isolates included in the dataset (Table 1M.1).  
Average pairwise SNP-distances for transmission cluster and IHO pig cluster isolates 
in the high-resolution phylogeny.  
The average pairwise SNP-distance between IHO-pig cluster isolates was 24 
SNP’s (95% CI: 19.33, 28.67), and the average pairwise SNP-distance between 
transmission cluster isolates was 24.6 SNP’s (95% CI: 23.2, 25.9) and 10.8 SNP’s (95% 
CI: 6.67, 14.93) (Table 1M.2). These results showed that transmission clusters displayed 
a high degree of phylogenetic relatedness between IHO pig and human LA-S. aureus 
CC9 isolates.  
Growth curves for SF8300, NCHW8, IHW398-1, IHW398-2, and NCHW9 isolates. 
 No significant differences were observed between the optical densities of any S. 
aureus strain at any time point (Figure 2M.1). These growth curves established two (2) 
critical pieces of information: 1). CA-MRSA and LA-S. aureus do not differ in growth 
kinetics in vivo, and 2). The mid-logarithmic phase time point for each S. aureus strain 
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(2.5 hours). These results are summarized in the Chapter 2 main text, but the figure 
detailing growth curve results is provided only in the Miscellaneous Methods and Results 
section.   
Candidate S. aureus antigens. 
 Fourteen (14) S. aureus candidate antigens were identified through literature 
search (Table 3M.1), composed of S. aureus proteins playing a role in 
colonization/adhesion, immune evasion, or infection/toxicity. Five (5) of these antigens 
were selected for further development into a multiplex S. aureus immunoassay for 
application in OF samples.  
Coupling confirmation for S. aureus antigen xMap™ beads using pre- and post- 
infection mouse serum. 
The 5-plex S. aureus immunoassay was used to probe pre-infection, acute-phase 
(14 days post-infection), and convalescent-phase (28 days post-infection) mouse sera 
from 5 different groups of mice, each infected with a different S. aureus strain. Serum 
IgG antibody levels against ClfA, ClfB, AT, and BT were, in general, elevated in acute-
phase and convalescent-phase serum samples compared to pre-infection samples (Figure 
3M.1). Serum IgG antibody levels against SCIN were very low (Figure 3M.1), likely due 
to the inactivity of SCIN in a mouse model. Elevated mouse serum IgG antibody levels 
against ClfA, ClfB, AT, and BT at 14 and 28 days post-S. aureus infection confirms that 
each bead set was successfully covalently coupled to its respective S. aureus antigen. 
These results are summarized in the Chapter 3 main text, but no figure is provided in 
Chapter 3.   
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Preliminary association between S. aureus nasal carriage status and oral fluid IgA and 
IgG antibody levels against SCIN, ClfA, ClfB, AT, and BT. 
 22 OF samples were probed for IgA and IgG antibody levels against SCIN, ClfA, 
ClfB, AT, and BT. IgA antibody levels against ClfA and BT were significantly elevated 
among persistent S. aureus nasal carriers compared to non-carriers (p < .05) (Table 
3M.2). No antigen-specific IgG antibodies were significantly elevated among persistent 
S. aureus nasal carriers compared to non-carriers. These results informed the decision to 
include the ClfA coupled-bead set in the research outlined in Chapter 3. 
Correlation between OF IgA and IgG antibody levels against SCIN, ClfA, and AT.  
To determine whether OF IgA and IgG levels were correlated, we compared OF 
IgA and IgG antibody levels for each antigen specific target (SCIN, ClfA, and AT). In 
general, OF anti-SCIN, anti-ClfA, and anti-AT IgA and IgG levels were well correlated 
(anti-SCIN: r= .4449, p =.000; anti-ClfA: r= .4279, p = .000; anti-AT: r=.4385, p = 
.000) (Figure 3M.2). This dissertation does not expand further on the correlation between 
OF IgA and IgG antibody levels directed against S. aureus antigens. Future studies 
should consider the ratio of OF IgA to IgG antibody levels, and examine the relationship 








Table 1M.1. Quality metrics for whole genome sequencing datasets. 
Length_cov_base = length of S. aureus genome at 0x; Length_cov_comp = length of S. 

































































































































































CRA1 882765 867663 301 
Staphylococcus 
aureus G Staphylococcus 2.74 1 257.57 896,396 0 25 '2765507 2765507 0 124.5 49661 30486 47 1 
CRA2 1113048 1091955 301 
Staphylococcus 
aureus G Staphylococcus 1.81 1 274,988 952,606 0 25 2757757 2757757 0 163.7 52895 26265 21 0 
IHOC1 511597 499756 301 
Staphylococcus 
aureus G Staphylococcus 2.04 1 311,231 109,059 0 25 2755063 2755063 0 78.6 31937 18756 30 5 
IHOC2 578458 567002 301 
Staphylococcus 
aureus G Staphylococcus 1.67 1 316,727 111.58 0 25 2743445 2743445 0 91 73442 37203 43 1 
IHOC3 484525 473260 301 
Staphylococcus 
aureus G Staphylococcus 1.79 1 322,484 102,259 0 25 2771071 2771071 0 76.1 51623 30452 35 0 





Alteromonas 2.21 2 235,308 890,552 0 25 2742640 2742640 0 85.1 231352 127168 27 2 





Alteromonas 2.35 2 232,981 870,182 0 25 2749925 2749925 0 88.3 154222 70068 46 0 





Alteromonas 4.42 2 229,813 841,536 0 25 2745804 2710877 34927 42.5 107115 53464 38 1 





Alteromonas 1.88 2 333,195 145,306 0 25 2740697 2737728 2969 43.3 154603 65480 46 0 
IHOP4 396735 389055 301 
Staphylococcus 
aureus G Staphylococcus 2.17 1 346,538 119,191 0 25 2745162 2745162 0 63.2 55871 31448 32 0 
IHOP5 203301 198832 301 
Staphylococcus 
aureus G Staphylococcus 1.96 1 321,635 103,759 0 25 2738907 2738907 0 33 203063 130114 29 0 
IHOP6 527655 519279 301 
Staphylococcus 
aureus G Staphylococcus 1.69 1 317,605 107,689 0 25 2739847 2739847 0 83.8 68329 34324 36 0 





Alteromonas 4.1 2 235,098 891,131 0 25 2817867 2817867 0 59.2 150025 80023 47 0 





Alteromonas 5.51 2 233,557 869,022 0 25 2768557 2768557 0 62.8 224462 104813 41 0 





Alteromonas 5.86 2 234,232 874,311 0 25 2811983 2811983 0 67.2 138166 80064 51 2 





Alteromonas 2.28 2 346,448 155.35 0 25 2743441 2729429 14012 37.1 319158 130053 36 4 





Alteromonas 5.56 2 342,964 154,908 0 25 2750823 2750823 0 37.3 331706 127073 23 0 
IHOW11 441596 431371 301 
Staphylococcus 
aureus G Staphylococcus 3.32 1 321,851 107,149 0 25 2802081 2802081 0 68.3 49733 26080 32 2 





Alteromonas 1.58 2 337,982 145,396 0 25 2696642 2696642 0 33.5 280243 80855 48 2 
IHOW13 639189 629189 301 
Staphylococcus 
aureus G Staphylococcus 1.9 1 323.55 107,478 0 25 2698398 2698398 0 103.6 70350 52429 37 1 
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IHOW14 467277 457796 301 
Staphylococcus 
aureus G Staphylococcus 6.38 1 260,868 954,888 0 25 2746882 2737637 9245 64.2 151175 56167 49 0 





Alteromonas 1.76 2 339,341 150,972 0 25 2743605 2743605 0 37 379027 176212 20 0 
IHOW16 429757 419279 301 
Staphylococcus 
aureus G Staphylococcus 2.95 1 326,729 107,317 0 25 2706984 2706984 0 68.2 34719 16641 30 0 
IHOW17 478127 468565 301 
Staphylococcus 
aureus G Staphylococcus 2.2 1 330.86 110.72 0 25 2749045 2749045 0 76.6 73522 37203 35 2 





Alteromonas 2.16 2 331.09 135,468 0 25 2754547 2731782 22765 47.8 115689 53504 20 0 





Alteromonas 3.79 2 255,278 101,476 0 25 2743438 2743438 0 58.5 150675 68337 42 0 





Alteromonas 5.35 2 340,071 153,226 0 25 2768658 1778155 990503 34.1 152191 73314 40 0 
IHOW20 273655 267164 301 
Staphylococcus 
aureus G Staphylococcus 3.91 1 344,781 109,756 0 25 2788636 2788636 0 43.7 280149 114104 30 0 





Alteromonas 6.78 2 385,355 163,192 0 25 2750408 2750408 0 35.1 280243 124596 23 1 





Alteromonas 8.75 2 358.74 149.93 0 25 2785520 2785520 0 70.4 62372 34599 49 0 





Alteromonas 4.54 2 376,764 157,352 0 25 2713392 2713392 0 68.2 280185 151266 39 3 
IHOW24 416596 407283 301 
Staphylococcus 
aureus G Staphylococcus 4.25 1 343,042 111,839 0 25 2780690 2780690 0 66.3 76196 40769 46 0 





Alteromonas 3.99 2 261,923 107,755 0 25 2732208 2732208 0 44.8 162447 76810 50 0 
IHOW26 370219 362010 301 
Staphylococcus 
aureus G Staphylococcus 1.72 1 334,051 104,977 0 25 2744379 2744379 0 59.2 43386 26001 27 3 





Alteromonas 6.91 2 354,423 148,595 0 25 2713265 2663882 49383 34.2 305473 126029 29 0 





Alteromonas 10.04 2 350,546 159,731 0 25 2768059 2463604 304455 47.2 174526 85030 34 1 





Alteromonas 3.68 2 247,019 973,943 0 25 2730801 2730801 0 59.6 151223 63621 49 0 





Alteromonas 3.88 2 389,892 166,303 0 25 2751311 2701928 49383 34 283087 114580 19 0 
IHOW30 525369 514581 301 
Staphylococcus 
aureus G Staphylococcus 1.74 1 316,105 109,865 0 25 2742687 2742687 0 81.9 61854 36052 35 0 
IHOW31 970905 896350 102 
Staphylococcus 
aureus G Staphylococcus 2.42 1 430,573 634,584 0 25 2706863 2705294 1569 64.5 220083 73175 54 41 
IHOW32 3038210 2812586 102 
Staphylococcus 
aureus G Staphylococcus 3.63 1 423.15 685,722 0 25 2735008 2715140 19868 194.3 140824 61700 78 41 
IHOW33 348971 338842 251 
Staphylococcus 
aureus G Staphylococcus 2.91 1 300,608 728,277 0 25 2822362 2822362 0 55.1 297424 114117 28 0 
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IHOW34 551014 541521 301 
Staphylococcus 
aureus G Staphylococcus 1.65 1 269,602 100.51 0 25 2752608 2752608 0 80.2 65342 38056 50 0 
IHOW4 644311 635408 301 
Staphylococcus 
aureus G Staphylococcus 1.64 1 293.43 946,233 0 25 2748653 2748653 0 99.9 50636 31071 31 2 
IHOW5 360246 340228 301 
Staphylococcus 
aureus G Staphylococcus 5.73 1 349,383 136.19 0 25 2796134 2796134 0 56.6 20883 12645 43 5 
IHOW6 748398 715835 301 
Staphylococcus 
aureus G Staphylococcus 1.33 1 375,213 151,892 0 25 2758820 2758820 0 126.4 36934 20192 35 5 
IHOW7 547047 536337 301 
Staphylococcus 
aureus G Staphylococcus 1.7 1 275,267 930,832 0 25 2751044 2746545 4499 80.2 36235 21062 35 0 
IHOW8 316981 301339 301 
Staphylococcus 
aureus G Staphylococcus 2.62 1 368,033 165,973 0 25 2723580 2722285 1295 51 36377 19960 22 0 
IHOW9 557707 545857 301 
Staphylococcus 
















IHO pig cluster 6  2-42 24 19.3-28.7 
 
Transmission  
cluster A 14  0-42 24.6 23.2-25.9 
 
Transmission 
cluster B 5  1-25 10.8 6.67-14.9 
 
Table 1M.2. Table of average pairwise SNP-distances by cluster in high-resolution 
phylogeny. The range of pairwise SNP-distances calculated for the IHO pig cluster was 
used to set a threshold for transmission and identify transmission clusters with 
intermingled IHO pig and human LA-S. aureus CC9 isolates separated by 42 SNP’s or 





































Table 3M.1. Table of candidate S. aureus antigens with references. Listed antigens 
are supported in prior literature as biomarkers of S. aureus colonization or infection. 









S. aureus antigens of known immunogenicity and role in pathogenesis 
Stage Antigen/Antibody 
Colonization 
Clumping factor A (ClfA)99 
Clumping factor B (ClfB)99 
Fibronectin binding protein A (FnbpA)123 
Fibronectin binding protein B (FnbpB)123 
Host defense 
evasion 
Staphylococcal complement inhibitor (SCIN)99 
Formyl peptide receptor-like inhibitory protein (FLIPr-L)123 
Staphylococcal superantigen-like protein 5 (SSL5)123 
Infection/toxicity 
Alpha hemolysin (Hla)27 
Beta hemolysin (Hlb) 
Panton-Valentine Leukocidin (PVL)124 
Staphylococcal enterotoxin A99,123 
Staphylococcal enterotoxin B99,123 












Mean (CI) Mean (CI) p-value 
   
 
n=11 n=11 
    
IgG 
      
anti-ClfA 3175.84 (494.78, 5856.89) 2994.66 (1083.22, 4906.09) 0.9036 
   
anti-ClfB 1664.34 (558.51, 2770.17) 2583.61 (1074.89, 4092.32) 0.2865 
   
anti-AT 11652.36 (6520.76, 16783.96) 11219.23 (6304.31, 16134.15) 0.8933 
   
anti-BT 13588.47 (6940.95, 20236) 12526.38 (6855.37, 18197.39) 0.7893 
   
anti-SCIN 6846.59 (2336.845, 11356.34) 6690.23 (2442.91, 10937.54) 0.9557 
   
       
IgA 
      
anti-ClfA 1002.773 (197.58, 1807.96) 167.14 (68.87, 265.40) 0.0327 
   
anti-ClfB 179.15 (38.73, 319.58)  117.8364 (30.73, 204.95) 0.4181 
   
anti-AT 572.47 (-30.08, 1175.028) 316.47 (69.99, 562.95) 0.3913 
   
anti-BT 1875. 16 (791.79, 2958.53) 753.85 (251.85, 1255.837) 0.0494 
   
anti-SCIN 1469.38 (365.06, 2573.70) 1146.34 (425.39, 1867.28) 0.5913 
   
 
       
Table 3M.2. Preliminary association between S. aureus nasal carriage status and 
oral fluid IgA and IgG antibody levels against SCIN, ClfA, ClfB, AT, and BT. 
Geometric means and 95% confidence intervals are provided for oral fluid IgA and IgG 
antibody levels against ClfA, ClfB, AT, BT, and SCIN. p values were estimated using a 
students t test, comparing the average antibody levels among carriers to that of non-
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Figure 2M.1. Growth curves for SF8300, NCHW8, IHW398-1, IHW398-2, and 
NCHW9 S. aureus isolates. No statistically significant differences were observed 
between OD600 of any S. aureus strain at any time point. Mid-logarithmic phase for all 
S. aureus strains determined to be 2.5 hours. Note. Black = SF8300; red = IHW398-1; 












Figure 3M.1. Coupling confirmation for S. aureus antigen xMap™ beads using pre- 
and post- infection mouse serum. Absolute MFI values are provided for each serum 
time point, for each S. aureus antigen target. Serum IgG levels against ClfA, AT, and BT 
were especially strong at 14 and 28 days post-infection. BT was not included in the S. 
aureus immunoassay described in Chapter 3 because it can be disrupted by prophage 
integration in humans55. A). Mouse serum anti-SCIN antibody levels; B). Mouse serum 
anti-ClfA antibody levels; C). Mouse serum anti-ClfB antibody levels; D). Mouse serum 
anti-AT antibody levels;  E). Mouse serum anti-BT antibody levels. All bead sets were 
run in multiplex (5-plex). Note. SCIN = staphylococcal complement inhibitor; ClfA = 
clumping factor A; ClfB = clumping factor B; AT = alpha toxin; BT = beta toxin; Day 0 
= pre-infection; Day 14 = acute-phase infection; Day 28 = convalescent-phase infection. 
SF8300 = serum from SF8300 infected mouse; IHW398-1 = serum from IHW398-1 
infected mouse; IHW398-2 = serum from IHW398-2 infected mouse; NCHW9 = serum 





























































































































Figure 3M.2. Correlation between OF IgA and IgG antibody levels against SCIN, ClfA, and AT with LOWESS curve. A). 
Correlation between OF anti-SCIN IgG and anti-SCIN IgA. B). Correlation between OF anti-ClfA IgG and anti-ClfA IgA. C). 
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resistant S. aureus in humans 
 Presented on research findings to scientific audiences and published 
research findings in peer-reviewed scientific literature 
 
MedStar Health Research Institute, Firefighters’ Burn and Surgical Research 
Laboratory (Washington, DC) 
Graduate research assistant; Advisor: Jeffrey W. Shupp, MD 
2010-2013 
Pathophysiologic basis of burn wound progression  
 Advanced in-vitro and in-vivo projects aimed at understanding MRSA 
infection and cutaneous burn-wound healing, the systems biology of infected 
burn-wound injury at the host-pathogen interface, and the role of microbiome 
in cutaneous wound healing. 
 
  
TEACHING EXPERIENCE  
Johns Hopkins Bloomberg School of Public Health (Baltimore, MD) 2016-2018 
 Graduate teaching assistant, Introduction to Public Health Emergency 
Preparedness 
 
National Science Foundation Teaching Fellow (Prince George’s County, MD) 2011 
 Physics instructor, Advanced Placement Physics, Eleanor Roosevelt High School  
Aston Language Center (Wuhu, China) 2011 
 English teacher for students in China  
  
RELATED PROFESSIONAL EXPERIENCE  
QIAGEN, Molecular Diagnostics (Frederick, MD) 2013-2015 
Associate Scientist  
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 Collaborated with large R&D division to design and develop cutting edge 
molecular diagnostic tools for clinical application 
 Successfully advanced DNA sequencing based diagnostic tools from 




AWARDS AND HONORS 
 The Johns Hopkins NIOSH Education and Research Center, Pilot Project Research Training 
Award; $10,000 (2015) 
 Johns Hopkins University Center for Global Health, Global Health Established Field Placement 
Award; $5,000 (2016) 
 Environmental Health and Engineering Student Pilot Project Award; $3,000 (2017) 
 Georgetown University, Academic Excellence Award (2013) 
 Georgetown University, Excellence in Biochemistry Internship (2013) 
 Werner H. Kirsten Student Intern Cancer Research Training Award (2008) 
 Maryland Distinguished Academic Scholar (2008) 
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